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Abstract 
Vitellogenin is a complex phosphoglycolipoprotein that is secreted into the 
bloodstream of sexually mature, female, oviparous animals in response to circulating 
estrogens. It is then incorporated into the ovaries by receptor mediated endocytosis, where 
it is further cleaved into smaller peptides which are constituents of the egg yolk proteins. 
It is generally accepted that these peptides serve as the main nutritional reserve for the 
developing embryo. 
Quantification of vitellogenin in blood is useful for different purposes. The 
reproductive status and degree of sexual maturation of oviparous animals can be assessed 
according to the levels of vitellogenin in plasma. The expression of this protein can also 
be induced in males under the effect of estrogenic compounds. Relying on this 
observation, some studies have used vitellogenin as a biomarker of environmental 
endocrine disruption in many species. 
The objective in this work was to develop a novel quantitative technique for 
measuring plasma levels of Atlantic salmon and rainbow trout vitellogenin using high 
performance liquid chromatography coupled to tandem mass spectrometry. These two 
species are of vital importance for the sustainable commercial fisheries and aquaculture 
activities in Atlantic Canada. 
To achieve this goal, the first step of this project consisted of a comprehensive 
characterization and partial sequencing of Atlantic salmon and rainbow trout vitellogenin. 
The initial approach employed both chemical and enzymatic digestions of vitellogenin 
coupled with tandem mass spectrometry, one of the most powerful techniques available 
for sequencing, identification and characterization of proteins. The information from 
these studies was then used to select a 'signature peptide' characteristic for both species. 
This peptide was used as a surrogate of the precursor protein for quantification purposes. 
A detailed account is given on all the technical features of the quantitative technique. 
Special attention was placed on the tuning and testing of this system, focusing on the 
recovery, specificity and sensitivity of the method. Additional characterization and 
11 
sequencing was also performed for Atlantic cod vitellogenin. The results obtained in this 
work allow this method to be considered as an alternative to existing immunological 
assays. 
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Chapter 1: Vitellogenin and the egg yolk proteins. Introduction and overview 
The work presented in this thesis will deal mainly with the nature of vitellogenin 
(Vtg), a complex phosphoglycolipoprotein, which is synthesized in the liver of all egg 
laying oviparous animals. As expected with any protein, structural and even functional 
differences are likely to be found among different species. In this particular work, a 
special focus was placed on rainbow trout (Oncorhynchus mykiss), Atlantic salmon 
(Salmo salar) and Atlantic cod (Gadus morhua) Vtg, although other species are 
occasionally mentioned whenever comparisons and analogies were considered relevant. 
In this chapter, an introduction to the egg yolk proteins is given for the purpose of 
placing the reader into the historical context that led to the discovery of Vtg. The 
subsequent sections describe the biochemical aspects of Vtg synthesis, together with a 
detailed description of its structural characteristics. 
Since its discovery, there has been a renewed interest in this protein, especially in 
the past decade when its use as biomarker was discovered. Moreover, in recent years, the 
use of this protein for assessing the sexual reproductive status of fish has been analyzed. 
Both of these issues are also discussed in this chapter. 
A critical element in the nature of this work involves the quantification of Vtg. 
Throughout the years, different techniques have been developed in pursuit of obtaining 
reliable quantitative values of this protein in blood plasma. The advantages and 
drawbacks inherent to many of these techniques are described in section 1.6. Once a 
broad idea of the topic has been introduced, the purpose and significance of this work is 
presented in the last section of this chapter. 
1 
Finally, many of the Figures and Tables described in thesis deal with protein and 
peptide amino acid sequences. The single letter amino acid code was usually used to 
express these sequences. Appendix 1 contains the complete protein amino acid list, 
together with the single and three letter amino acid codes. 
1.1 The egg yolk proteins 
The definition of the word 'yolk' according to the Third Edtion of the Oxford 
Dictionary of Current English is: 
Yolk: the yellow inner part of a bird's egg, which is rich in protein and fat and nourishes 
the developing embryo. 
This definition could easily be extended not only to birds, but in general to all 
oviparous animals. A microscopic look into the yolk unveils a granular constitution. 
These granules are large, membrane-bound, quasi-crystalline storage vesicles formed 
from the accretion of smaller pinocytic vesicles. As stated in the definition, the 
components of these granules are mainly proteins and lipids. The accumulation of this 
material and the mobilization of its constituents are vital requirements for the successful 
development of the embryo. 
It is important to remember that the eggs are essentially closed systems. This 
means that during embryogenesis, the yolk granules will be the only source of nutrients 
2 
and provide the raw materials necessary for the developing embryo, until the hatchlings 
are free to seek their own food. 
It should be noted that not all species produce 'yolky' eggs, as for example in the 
sea urchin. However, even in these species, small amounts of yolk-like proteins are 
present as reserve material. In these cases, eggs undergo quick development and hatch at 
an early stage. Much of the research on yolk proteins has been done on insects and a 
detailed description can be found in published reviews (Kunkel and Pan, 1976; Kunkel 
and Nordin, 1986). 
Vitellin is the generic name given to the protein constituents of the yolk granules. 
The origin of these proteins was a puzzle that took a couple of decades to be solved and 
the development of chromatography, electrophoresis and immunological assays played a 
critical role in unveiling this mystery. 
It is now widely accepted that the major precursors to the egg yolk proteins are the 
Vtg proteins synthesized in the liver of vertebrates and in the fat body cells of non-
vertebrates such as insects. The accumulation of Vtg in the blood of ovariectomized 
insects was a strong evidence that supported this idea in early Vtg studies (Telfer and 
Telfer, 1954). However, numerous studies in insects have also demonstrated that proteins 
similar to the Vtgs are synthesized in a number of ovarian cell types (Srdic et al., 1979; 
Jowett and Postlethwait, 1980; Brennan et al., 1982). 
The term vitellogenin was first coined in Pan et al. (1969), who refer to Vtg as the 
female specific proteins found in the blood of mature female insects. In this work, the 
female fat body of two insect species incorporated radio-labeled amino acids in vitro into 
substances which were precipitated by antibodies formed in response to the vitellogenic 
3 
blood proteins. This was not observed in the fat bodies of males or even females before 
the appearance ofthe Vtgs in blood (Pan eta/., 1969). 
It is not surprising that much of the initial research on the composition and 
function of the yolk granules and its precursors was done in birds and amphibians, 
probably due to the large amounts and ease of accessibility to the studying material. This 
work was carried out at the beginning of the 20th century. In this regard, the first clues 
indicating a relation between the sexual maturation and the appearance of changes in the 
serum profiles were obtained by experiments which demonstrated that calcium and 
phosphorus levels were increased in female fish during the egg-laying season (Miescher, 
1897; Hess eta/., 1928; Laskowski, 1935). Similar studies were demonstrated in frogs 
(Zwarenstein and Shapiro, 1933) and birds (Riddle and Reinhart, 1926; Hughes et a/., 
1927; Buckner et a/., 1930; Charles and Hogben, 1933). These changes in the blood 
components would seem obvious nowadays considering the high concentration of both 
elements present in the egg shell. 
Subsequent studies demonstrated that the same changes could be induced by the 
administration of estrogens (McDonald and Riddle, 1945). It was not until 1957, that 
changes in the serum protein concentrations were unexpectedly observed, while studying 
the effects of estradiol on calcium metabolism in goldfish (Bailey, 1957). This study 
showed that estradiol increased the concentration of calcium and phosphorus only in the 
non-ultrafilterable fraction, that is, the fractions bound to protein; changes which were the 
same as those found during the breeding season. However, the most remarkable 
observation was the concomitant increase in the total protein concentration in serum. At 
this time, it was hypothesized that most of the increase was due to an increase in 
4 
'vitellin', a protein believed to be synthesized in the liver and further deposited in the 
ovaries. This was the first evidence to support the idea that this particular protein was 
induced by the action of estradiol. Of course, at this time, the exact role and biochemistry 
of the sex hormones had not been completely elucidated. Interestingly, the results from 
this experiment were reproduced in both females and males; nevertheless this observation 
didn't catch the attention of the authors. As will be discussed later, this observation is one 
of the main pillars for the use of Vtg as an environmental biomarker for exposure to 
estrogenic compounds. 
Stronger evidence was being built at that time through a study made on English 
sole and Pacific halibut (Utter and Ridgway, 1965). An antigenic serum component 
whose presence was related to age, length and maturity in maturing female pleuronectids 
was detected by immunodiffusion techniques. The factor which had a qualitative seasonal 
variation for English sole had its highest incidence during the spawning season and the 
lowest at midsummer and was detected in all the mature female halibut sampled. The 
factor was also detected in the serum of some immature females of both species during 
the spawning season. Evidence associating the synthesis of this factor with the production 
of estrogenic hormones was obtained when 17~-estradiol was injected into male English 
sole and induced them to produce the factor. Interestingly, the word 'protein' was not 
used to describe this factor in the entire paper, since at that time, the nature of the 
described factor probably remained uncertain. 
In spite of all the previous experiments, it was not until 1973 that the hypotheses 
involving the sources of Vtg and its fate in fish were demonstrated and widely accepted 
(Aida et a/., 1973). This study proposed strong evidence that in maturing female Ayu 
5 
(Plecoglossus altivelis), female specific proteins formed outside the ovary, with the 
stimulation of 17~-estradiol, were incorporated into the oocyte with the commencement 
of vitellogenesis. Many of the early studies on the formation of yolk and differentiation in 
teleost fishes have been recompiled in a single book chapter (Ng and Idler, 1983). 
1.2 Vitellogenesis 
According to the latest literature, vitellogenesis is defined as the estradiol-induced 
hepatic synthesis of Vtg, its secretion and transport in blood to the ovary, and its uptake 
into maturing oocytes (Mommsen and Walsh, 1988; Tyler and Sumpter, 1996). This 
definition implies a series of sequential complex biochemical processes which must be 
individually analyzed in order to fully understand their significance. It should be noted 
that literature published prior to approximately 1970 use this term referring to the stage 
during oogenesis where accumulation of yolk occurs. An extensive list of comprehensive 
reviews on Vtg and vitellogenesis can be found in the literature (Tata and Smith, 1979; 
Kunkel and Nordin, 1986; Arukwe and Goksoyr, 2003b). 
Oocytes are the female ovarian cells that undergo meiosis to form eggs. They are 
derived from cells that develop from primordial germ cells that migrate into the ovaries 
early in embryogenesis. In female teleost fish, the oocytes in the ovary are arrested in the 
first meiotic prophase. Fertilization of these oocytes is only possible under hormonal 
stimulation, which results in the completion of the first meiotic division. At this stage 
6 
they are termed secondary oocytes; only after the second meiotic divisions they become 
mature eggs. 
In fish, oocyte post-ovulatory agemg is associated with egg quality decrease. 
During this period, eggs are held in the body cavity bathed in a semi-viscous liquid 
known as coelomic fluid whose components are suspected of playing a role in 
maintaining oocyte fertility and developmental competence. The rainbow trout (R T) 
coelomic fluid proteome has been studied during the egg quality decrease associated with 
oocyte post-ovulatory ageing. The results from this study suggest that egg protein 
fragments accumulate in the coelomic fluid during the post-ovulatory period and could 
be used to detect egg quality defects associated with oocyte post-ovulatory ageing (Rime 
et al., 2004). 
The developing oocyte is situated in the centre of the ovarian follicle. The external 
part of this structure consists of an inner sub layer known as the granulose cell layer, and 
an outer sublayer, one or two cells wide, called the theca. These sublayers are separated 
by a basement membrane. The interface between the oocyte and the granulosa cell layer 
consists of an acelular eggshell or zona radiata. The zona radiata has also been referred to 
as pellucid, vitelline membrane, zona pellucida, chorion, eggshell and vitelline envelope. 
The proteins which constitute the egg shell are also incorporated from a precursor 
synthesized in the liver known as the zona radiata proteins (also referred to as 
choriogenin). The formation of the vitelline envelope precedes the active uptake of 
vitellogenin during oocyte development in the RT (Hyllner et al., 1994). Similar results 
have been observed for Atlantic salmon (AS), where 'in vitro' and 'in vivo' experiments 
have demonstrated that zonagenesis precedes vitellogeneis (Celius and Walther, 1998). 
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The interior of the oocytes are filled with the yolk proteins during the oocyte 
development. These proteins are derived from the Vtgs, which are enzymatically cleaved 
into smaller components once incorporated inside the oocyte (Wallace, 1985). In RT the 
breakdown products ofVtg are known as lipovitelline proteins and phosvitin, a serine rich 
highly phosphorylated polypeptide. The different processes involved in the processing 
and mobilization of Vtg are not completely known, and according to literature, vary 
among species. 
The identification and characterization of the proteases involved in specific 
proteolysis of vitellogenin and yolk proteins in salmonids has been studied (Hiramatsu et 
al., 2002). A recent publication has demonstrated that in RT, certain enzymes like 
cathepsin B and lipoprotein lipase were over expressed exclusively during oogenesis 
while cathepsin D and cathepsin L were expressed constitutively throughout oogenesis 
and embryogenesis (Kwon et al., 2001). The difference in the temporal expression pattern 
observed in these and probably other proteolytic enzymes indicate the carefully organized 
regulation during the processing of the yolk proteins. Degradation of Vtg in sea urchins 
seems to proceed by similar enzymatic routes (Yokota and Kato, 1988). With respect to 
yolk protein hydrolysis and oocyte hydration, cytoplasmic maturation appears to be 
controlled by a change in the pH (Matsubara et al., 2003). 
Both the zona radiata proteins and Vtg are synthesized in the liver of the fish 
under the hormonal control of the hypothalamic-pituitary-gonadal-liver axis. The 
principal external factors that affect the endocrine regulation of the oocyte maturation in 
fish are probably water temperature and the photoperiod cycles, which trigger in the 
hypothalamus the release of the gonadotropin-releasing hormone. In response to these the 
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pituitary gland secretes the gonadotropin hormones (GtH I and GtH II), which are 
structurally related to the follicle-stimulating hormone (FSH) and the luteinising hormone 
(LH) found in humans. GtH I (FSH) is involved in vitellogenesis and zonagenesis while 
GtH II (LH) is related to oocyte maturation and ovulation. 
GtH I ultimately induces in the follicular cells the secretion of 17~-estradiol into 
the bloodstream. Testosterone is initially synthesized by the theca cells and is further 
transformed to 17~-estradiol in the granulose cells by the action of cytochrome P450 
aromatase (CYP19). Once exported to the blood, estradiol is transported to other organs 
by the sex-hormone binding protein, and is incorporated into the liver either by diffusion 
or receptor mediated uptake. According to a study, 17~-estradiol appears also to be 
regulated by the concentration of Vtg in the oocyte (Reis-Hemiques et a/., 1997). The 
dose-response relationships and pharmacokinetics of vitellogenin in RT after 
intravascular administration of 17a-ethynylestradiol have also been studied (Schultz et 
a/., 2001). 
Once inside the hepatocyte, estradiol initiates a long chain of biochemical events 
which finally results in the activation or enhanced transcription of the Vtg and the zona 
radiata protein genes. Firstly, 17~-estradiol is attached to a specific steroid-receptor, 
monomeric protein known simply as the estrogen-receptor. Vtg gene expression has been 
extensively studied in RT (Le Guellec eta/., 1988). 
In AS, the structural modulation of the hepatic chromatin in response to 17~­
estradiol induced activation of the vitellogenin gene regions has been described (von der 
Decken and Waters, 1993). Furthermore, the estrogen-controlled gene expression 
induction of two estrogen-responsive genes in the liver of RT have been determined 
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(Chen et a/., 1989). Similar gene expression studies have demonstrated that temperature, 
calcium concentrations and calcium antagonists modulate the responsiveness of the liver 
to 17~-estradiol (Yeo and Mugiya, 1997). Temperature seems to affect only the stages 
which are independent of 17~-estradiol or estrogen receptor concentrations (Mackay and 
Lazier, 1993). Many other studies have demonstrated that the estrogen receptor plays an 
important role in the presence of different endocrine disruptors (Anderson et al., 1996; 
Tollefsen et al., 2002; Latonnelle et al., 2002a; Bemanian et al., 2004), and these will be 
discussed later in the section which deals with Vtg as a biomarker. 
In the absence of ligand, the estrogen receptor is bound to the heat shock protein 
90 (hsp90). When 17~-estradiol binds to the receptor, the hormone-receptor complex 
undergoes dimerization, enters the nucleus and binds to the DNA at the estrogen 
responsive elements situated upstream from the constitutive Vtg transcription genes. A 
summary of all the events from the release of the pituitary gonadotropins to the final 
synthesis of Vtg DNA can be seen in Figure 1.1. Interestingly, a study performed on 
goldfish also demonstrated the induction of Vtg synthesis by massive doses of androgens 
(Hori et a/., 1979). 
Vitellogenin undergoes post-translational modification (PTM) by the addition of 
carbohydrate and phosphate functional groups to the amino acid backbone. Lipids are 
also incorporated into the protein, although evidence suggests that these are linked via 
non covalent bonding. Vtg also binds ions such as Ca2+ and Pol- to its molecule, serving 
as a major source of minerals to the developing oocyte. Early studies suggested that the 
female-specific serum proteins also had iron binding properties (Kunkel and Pan, 1976). 
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Figure 1.1 Scheme of the hypothalamic-pituitary-gonadal-liver axis 
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Furthermore, recent studies in different species suggest there might be a 
connection between retinol transport and Vtg (Lubzens et al., 2003; Sammar et al., 2005). 
Due to the complexity of Vtg, it would not be surprising to find in future studies, other 
lipid soluble vitamins and compounds present in this transport lipoprotein. 
Once exported from the liver, Vtg circulates in the bloodstream and reaches the 
ovaries, where it is incorporated into the growing oocyte through receptor mediated 
endocytosis. The ovarian uptake and processing ofVtg in RT has been thoroughly studied 
(Tyler et al., 1988; Tyler et al., 1991). The Vtg receptors are distributed on the oocyte 
plasma membrane clustered in clathrin-coated pits (Le Menn et al., 2000). Isolation and 
characterization studies of the RT Vtg receptors showed their molecular mass to be 
approximately 200kDa, probably comprising two 1 OOkDa subunits (Tyler and Lancaster, 
1993). These receptors also showed some affinity for Vtg of other species such as brown 
trout (Salmo trutta) and carp (Cyprinus carpio). 
Cloning and sequencing experiments performed on the receptors revealed strong 
homology with the low density lipoprotein receptor (LDLR) (Schneider, 1996; Brown et 
al., 1997b; Davail et al., 1998). The Vtg receptor contained a cluster of 8 cysteine-rich 
repeating units close to its amino terminal ligand binding domain, also observed in the 
LDLR. Also, the short intracellular portion contained the internalization signal typical of 
the LDLR superfamily, Phe-Glu-Asn-Pro-Val-Try. However,' 'in vitro'' translation ofthe 
cloned eDNA produced a 97kDa protein, contrary to 200kDa observed by previous 
experiments (Tyler and Lancaster, 1993). 
From an evolutionary point of view, the homology between the LDLR and the Vtg 
receptor strongly suggests that both have co-evolved from a common ancestor gene. 
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Interestingly LDLR is expressed not only in oviparous animals but in mammalian species 
also (Schneider, 1996). The Vtg receptor recognizes ligands that have similarities to 
structural elements found in the human apolipoproteins B-1 00 and E, as will be discussed 
below. 
Modem eDNA cloning techniques have also allowed the determination of the 
amino acid sequence of Vtgs corresponding to different species. No sequence is available 
for AC Vtg, while AS Vtg has been partially sequenced (Yadetie et al., 1999; Buisine et 
a/., 2002) and the complete amino acid sequence ofRT Vtg has been elucidated (Mouchel 
et a/., 1996; Goulas et a/., 1996; Trichet et a/., 2000). These published sequences are 
shown in Appendix 2. As discussed later in Chapter 5.1, the RT and AS Vtg sequences 
bear high homology with each other. Genomic studies have demonstrated the complex 
evolution of the Vtg genes in salmonid fishes. Phylogenetic trees constructed from Vtg 
sequences revealed conflicting nodes with the consensus tree based on morphological and 
anatomical data (Buisine et a/., 2002). A comparative study with other marine teleost 
fishes has shown other common properties among these species (Covens eta/., 1987). 
Atlantic salmon and RT Vtg also share regions of homology with other vertebrate 
Vtgs. However, their similarities with some mammalian proteins are even more striking. 
A sequence of approximately 670 amino acids located near theN-terminal region of Vtg 
is homologous to a similar sized region found in the same location of the microsomal 
triglycerol transfer protein (Shoulders et a/., 1993; Shoulders et a/., 1994) and the 
ApoBIOO of LDL (Baker, 1988a; Baker, 1988b; Babin eta/., 1995; Li et al., 2003). In 
LDL, this region is involved in lipoprotein assembly (Knott eta/., 1986). Surprisingly, it 
is not involved in receptor binding, in spite of the fact that both LDL and Vtg share the 
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same type of ligand receptors, as explained in the previous section. This task is performed 
by a region near the C-terminal part of ApoB 100, curiously absent in Vtg (Milne et al., 
1989). 
Additionally, a region of 150 ammo acids near the C-terminal region of Vtg 
resembles a cysteine rich D domain found repeatedly in the pro-von Willebrand factor 
(Baker, 1988a) and the intestinal mucine 2 glycoprotein. This domain plays an essential 
role in the polymerization of these two proteins into large oligomers, via the formation of 
disulfide bonds. Furthermore, the CGLC motif found within the D domains is also 
conserved in most vertebrate Vtgs. In the pro-von Willebrand factor, this sequence is 
required for multimer assembly (Mayadas and Wagner, 1992). In the case of Vtg, this 
suggests that the same region could be involved with protein interaction functions such as 
dimer formation, reception binding to oocytes, sequestration in transitional yolk bodies or 
assembly and accretion of the yolk granules. 
As observed from the homology studies, there seems to be much more to Vtg than 
just a nutritional reserve for the developing embryo. However, many of its functions are 
probably still to be discovered. 
1.3 Vitellogenin size and structure 
According to the literature, it IS generally accepted that Vtg is a 
phosphoglycolipoprotein. The structural differences found in this complex protein vary 
within different taxonomic classes. Vtg has been purified and characterized from a variety 
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of species ranging from sea urchins (Strongylocentrotus purpuratus) (Shyu eta/., 1987; 
Brooks and Wessel, 2004), nematodes (Spieth eta/., 1991), frogs (xenopus laevis) (Wiley 
and Wallace, 1981), goldfish (Carassius auratus) (De Vlaming eta/., 1980), coho salmon 
(Oncorhynchus kisutch) (Hara et a/., 1993), English sole (Pleuronectes vetulus) (Roubal 
et a/., 1997) to the exotic tuatara reptile (Sphenodon punctatus) (Brown et a/., 1997a). 
The main differences lie simply in the primary amino acid sequence, length and 
composition, although, as expected, evolutionary related species share many regions of 
conserved homology (Chen et a/., 1997). The post translational modifications observed in 
Vtgs of different species also vary considerably. 
Because Vtg is generally considered a reserve of raw materials for the developing 
embryo, its amino acid composition is considered to be an issue of particular interest. 
Some researchers have considered this composition to be in strict relation to the essential 
biochemical requirements of the developing embryo for each species. For example, 
insects do not require large amounts of Ca2+ and Pol- during embryogenesis, since bone 
synthesis is not necessary. Therefore, insect Vtg has not evolved as a major carrier of 
these ions. Conversely, vertebrate Vtgs contain a high number of serine residues which 
provide the sites necessary for phosphorylation and Ca2+ binding. 
Some authors have tried to compare the amino acid composition of Vtg in terms 
of providing useful information on the nutritional requirements during embryogenesis in 
different species (Hagedorn and Kunkel, 1979). One work demonstrated that lysine is 
present in relatively high levels (8.44-8.74%) in ocean pout (Macrozoarces americanus), 
lumpfish (Cyclopterus lumpus) and AC Vtg. The authors suggest that this information 
could be considered when formulating a starter diet for young marine fish of aquaculture 
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importance (Yao and Crim, 1996). However, other studies that compared insect Vtgs to a 
large number of purified and sequenced proteins showed no significant difference in the 
observed average amino acid composition (Hagedorn and Kunkel, 1979). This work 
provides an interesting example in which composition and structure, but not sequence, are 
being conserved. The authors propose that if the precise amino acid sequence is 
unimportant and is being loosely conserved by evolutionary selection, random mutation 
could arrive at an average protein composition through the redundancy of the genetic 
code which biases all mutations towards a predictable average amino acid composition 
(King and Jukes, 1969). This view, however, seems to contrast with the selective force 
that different animal groups have, according to their nutritional needs. The idea of Vtg as 
a source of nutrients has even led some researchers to develop a novel strategy for 
genetically engineering a yeast strain (Pichia pastoris) to constitutively produce 
recombinant Vtg for application as an enriched feed (Ding et al., 2004). The clones 
exhibited a significant increase in essential amino acids and long-chain polyunsaturated 
fatty acids, which are important for its application as a high-quality nutrient feed. 
The calculated molecular mass for RT Vtg according to the 1659 amino acids (See 
Appendix 2) obtained from cloning and sequencing experiments is approximately 182 
kDa. This value probably is an underestimate since it does not consider the additional 
mass corresponding to the post-translational modification. 
On the other hand, most of the values obtained for the molecular mass of the 
native Vtg protein have traditionally relied on chromatographic and electrophoretic 
techniques which have been readily available in the past decades. The first electrophoretic 
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patterns of blood serum proteins from RT were done nearly 40 years ago (Thurston, 
1967). 
Some of these techniques have been used in pursuit of obtaining purified Vtg 
(Wiley et a!., 1979). Nevertheless it is surprising to find in the literature so many 
contradictory results with respect to the molecular mass of a protein, even for reports on 
the same species. For that reason it is very important to consider the experimental 
conditions under which these experiments have been conducted. For example, the 
molecular mass of the RT Vtg has been reported by different research groups. An early 
study showed that RT Vtg had a molecular mass of around 600 kDa by size exclusion 
chromatography on a Sepharose column (Hara and Hirai, 1978). The same study reported 
a molecular mass of 220 kDa when analyzed by sodium dodecyl sulphate polyacrylamide 
gel electrophoresis (SDS-PAGE). Without much evidence, this work assumes Vtg to be a 
polymer of protein of molecular weight 220,000 Da bound with some lipids and 
carbohydrates, giving a molecule of molecular weight about 600,000 Da. 
A study performed some years later, also on RT Vtg (Campbell and Idler, 1980) 
reported a molecular mass of 440 kDa by size exclusion chromatography on a Ultrogel 
AcA 22 column, 470 kDa by gradient gel electrophoresis and 342 kDa by 
ultracentrifugation. Another study also reported a molecular mass of 440 kDa, but 
performed on a Sepharose 6B column. However, these authors state that molecular 
masses obtained from studies done on lipoproteins by gel chromatography should be 
viewed with caution since these types of biomolecules exhibit 'aberrant behaviour' on 
this type of separation media due to chemical interactions between this protein and the 
stationary phase. This was the first paper to propose the dimeric nature of RT Vtg .. 
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Further studies analyzed the molecular mass of Vtg by SDS-PAGE, obtaining values in 
the range of 170-180 kDa (Fremont and Riazi, 1988; Tyler, 1993; Silversand et al., 1993; 
Kwon et al., 1993; Folmar et al., 1995),. One of these studies still reported a molecular 
mass of 560 kDa when analyzed by different commercial size-exclusion chromatography 
media such as Sepharose CL6B, Biogel 1.5M, Sephacryl S300 and AcA 22 (Fremont and 
Riazi, 1988). In this contribution, the chromatographic profile was shown to be affected 
by the presence of Ca2+ in the mobile phase when AcA 22 was used as the stationary 
phase. One particular study was obtained from a culture of primary hepatocytes (K won et 
al., 1993), in contrast with all the previous experiments in which Vtg had been obtained 
from serum or plasma. Similar experiments, carried out by another research group 
developing a two-step method for purification of RT Vtg, reported the molecular masses 
to be 442 kDa and 240 kDa by gel chromatography (Supedex 200HR) and SDS-PAGE, 
respectively (Brion et al., 2000). 
The dimeric nature of Vtg was also suggested in a study while validating a 
competitive enzyme-linked immunosorbent assay (ELISA). An interesting observation 
made by this study was the discovery of not one, but two bands present on SDS-PAGE, 
which were confirmed to be Vtg by western blotting. The molecular masses associated 
with these bands were 393 and 176 kDa, which the authors link to the dimeric and 
monomeric form ofVtg, respectively. It is surprising that none of the previous works had 
ever noted the band at higher molecular mass in the same type of experiments (Bonet al., 
1997). The band observed at 393 kDa implies that the dimer was able to withstand the 
non-denaturing conditions of SDS performed in this experiment. These conditions might 
have not been met in the previous referenced studies. 
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The lowest molecular mass obtained by size exclusion chromatography was 383 
kDa. Interestingly, this group obtained 154 kDa by SDS-PAGE, also the lowest figure by 
this technique (Watts et al., 2003). 
This is just a fraction of the published literature which covers the characterization 
of intact RT Vtg. It is obvious, as stated previously, that the experimental conditions are 
critical for determination of the molecular mass of intact Vtg. However, even under the 
non-denaturing conditions employed for the different types of size-exclusion 
chromatography, the results obtained varied from 383 to 600 kDa. On the other hand, the 
results obtained from SDS-PAGE varied from 154 to 393 kDa. The denaturing conditions 
confered by the SDS disrupt the non-covalent interaction, thus, the protein looses its 
native secondary and tertiary structure, and any lipids non-covalently attached to it. There 
are some inherent causes that might explain the discrepancies within the same type of 
techniques. The limitation for accurately determining the band positions and the poor 
band resolution can probably account for some variability observed in the SDS-PAGE 
experiments, even in the order of 1 OkDa. 
Even greater differences were encountered in the size-exclusion chromatography 
experiments. The mass resolution for this technique is even lower than the SDS-PAGE. 
Furthermore, the differences reported indicate that certain interactions might have existed 
between the Vtg molecule and the stationary phases employed. 
What most research groups observed, independent of the techniques employed, 
was a disparity of results when comparing the molecular masses obtained in denaturing 
and non-denaturing conditions. Some authors suggest that this difference is only due to 
the dimeric nature of Vtg, which unfolds into subunits in denaturing conditions (Norberg 
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and Haux, 1985; Bonet al., 1997; Brion et al., 2000). In most of these experiments, mass 
calibration of size-exclusion chromatography was performed by relating the molecular 
masses of the standards to their elution volumes or times. Alternatively, a group working 
with winter flounder (Pleuronectes americanus) Vtg, used the same laboratory procedure, 
but made their calibrations by relating the Stokes radius (r = f I 61t11, where f stands for 
frictional coefficient and 11 for the viscosity) of their standards to the corresponding 
column partition coefficients. Based on their results, they also concluded that Vtg in 
serum exists as a dimer (Hartling et al., 1997). 
Other groups simply state that Vtg circulates as a polymeric protein, without 
specifying the number of subunits present (Hara and Hirai, 1978; Fremont and Riazi, 
1988). Nevertheless, a close inspection of their results reveals some intriguing facts. For 
example, the study that determined a native molecular mass of the RT Vtg to be 560 kDa 
by gel filtration, also determined that the monomer was 170 kDa by SDS-PAGE (Fremont 
and Riazi, 1988). However, the chemical analyses of Vtg showed that 79% of the native 
molecule corresponded to protein, 19% to lipids, 0.3% to carbohydrates and 0.7% to 
phosphate and calcium. The molecular mass does not agree with the proposal of a dimeric 
structure for Vtg, since the sum of both monomers is far from the mass obtained for the 
native Vtg, even with the addition of the non-protein components of the molecule. 
However, a trimeric situation is not convincing. 
Fewer studies have been carried out on AS Vtg. A publication referenced earlier 
(Watts et al., 2003) reported a molecular mass of 557 kDa for the native protein by size-
exclusion chromatography and a major band of 159 kDa by SDS-PAGE. Another study 
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reported a molecular mass of 495 and 520 kDa using gel chromatography and gradient gel 
electrophoresis, respectively. 
Atlantic cod Vtg is the least studied protein of the three species covered in this 
thesis. Its molecular mass was reported to be 485 and 167 kDa according to studies 
carried out by gel filtration and SDS-PAGE, respectively (Silversand et al., 1993; Yao 
and Crim, 1996). 
From the disparity of results obtained from various experiments carried out to 
determine the size and quaternary structure of Vtg, one can draw two conclusions: the 
techniques employed in different experimental conditions are difficult to reproduce and/or 
the heterogeneity exhibited by this particular protein is much higher than expected for the 
expression of a gene from a single species. Regardless, this shows that much light has yet 
to be shed on this matter. Similar situations can be recompiled from literature for other 
species. 
The biochemical and structural characteristics of Vtg not only depend on its 
primary structure, but also on its post translational modifications. Again, literature in this 
area is vast and overwhelming. In this case, the discrepancy might not only be due to 
analytical limitations, but to actual differences in the materials studied since some of the 
post translational modifications are known to be temporary signaling groups in the 
lifespan of a protein. 
The first studies focused on unraveling the biochemical complexity of RT Vtg 
were performed in the late 70's (Hara, 1976; Hara and Hirai, 1978) based on earlier 
studies performed on other species. One of these studies, using disc electrophoresis, 
confirmed the presence of lipids and carbohydrates by staining techniques with Sudan 
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BlackBand Schiff's reagent, respectively. A later study performed quantitative analyses 
on these components and discovered that the total lipid and phosphorus contents were 
21.5 and 0.6 % by weight, respectively. These values have been reproduced by other 
authors in subsequent publications (Norberg and Haux, 1985). The lipids in Vtg are non-
covalently attached to the protein component of the molecule and its content is likely to 
vary slightly, as with other lipoproteins. Even so, the lipid values are considerably lower 
than those found in other lipoproteins. For example, the normal lipid content values for 
RT VLDL, IDL, LDL and HDL are 95, 87, 70, and 55%, respectively (Babin and 
Vernier, 1989). This makes Vtg the molecule with the highest density among the 
lipoproteins (d > 1.210). 
A study that assayed the compositional analyses of the lipid fraction of RT Vtg 
reported the total lipid content to be 18%, phospholipids 11%, triglycerides 4% and 
cholesterol 2% of the total weight of the purified Vtg (Norberg and Haux, 1985). These 
values are very similar to those obtained by other researchers who also analyzed their 
distribution in the phospholipid classes, their fatty acid composition and the carbohydrate 
composition (Fremont and Riazi, 1988). A comparison of the lipid content in ocean pout, 
lumpfish and Atlantic cod seems to agree with those found in RT Vtg although the 
phosphorus content appears to be slightly lower in the latter (Y ao and Crim, 1996). 
Not much is known about RT Vtg regarding the carbohydrates moieties. Two 
consensus motifs for potential asparagine linked glycosylations at positions 1089 and 
1627 were found by sequence homology studies. More information on the Vtg 
oligosaccharides is available in insects (Kunkel and Nordin, 1986) and crustaceans 
(Khalaila et al., 2004). These studies indicate that most, if not all of their carbohydrate 
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content is present as high mannose type oligosaccharides. Since insect glycans do not 
contain sialic acid (Ng and Dain, 1976) it is improbable that complex types of 
oligosaccharides will be found. Also, experiments have shown a high micro-heterogeneity 
in the oligosaccharide fraction of newly secreted Vtg molecules, even within a single 
specimen. 
In contrast, the oligosaccharide moiety of the African clawed frog (Xenopus 
laevis) Vtg is a complex type glycan, linked to the protein via an N-glycosydic bond 
between an asparagine residue and N-acetlyglucosamine (Gottlieb and Wallace, 1982). 
The same authors have determined the mechanisms of Vtg phosphorylation in Xenopus 
laevis (Gottlieb and Wallace, 1981 ). 
X-ray crystallography and nuclear magnetic resonance (NMR) are two techniques 
that allow determination of the secondary and tertiary structures of proteins. Proteins 
must first be crystallized before they can be subjected to x-ray crystallography. Vtgs have 
not been amenable to this technique because researchers have not been able to obtain 
crystallized samples. The main reason for this is their varying amount of heterogeneous 
lipid. However, lipovitelline from lamprey was crystallized with a substantial portion of 
associated heterogeneous lipid (Meininger et al., 1984) and subjected to X-ray analysis. 
The visualization of the three dimensional image indicates that the protein is organized 
into a single domain with a large cavity enclosed by 3 anti-parallel ~-sheets and one 
helical domain. This cavity was proposed to be the lipid binding site of lipovitelline, 
which is probably conserved in Vtg. The preponderance of hydrophobic residues along 
the inner surface of this cavity supports its lipid binding nature. However, the total 
absence of electron-density for any bound lipid in this cavity leaves unanswered any 
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questions regarding their orientations and protein interactions. The structure also revealed 
two additional sites of ordered lipid molecules and an additional site for Zn2+ binding 
(Anderson et al., 1998). Some of the observations obtained from the X-ray 
crystallographic investigations have been confirmed by NMR studies (Banaszak and 
Seelig, 1982). The results of the 31 P and 2H NMR experiments correlated with the low-
resolution model of the crystalline lipovitellin complex obtained by diffraction studies. 
Such studies proposed that each subunit of lipovitellin contains a microdomain of 
phospholipid in a bilayer-like arrangement. 
Interestingly, the studies on the structure of Vtg have gone beyond any interest 
ever imagined by the initial researchers of this protein. The structural information derived 
from the x-ray crystallographic studies of lipovitellin have provided a model for the 
assembly and secretion of atherogenic lipoproteins (Mann et al., 1999). This work 
demonstrates that the structural and functional evolution of Vtg provides a unifying 
scheme for the invertebrate origins of the major vertebrate lipid transport system. 
1.4 Vitellogenin as a sexual maturation indicator 
Determining the reproductive status of caged and wild fish stocks is extremely 
important from various points ofview. For example, some species which are endangered 
due to natural predation or excessive fishing pressure exhibit an early onset of sexual 
maturation and increased frequencies of the reproductive cycle. This reaction can be 
interpreted as a response of the species to adverse survival conditions which would lead 
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to earlier spawning and higher chances to restore the fish population. Therefore, relating 
fish age to the onset of reproductive maturation is a good indicator of the selective 
pressure on that species, considering the reference values are known for each particular 
ecosystem. For example, the plasma Vtg levels during the annual reproductive cycle of 
the female RT has been established (Bon et al., 1997). These values oscillate between 0.5 
and 60 mg/mL during the reproductive cycle. These levels can be considered as reference 
values for mature females and used for comparison purposes. 
In aquaculture, a different situation is encountered. The objective of this 
commercial activity is to obtain large fish with a maximimum ratio of flesh to body 
weight. Therefore, it is expected for feed to be transformed to muscle synthesis with a 
high efficiency. High muscle content translates into increased commercial value given 
primarily by the fillet market. However, sexual maturation is an expensive metabolic 
process, where much of the food energy is transformed into the development of the 
gonads, especially in females where the fully grown gonads account for up to about 25% 
of the total weight of a mature fish. For this reason, it is very important to detect the onset 
of sexual maturation to determine the optimal slaughter time in terms of maximizing the 
profits. 
Thus, estimation of the sexual maturation is an important objective. Observation 
of increased gonad size is an obvious way to determine sexual status, although 
macroscopic changes are usually the last indicators. Microscopic histopathology is an 
earlier indicator, although both imply destructive techniques. More recently, invasive but 
non-destructive techniques have been proposed. Serum calcium, total phosphoprotein 
phosphorus and alkali-labile phosphoprotein phosphosphorus have been shown to 
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increase during vitellogenesis (Nagler et a!., 1987). Other studies additionally propose 
serum Mg levels to increase during this stage (Wiegand, 1982; Bjornsson et a!., 1986). 
All these parameters can be used as indicators of plasma Vtg levels (Arukwe and 
Goksoyr, 2003a). Alternatively, the hormones of the hypothalamic-pituitary-gonadal-liver 
axis can be measured. However, direct measurement of plasma Vtg levels seems to be the 
most appropriate indicator since it is the last in a series of biochemical pathways leading 
to sexual maturation. 
1.5 Vitellogenin as a biomarker 
Vitellogenin synthesis is induced by 17~-estradiol, the physiological ligand of the 
estradiol receptor in the liver of vertebrate oviparous animals. In invertebrates, this 
synthesis can occur in analogue tissues or organs such as the fat body of insects or the 
hepatopancreas of crustaceans. There are, however, other molecules that can interact with 
the estradiol receptor too, producing an agonistic effect on Vtg synthesis. These 
compounds are given the generic name of "xenoestrogens". The basic meaning of this 
word refers to any chemical foreign to that particular organism, which will have an 
estrogenic effect. Xenoestrogens are one of the many types of endocrine disrupters or 
modulators. These compounds affect not only wildlife, but also humans, as discussed in 
some publications (Toppari eta!., 1996; Damstra eta!., 2002a). 
The xenoestrogens originate from diverse sources, and can be classified on 
different bases. Some occur naturally in the environment, such as the phytoestrogens. 
26 
Others are of anthropogenic nature, chemically synthesized by humans and released into 
the environment by agricultural and industrial activities. It is common to find in literature 
other names that refer to this type of compounds, namely, environmental estrogens, eco-
estrogens, xenobiotic estrogens, environmental hormones, or hormone related toxicants, 
among others. 
The exact mechanism of action of the xenoestrogens is not completely understood 
although it is generally accepted that most of them act as estradiol mimics and trigger the 
cascade of biochemical events, such as Vtg synthesis. The zona radiata proteins are also 
altered by the presence of these compounds and its increased expression is also 
considered an important biomarker for environmental estrogens (Arukwe et al., 1997). 
However, other mechanisms of Vtg induction have also been proposed. In this respect, a 
study with nonylphenol suggested that this molecule is involved in a post-transcriptional 
regulation process (Ren et al., 1996). 
Other types of molecules also bind to the estrogen receptor producing an 
inhibition or antagonistic effect. These types of endocrine disruptors are named 
antiestrogens (Safe, 1995; Safe and Krishnan, 1995; Ahlborg et al., 1995). An example of 
this type of inhibitors is 2,3, 7 ,8-tetrachlorodibenzo-p-dioxin (TCDD). Presence of TCDD 
inhibits Vtg induction probably through the action of the aryl hydrocarbon receptor in 
complex with its nuclear translocator, and possibly by direct interference with the 
autoregulatory transcriptional loop of the estrogen receptor. In addition, 17~-estradiol 
does not interfere with TCDD induced CYP1A gene expression, suggesting that cross-
talk between the estrogen receptor and the aryl hydrocarbon receptor signaling pathway is 
unidirectional (Bemanian et al., 2004). Cadmium has also been discovered to inhibit Vtg 
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express10n and will be discussed later. Also, studies companng the ligand-binding 
properties of estrogen receptors to endogenous steroids and environmental estrogens have 
demonstrated similar affinities for both RT and AS (Tollefsen et al., 2002). 
As a result of exposure to xenoestrogens, Vtg is over-expressed in sexually mature 
females and in young immature females. Nevertheless, the most striking finding is that 
Vtg is also found circulating in blood of males exposed to either estrogenic hormones or 
xenoestrogens. Endogenous 17p-estradiol levels in males are usually undetectable, 
however, the biochemical machinery required to synthesize Vtg is readily available given 
the proper stimulation. 
For all these reasons, Vtg has been used as a biomarker for environmental 
xenoestrogens and measurement of Vtg plasma levels has consequently formed a central 
component of a wide spectrum of investigations. The values of plasma Vtg obtained when 
fish are exposed to xenobiotic estrogens depend on the nature of chemical, its 
concentration and the route of exposure. For example, a study on the estrogenicity of 
butylparaben in RT exposed via food and water showed Vtg values ranging from 1 to 
1 OOJ.tg/mL, according to the doses of fed butylparaben (Alslev et al., 2005). Another 
study investigating the estrogenic activity of a wide variety of chemicals such as 
nonylphenol, bisphenol A and phtalates, showed Vtg levels in inmature RT vary from 1 
J.tg/mL to 1 mg/mL when injected intraperitoneally with single doses of the test 
compounds (Christiansen et al., 1998). 
28 
According to the nature of the source to which the species are exposed, these 
investigations can be classified into two main groups. One type of experiment is that 
performed mainly by environmental scientists concerned with contamination or pollution 
of the environment. In these studies, Vtg is measured 'in vivo' in indigenous species and 
compared to control levels to assess the degree of xenobiotic estrogens present in the 
environment. Alternatively, the estrogenic activity of the environmental samples can be 
analyzed in sentinel species. In this case, the test animals in the laboratory are exposed to 
the environmental samples for a period of time, after which Vtg levels are measured. An 
'in vitro ' variation of this approach has also been done by replacing the sentinel species 
with hepatocyte cultures. This type of investigation provides very important information. 
Although the presence of some xenoestrogens can be individually tested, the composition 
of the environmental sample is never completely known. Thus, Vtg plasma levels 
represent a valuable indicator for the combined effect of the environmental estrogens 
present. 
Examples of this approach can be seen in studies performed on different sources 
suspected with estrogenic activity such as municipal sewage, wastewater treatment works 
and effluents derived from diverse industries such as paper mills and oil refinery 
treatment works (Knudsen et a/., 1997; van den Heuvel and Ellis, 2002; van den Heuvel 
et a/., 2002; McClain et a/., 2003; Nakari, 2004; Jobling et a/., 2004; Tyler et a/., 2005; 
Johnson eta/., 2005). These studies have been done both 'in vitro' and 'in vivo' to either 
cell cultures or animals of different species. 
The other type of experiment is done usually by eco-toxicologists and biologists 
interested in the estrogenic potency of known chemicals. In these studies, a special focus 
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is placed on assessing the developmental, reproductive and health effects produced by the 
xenoestrogens in wildlife and laboratory animals (Lam, 1983; Colborn and Clement, 
1992; Kime, 1995; Arukwe and Goksoyr, 1998; Pedersen eta/., 1999; Pedersen eta/., 
2000; Damstra eta/., 2002a; Damstra eta/., 2002b; Goks0yr eta/., 2003; Madsen eta/., 
2004). The Vtg assay is one of the many biochemical and biological parameters measured 
to assess the health of the organisms studied. The experimental procedure is analogous to 
the one described above, however, in this case, the composition of the chemicals in the 
administration source is known beforehand. Thus, Vtg levels after exposure are 
proportional to the estrogenic potency of the studied chemicals. This approach can also be 
done both 'in vivo' using a sentinel species, or 'in vitro' via hepatocyte cultures (Radice 
eta/., 2002). 
Extensive studies have been performed on a variety of organic compounds with 
estrogenic activity, including polychlorinated biphenyls, polycyclic aromatic 
hydrocarbons, polychlorinated dibenzodioxins, alkylphenols, alkylhydroxy benzoates and 
synthetic estrogens (Sumpter and Jobling, 1995; Palmer et a/., 1998; Bjerregaard et a/., 
1998; Christiansen et a/., 1998; Yadetie et a/., 1999; Lindholst et a/., 2000; Lindholst et 
a/., 2001; Boon et a/., 2002; Verslycke et a/., 2002; Yadetie and Male, 2002; 
Okoumassoun eta/., 2002; Thomas-Jones eta/., 2003; Tollefsen eta/., 2003; Pedersen et 
a/., 2003; Bjerregaard eta/., 2003; Lindholst eta/., 2003; Jobling eta/., 2004; Meucci and 
Arukwe, 2005; Alslev et a/., 2005).These compounds are usual components of 
surfactants, plasticizers, flame retardants, pesticides, herbicides, fungicides, paints, 
cosmetics, pharmaceuticals and food preservatives used in agriculture and industries. 
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Most of these chemically synthesized compounds will eventually end up m the 
environment. 
As an example, a study performed in an AS hepatocyte culture showed the 
estrogenic effect of both endogenous steroids (17~-estradiol, estriol, estrone and 17a-
estradiol) and estradiol mimics ( ethynylestraiol, diethylstilbestrol, zearlalenone, bisphenol 
A, 4-t-octylphenol, 4-n-nonlyphenol and 2-chloro,4-chloro-diphenyltrichloroethane ( o,p'-
DDT)). However, this study did not show response to dieldrin and toxaphene, two 
putative estrogenic compounds. Other investigations have also demonstrated differences 
between 'in vitro' and 'in vivo' studies (Folmar et a!., 2002). These studies have 
demonstrated that 'in vitro' bioassays underestimate the results obtained in 'in vivo' 
experiments. This raises the issue of the limitations of the 'in vitro' bioassays, especially 
for proestrogens, substances that require metabolic activation. Furthermore, 'in vitro ' 
experiments are not capable of providing other physiological alterations. Consequently, 
the same authors recommend that these assays supplement 'in vivo ' studies, much to the 
dislike of animal rights supporters. Other scientific papers also observed differences in 
both types of assays and even marked notorious interspecies dissimilarities (Latonnelle et 
a!., 2002b ). 
Another work studied the effect on the reproductive impairment of medaka 
(Oryzias latipes) based on the fecundity, fertility and hatching success of eggs from fish 
that had previously been exposed to different concentrations of diphenyltrichloroethane 
(DDT). This study concluded that Vtg expression may be interpreted as a warning of 
reproductive consequences, but its absence does not imply a deficiency of consequences 
(Cheek eta!., 2001). ~-sitosterol and other wood derived phytoestrogens present in pulp 
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and paper mill effluents have also shown some estrogenicity in RT exposure experiments 
(Mellanen et a!., 1996). Binding affinities of these phytoestrogens for the hepatic nuclear 
estrogen receptors has also been calculated (Latonnelle et al., 2002a). 
Other compounds like 4-tert-octylphenol, 4-nonylphenol, bisphenol and dibuthyl 
phthalate have also been tested in RT and zebrafish (Dania rerio) (Van den et al., 2003). 
All compounds exhibited estrogenic effects except for dibuthyl phtalate. No interspecies 
differences were observed except for nonylphenol, for which zebrafish was five times less 
sensitive. 
Long term effects ofnonylphenol on gonadal development in juvenile RT showed 
no effect on sexual differentiation in the concentrations normally found in sewage 
treatment effluents, although Vtg was over expressed (Ackermann et al., 2002). 
Nevertheless, a trans-generational study done with the same compound raised a serious 
issue. The published results showed not only a reduction in reproduction success 
indicated by decreased hatching rates but also hormonal imbalances in the offspring of 
exposed fish (Schwaiger et al., 2002). 
As mentioned, some studies have tried to determine biomarker lowest-observed-
effect concentrations (Thomas-Jones et al., 2003). Conclusions drawn by these 
experiments are very clear under controlled laboratory conditions, however, there is a 
clear uncertainty if these values are of any use for assessing the estrogenic potency of 
environmental samples. The relative potencies and combination effects of a mixture of 
steroidal estrogens have been measured using Vtg induction in a 14-day 'in vivo' juvenile 
RT screening assay (Thorpe et al., 2003). This study confirmed the ability of each 
individual estrogen to contribute to the overall effect of a mixture in a way predicted by a 
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concentration addition model. This is particularly interesting since most estrogens in 
domestic effluents are usually present as mixtures. This means that the overall effect of a 
mixture can be harmful, even if each individual estrogen is present in no effect 
concentrations. It should be noted that this study was carried out using natural steroids 
like 17~-estradiol and estrone. Although these compounds would not fit into the 
definition of xenoestrogens, their presence in domestic effluents converts them into 
potential natural endocrine disrupters (Routledge et al., 1998). 
Binary mixtures using other compounds such as nonylphenol and methoxychlor 
were also assayed yielding similar results (Thorpe et al., 2001). Again, the model of 
concentration addition accurately predicted the effects on Vtg induction for compounds 
sharing the same mechanism of action. On the contrary, cadmium was shown to inhibit 
the transcription of Vtg when co-injected in RT with 17~-estradiol (Olsson et al., 1995; 
Vetillard and Bailhache, 2005), although opposite results have also been obtained in 
similar experiments (Ait-Aissa et al., 2003). 
Vtg in body surface mucus has also been measured as an alternative sample to 
serum or plasma. The detectable values of Vtg and zona radiata proteins found after 
exposure to waterborne nonylphenol suggest that this noninvasive and nondestructive 
example could be used for the detection of endocrine disrupting chemicals and related 
pollutants in the environment (Meucci and Arukwe, 2005). Also, estrogenicity in bile of 
juvenile RT has been studied as a measure of exposure and potential effects of endocrine 
disrupters (Allard et al., 2004). 
In a different approach, other studies have addressed the problem of endocrine 
disrupters by analyzing differential gene expression in fish by Northern blotting, 
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quantitative reverse transcriptase polymerase chain reaction (PCR), subtractive 
hybridizations, and gene arrays. Each of these systems showed advantages and 
disadvantages. However, the experiments with each of these methods provided important 
information about the molecular mechanisms that resulted from exposure to endocrine 
disruptors and this information can be used in risk assessment of polluted invironmental 
sites (Larkin eta!., 2003). 
There have been innumerable investigations to determine the biological effects of 
the environmental estrogens. In spite of all these efforts, a comprehensive review 
published recently suggests that the evidence supporting the impact of these compounds 
on the reproductive health and sustainability of indigenous fish populations is not very 
convincing (Mills and Chichester, 2005). According to this review, there appears to be 
sufficient evidence from laboratory experiments to link the exposure to endocrine 
disrupting chemicals with reproductive impairment in many fish species. However, 
studies of the impact of these chemicals on real fish populations are lacking. Futhermore, 
this review suggests that a reliable method or indicator to determine the reproductive 
success of fish has yet to be developed. 
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1.6 Quantification of vitellogenin 
As described in the previous sections, different experimental objectives have lead 
scientists to be involved in measuring Vtg plasma levels. Over the last two decades, a 
wide spectrum of analytical methods has been developed to meet this purpose. The first 
indirect estimates of Vtg were performed colorimetrically by determining the alkaline-
labile phosphorous content of fish plasma (Wallace R.A. and Jared D.W., 1968; 
Verslycke et al., 2002). Other techniques have also been used, such as 
immunoagglutination (Le Bail and Breton, 1981 ), densitometry following electrophoresis 
(van Bohemen et al., 1981; van Bohemen and Lambert, 1981), immunobloting (eg 
western blot) (Kwon et al., 1993), radial immunodiffusion (Hara and Hirai, 1978) and by 
liver tissue slice immunoassays (Schmieder et al., 2000). 
Vitellogenin synthesis can also be estimated by quantification of Vtg mRNA 
levels in liver tissues and different approaches are possible for this task. mRNA can be 
qualitatively assayed by direct northern blotting while more sophisticated methods such 
as reverse transcriptase PCR and quantitative PCR provide more accurate results. 
Quantitative PCR is also known by the name of real time PCR, although this term usually 
is mistaken for reverse transcriptase-PCR. 
A detailed protocol to develop a reverse transcriptase-PCR method against Vtg 
mRNA can be found in the literature (Bowman and Denslow, 1999). Similar reverse 
transcriptase-PCR techniques have been used in experiments that measured the effects of 
nonylphenol, (Ackermann et al., 2002), benzo[a]pyrene, 17P-estradiol and cadmium 
(McClain et al., 2003) on RT Vtg induction. Both reverse transcriptase and quantitative 
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PCR have been used in studies to determine Vtg mRNA of male mummichog (Fundulus 
heteroclitus) exposed to 17~-estradiol and common carp (Cyprinus carpio) in a river 
known for its high levels of estrogenic alkylphenols. 
Sample preparation for PCR techniques is very critical. One of the major obstacles 
in RNA preparation is the RNAases since these ubiquitous enzymes are very difficult to 
inactivate. Also, extreme laboratory precautions must be taken to prevent external 
contaminations. However, the main drawback to this approach is that sample handling 
and the procedure to obtain the liver tissue homogenates is more cumbersome, costly and 
time consuming than the techniques for measuring Vtg in serum. Consequently, this 
approach is prohibitive for large scale sampling and high throughput analyses. 
The advantages of the techniques that measure mRNA are their increased 
sensitivity and their potential to detect earlier the estrogenic response, since mRNA 
synthesis always precedes protein synthesis. Measurements done on the mRNA indicate 
recent exposure, since mRNA is quickly degraded, with a half life of approximately 2 
days (Denslow et al., 1999). This characteristic is particularly valuable for biomarker 'in 
vitro' studies performed on hepatocyte cultures to assess the estrogenic potency of 
endocrine disruptors. 
An alternative to PCR for the detection and quantification of mRNA is the 
chemiluminescent hybridization assay. This technique relies on the hybridization of 
acridinium ester-labeled oligonucleotide probes to target RNA. In this duplex, the labeled 
oligonucleotides are resistant to the hydrolytic step that follows. Detection is done by 
chemiluminiscence which is measured in a luminometer and the signal is proportional to 
the original amounts of RNA. This extremely sensitive and specific technique has been 
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used to study the dynamics of estrogen biomarker responses in RT exposed to 17P-
estradiol and 17a.-ethinylestradiol (Thomas-Jones eta/., 2003). 
It was not until the development of radioimmunoassays (RIA) and ELISA that 
plasma or serum Vtg levels were first accurately and rapidly measured. Both techniques 
have had a wide acceptance in the last decades, mainly due to the very low limits of 
detection (LOD) they have attained, in the order ofng/mL, and their high reproducibility. 
The latest publications describing quantitative analyses of Vtg indicate that there 
has been a declining trend in the use of RIA, probably due to the radioactivity hazards, 
their higher regulatory costs and the significant disposal problems caused by 
radiochemicals. Because of these concerns, RIAs have continuously been replaced by 
ELISAs, which have reached similar levels of sensitivity. 
The first RIA for RT Vtg was developed in 1980 by raising antibodies against 
Vtg purified from the plasma of estrogen induced fish. Little cross reactivity with AS Vtg 
was found (Campbell and Idler, 1980). RIA techniques are so sensitive that Vtg has even 
been detected in the plasma of male and immature females, although several 
methodological issues have been raised regarding the validity of these results (Copeland 
et a/., 1986). RIAs have also been developed with antibodies raised against AS Vtg 
purified from plasma (So eta/., 1985; Sumpter and Jobling, 1995). Again, this method 
demonstrated poor cross-reactivity with purified Vtg of RT and other teleosts. It is 
interesting to observe this high immunospecificity between such high-molecular mass 
proteins in such closely related species as RT and AS. RIAs for other species such as 
brown trout (Salmo trutta) have also been described. 
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The first ELISAs for RT Vtg were developed approximately one decade after the 
appearance of the RIAs. Before the commercial ELISA kits were introduced, researchers 
prepared their own procedures using polyclonal antibodies raised against purified samples 
of Vtg. The first ELISAs described were 'sandwich' type methods, where the Vtg 
molecules were 'sandwiched' between the raised antibodies coated on the microtitre 
plates and the labeled antibodies used for color development (Crowther, 2000). 
Validation of the techniques was usually done with well understood systems such as the 
induction of Vtg by 17~-estradiol in primary hepatocyte cultures (Kwon et al., 1993). 
Other sandwich type ELISAs were tested for amphibian models (Xenopus laevis) (Palmer 
et al., 1998). 
A simplified version of the 'sandwich' type approach has been reported for winter 
flounder Vtg (Hartling et al., 1997). In this 'direct' assay, protein solutions from 
standards and unknowns were dot blotted onto a nitrocellulose membrane. Blots were 
first incubated with the rabbit antiserum followed by the secondary conjugated goat anti 
rabbit IgG. The color reaction was quantified by densitometry of a video camera acquired 
image. An alternative approach to this direct assay has been described by coating the 
samples and standards on microtitre plate wells instead of blotting on a membrane 
(Denslow et al., 1999). In this case, the results can be measured colorimetrically by a 
microplate reader. Other 'sandwich' type ELISAs have been developed for a variety of 
species such as the common carp ( Cyprinus carpio), fathead minnow (Pimephelas 
promelas), zebrafish (Dania rerio) and Japanese medaka (Oryzias latipes) (Nilsen et al., 
2004). An immunochemical assay ofmedaka Vtg has also been documented (Hara et al., 
1983). 
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In addition to the 'sandwich' type, competitive ELISAs have also been developed. 
In this type of ELISA, purified Vtg coated on the microtitre plates is incubated with the 
specific antiserum and serial dilutions of samples or standards. After incubation, color is 
revealed by means of a secondary labeled antiserum. Vtg concentration in samples or 
standards is inversely proportional to color intensity. Again, calibration by this technique 
showed very low LOQ, with the most reliable results ranging between 20 and 320 ng/mL 
(Bon et al., 1997). In contrast with some RIA assays, male serum was shown not to 
contain Vtg. 
Both polyclonal and monoclonal antibodies have been used for these techniques. 
Polyclonal antibodies are easier to prepare and offer higher signal to noise ratios. 
Nonetheless, ELISAs using these antibodies are usually less specific and harder to 
validate. Monoclonal antibodies directed to a single epitope present higher specificity but 
are more expensive to produce and may be less sensitive (Denslow et al., 1999). 
However, the benefit of the increased specificity of monoclonal antibodies IS 
questionable. Some researchers have taken advantage of the lower specificity of 
polyclonal antibodies by developing ELISAs which could be used for Vtgs of related 
species. 
The question of whether a universal monoclonal assay could be developed was 
also addressed (Heppell et al., 1995). Promising results were obtained from both 
monoclonal and polyclonal antibodies. Monoclonal antibodies generated against purified 
RT Vtg recognized other estrogen-inducible proteins in serum of species representing 
four of the vertebrate classes (fish, amphibians, reptiles and birds). Similar results were 
obtained from polyclonal antibodies raised against a synthetic consensus peptide 
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representing the conserved N-terminal amino acid sequence ofVtg from phylogenetically 
diverse teleost fish. 
Other examples of cross reactivity are extensively described in the literature. RT 
Vtg has been measured using an ELISA with monoclonal antibodies raised against AS 
Vtg (Tyler et al., 2002). This work is particularly interesting because it shows no 
significant difference when the same samples are analyzed with a homologues polyclonal 
RT ELISA. Another study showed variable results in cross reactivity when comparing 
ELISAs from greenback flounder (Rhombosolea tapirina), RT and AS. Also, fathead 
minnow (Pimephales promelas) Vtg has been quantified using an ELISA based on carp 
(Cyprinus carpio) (Tyler et al., 1999). 
The quest for measuring Vtg has even gone beyond traditional chemical and 
physical analytical techniques. A specific immunosensor for carp (Carassius auratus) has 
been developed by coating a conducting polymer electrode with anti Vtg monoclonal 
antibodies. The antigen-antibody interactions were measured by means of a quartz crystal 
microbalance and impedance spectroscopic techniques. The sensor showed a dynamic 
range from 1 to 8 J..Lg/L with a 0.41 J..Lg/L LOD and no cross reaction with non-target 
proteins such as IgG, horseradish peroxidase and bovine serum albumin (Darain et al., 
2004). 
In spite of the many advantages offered by immunoassays, certain issues need to 
be considered before starting to develop a new technique. The first step in the process is 
obtaining a highly purified homogenous standard. In the case of Vtg, extra precautions 
should be taken since this is a thermo-labile and susceptible to the action of proteases. 
Purification of this protein usually yields degraded or aggregated species (Kanungo et al., 
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1990; Tao et al., 1993; Silversand et al., 1993; Specker and Sullivan, 1994). Some 
researchers have avoided these problems by raising the antibodies against purified yolk 
proteins (Idler et al., 1979; Campbell and Idler, 1980; Kunkel and Nordin, 1986; Brown 
et al., 1997b ). The purification of this high quality standard is critical for the following 
step, the production of polyclonal or monoclonal antibodies. This is probably the most 
labor intensive and important step. Increased non-specific binding and background noise 
are the consequence of poor protein purification. 
Once issues regarding cross reactivity and false positive results are resolved, the 
technique must be validated using a standard. Here again, the issue regarding a reliable 
standard plays a key role. Usually, Vtg is purified after an extensive laboratory procedure. 
The concept of 'pure' is subject to many interpretations according to the analytical 
procedure performed. The amount of protein obtained can be calculated by simple weight 
or by assessing concentration via colorimetric protein assays or quantitative amino acid 
composition analysis. Colorimetric protein assays also raise the issue as to what standard 
should be used for calibration. It is usually assumed that the protein to be analyzed will 
behave the same way as the standard, which usually is bovine serum albumin, 
ovoalbumin or immunoglobulin G, however, this is usually not the case for Vtg. 
Moreover, the non-proteinaceous parts of Vtg should also be taken into account for the 
final calculations. In spite of the variety of PTM described for this protein, it is usually 
accepted that the protein part of the Vtg molecule accounts for 65-75% of the total 
molecular weight. 
After validation, the technique must be tried on serum or plasma from real 
samples, during which the dynamic range of Vtg concentrations found in fish creates 
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another problem. These values can vary from the ng/mL of male or immature females to 
the mg/mL found in fully mature female RT (Wallaert and Babin, 1994). For this reason 
serial dilutions for each unknown sample must be assayed in order to obtain signal values 
that fall within the optimum working range of the technique. 
1.7 Purpose and significance of study 
The objective of this study was to develop a novel 'signature peptide' approach 
for quantification of Vtg using combined techniques of mass spectrometry. For this 
purpose, a diagnostic proteolytic peptide was chosen as a surrogate of the precursor 
protein (Vtg) and monitored by HPLC-ESI-MS/MS for quantification. To attain this 
objective, this study was organized in three main parts. A summary of all the work 
involved in this thesis is portrayed in the scheme shown in Figure 1.2. 
The first part consists of the characterization ofVtg from the three studied species 
by different mass spectrometric techniques and involves the highly careful and 
descriptive experiments aimed at exploring the primary structure ofVtg. The information 
obtained from these experiments was essential to elaborate a list of 'signature peptides' 
for each species, necessary to conduct the subsequent experiments. 
The second part of this study was mainly methodological and consisted of 
optimizing and tuning the analytical instrumentation used for the quantitative analysis. 
The experimental conditions of high performance liquid chromatography coupled to the 
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tandem mass spectrometer were optimized to enhance the level of detection and the 
reproducibility capabilities of the system. 
Finally, the analytical system was used to assay real biological samples. Vtg levels 
were compared in fish prior to and following estrogenic induction with 17~-estradiol. RT, 
AS and AC were the species chosen for this study. The quantification technique was set 
and completed for RT and AS Vtg. AC Vtg was characterized, and a 'signature peptide' 
was also generated for this species, although no quantitative studies were performed. 
These three species are considered priority species at the NAFC, due to their 
important role in Atlantic Canada. RT and AS are used in aquaculture, while AC is a key 
species in the fisheries industries. Whether caged or in wild, these species are essential to 
maintain the fragile ecosystems found in this region. The development of this quantitative 
technique provides researchers with an alternative for measuring Vtg in plasma samples. 
The approach explored in this work offers an alternative to developing 
immunoassays, especially when no commercial kits are available for a particular species. 
The 'signature peptide' approach circumvents the need of protein purification and 
antibody production, two time consuming and costly steps required for immunoassay 
development. 
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Chapter 2: Application of mass spectrometry to protein chemistry 
The experimental work done in this thesis relies mainly on mass spectrometric 
analyses. This powerful tool provides researchers with qualitative information regarding 
the nature of the samples studied. Coupled to chromatographic techniques, mass 
spectrometry also provides valuable quantitative information. 
Until recently, mass spectrometry was exclusively employed for the analysis of 
inorganic ions or small volatile organic compounds. However, the development of 
electrospray ionization (ESI) and matrix-assisted laser desorption/ionisation (MALDI), 
two gentle non-destructive ionization sources, has permitted this technique to be 
employed for large biomolecules, including proteins and DNA. 
This chapter is not intended to be a detailed tutorial on mass spectrometry. A brief 
description of the outstanding features of this technique is given to provide the concepts 
necessary to understanding and interpreting the results obtained from the diverse mass 
spectrometric methods used in this work. 
2.1 The mass spectrometer 
Over the past two decades, mass spectrometry has evolved at a fascinating rate. 
Analysis speed, mass resolution and sensitivity levels have increased, while costs have 
continuously decreased. Regardless, the basic configuration of the mass spectrometer 
remains unchanged. No matter the degree of sophistication, all mass spectrometers 
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consist of four basic modules: an ionization source, the mass analyzer, the detector and 
the data integrator. 
The ionization source, as its name indicates, produces ions from the analytes of 
interest. Ionization sources were traditionally under vacuum, however new sources that 
operate at atmospheric pressures are now available. Examples of low pressure or vacuum 
sources are electron ionization (EI), chemical ionization (CI), fast atom bombardment 
(F AB) and MALDI (Muddiman et al., 1995). On the other hand, ESI, atmospheric 
pressure chemical ionization (APCI) and atmospheric pressure photoionization (APPI) 
are some examples of ionization sources that work under atmospheric pressure (Bruins, 
1991). There is also a modification of the MALDI source that can be operated at 
atmospheric pressure. 
The mass analyzer 1s the core component of the mass spectrometer. It is 
responsible for separating or sorting out the ions based on their mass to charge (mlz) ratio. 
Strictly speaking, mass spectrometers should really be called mass to charge 
spectrometers. The theory behind them is quite complex and goes beyond the scope of 
this introduction, however, detailed descriptions of each one can be found in the 
literature. Mass analyzers are classified according to the physical principles employed for 
ion separation. Magnetic sectors, electric sectors, quadrupoles (Dawson, 1986), ion-traps 
(Todd, 1991; March R.E., 2000; Douglas et al., 2005), time-of-flight (Wollnik, 1993; 
Guilhaus, 1995) and ion cyclotron resonance analyzers (Koster et a!., 1992; Marshall 
A.G. et al., 1998) are examples of these. 
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One of the parameters measured for each analyzer is the resolution, or the 
resolving power. Literature varies on the definition of this parameter, sometimes referring 
to it as equivalents. Resolution (R) is generally defined as: 
R=m/~m 
Where m is the mass at the center of the peak and ~m is the width of the peak at half 
height. According to their R, mass analyzers are usually classified as low resolution or 
high resolution mass spectrometers, although this definition is quite subjective and has 
changed for the same analyzers with the development of more powerful instruments. For 
example, ToF analyzers are currently working at R~l0000-15000, while the latest ICR-
FT-MS are capable of R~300000 and higher. However, caution should be taken when 
comparing R because this parameter might vary, even for the same instrument, along the 
m/z range. 
The detector simply transforms the arrival of the ions into a measurable signal 
which is finally acquired and processed by the data integrator. This last component is 
nowadays a computer loaded with analytical software used to assist the operator in the 
interpretation of the data. 
As mentioned earlier, until the last decade, mass spectrometry was exclusively 
used for the analysis of small volatile organic molecules and inorganic ions. The major 
breakthrough in this area arrived with the invention ofESI and MALDI. Since then, large 
biomolecules have been amenable to mass spectrometric analysis and this has been the 
starting point for a new era in protein biochemistry and proteomics. These ionization 
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sources in conjunction with mass analyzers such as the time-of-flight, permit the 
detection of macromolecules that go well beyond the mega Dalton mass range. 
2.2 Ionization sources for macromolecules 
2.2.1 Electrospray ionization 
This ionization source was introduced by John Fenn, who received the 2002 
Nobel Prize in chemistry for his invention (Fenn et al., 1990). Surprisingly, this 
ionization technique is by far one of the simplest to understand. Samples are usually 
dissolved in a buffer or solvent which is introduced into the mass spectrometer in the 
form of a spray (Smith et al., 1991 ). A high voltage electric field is applied between the 
tip ofthe nebulizing needle and the inlet (skimmer) of the analyzer. A carrier gas, usually 
air or nitrogen at elevated temperatures, is used to assist in the formation of the spray. 
This environment aids in the evaporation of the solvent, reducing the size of the micro 
droplets. The charged particles within the droplets are brought closer together until the 
repulsive electrostatic force expels them into the gas phase (see Figure 2.1) 
A characteristic of ESI for proteins is that it usually produces multi-charged 
species, according to the nature of the analyzed sample. These species are represented as: 
[M+nHt+ or [M-nH]n-, where M represents the molecular species and n the number of 
protons (added or lost) and charges. The distribution of these species, i.e. the amount and 
charge, and the presence ofadducts (eg. [M+Nat) can be can be experimentally modified 
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by changing the composition of the solvent or the pH. Some structural protein 
characterization can also be deduced from the charge distribution of these multiple 
charged species (Grandori, 2003). 
The production of multiple charged species also has an additional advantage. 
Their presence permits the analysis of high molecular mass biomolecules by lowering the 
m/z to a value compatible with the transmission range of the quadrupole mass analyzer. 
2.2.2 Matix-assisted laser desorption ionization 
Koichi Tanaka also shared the 2002 Nobel Prize in chemistry for his contribution 
in developing the MALDI source (Tanaka et a/., 1988). Nonetheless, much of the credit 
given to the development of this technique should also go to Michael Karas and Franz 
Hillenkamp, who developed the ideas of laser desorption techniques (Karas and 
Hillenkamp, 1988; Hillenkamp and Karas, 1990; Karas eta/., 1991; Hillenkamp eta/., 
1991; Gliickmann and Karas, 1999). This technique has permitted accurate mass 
measurements of peptides and proteins to be achieved with unprecedented success 
(Russell, 1997). 
The principle behind this source is quite unique. The samples of interest are co-
crystallized with a matrix compound onto a plate. This plate is placed in the low pressure 
compartment of the mass spectrometer. Ionization of the analyte is achieved by a laser 
beam that is aimed towards the plate (See Figure 2.2). 
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Figure 2.1 Basic principles ofthe electrospray ionization source 
Solvent and analyte molecules are indicated with the letters'S' and 'M', respectively. 
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Figure 2.2 Basic principles of the MALDI ionization source 
Matrix and analyte molecules are indicated with the letters 'm' and 'M', respectively. 
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The exact principle of ionization is not clear yet, although it is generally accepted 
that the energy from the laser is transmitted to the matrix ions, which vaporize together 
with the analyte molecules. A transfer of protons towards the analyte molecules also 
occurs in this process. These are finally accelerated towards the analyzer. 
An outstanding feature of the spectra produced by MALDI analysis is that the 
singly charged species [M+Ht are the most prevalent ions present, even for large 
biomolecules such as proteins and DNA. Many hypotheses have been proposed to explain 
this remarkable observation, yet none seem to be conclusive (Karas eta/., 2000). 
2.3 Tandem mass spectrometry 
As its name suggests, tandem mass spectrometry (MS/MS) is the result of 
performing two or more sequential separations of ions, usually coupling two or more 
mass analyzers. Some mass analyzers, such as the quadrupole ion traps can perform this 
task within the same mass analyzer. When coupled to ESI, tandem mass spectrometry 
results in a very powerful tool for a wide range of biochemistry applications (Griffiths et 
a/., 2001). 
The power of MS/MS is due to the capability of producing a fragmentation step 
between the mass analyzers. This is usually done in a collision cell filled with an inert gas 
situated between the analyzers (See Figure 2.3), in a process called collision induced 
dissociation (CID) (Shukla and Futrell, 2000). 
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The configuration of the tandem mass spectrometer allows different types of 
experiments to be performed. The one most commonly used in this work is the product 
ion scan. In this mode of operation, the first mass analyzer is set to a mass range, usually 
fixed to a window of 1 or 2 Da, thus acting as a filter. In this way, a precursor ion is 
selected for CID. The products obtained from the collision are then monitored in the 
second mass analyzer. The product ion spectrum is characteristic of the precursor 
selected and from this spectrum important structural features can be inferred. Most of the 
experiments performed in this thesis using tandem mass spectrometry were carried out on 
a QqToF-MS/MS configuration (Chemushevich et al., 2001). 
Ionization 
source 
1st stage 
mass analyzer 
Collision 
cell 
D 
MS controller 
& 
Data integrator 
2nd stage 
mass analyzer 
Figure 2.3 Basic components of the tandem mass spectrometer 
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Detector 
2.4 Mass spectrometry in proteomics 
The proteome is defined as the set of all expressed proteins in a cell, tissue or 
organism. In contrast to the genome, the proteome is dynamic, even for the same cell 
type. Recent advances in MS and bioinformatics have permitted the systematic analysis 
of all expressed cellular proteins. In this way, proteomics has been revolutionized by MS 
and MS/MS, which have enabled the identification of proteins in complex mixtures at a 
high output rate (Yates, III, 1998; Gygi et al., 2000; Gygi and Aebersold, 2000; Godovac-
Zimmermann and Brown, 2001; Aebersold and Goodlett, 2001; Griffin and Aebersold, 
2001; Peng and Gygi, 2001; Gygi et al., 2002; Jennie, 2003; Zimmer et al., 2006). An 
integral and comprehensive description of mass spectrometric techniques applied to 
proteomic studies is available (Kinter and Sherman, 2000), and this book was used as the 
source of information for most of the the methods and techniques used in this project. 
Different strategies have been developed for protein identification (Hernandez et 
a!., 2006). The 'top/down' and the 'bottom/up' are the two general approaches used in 
proteomics for identification and characterization purposes (Bogdanov and Smith, 2005). 
The 'top/down' approach is very straightforward. The intact protein molecules are 
introduced into the mass spectrometer, in which a series of fragmentation experiments are 
performed. The analyses of these spectra permit complete or partial sequencing to the 
primary structure of the protein. This information may be used for protein identification if 
the sequence is available in the protein databases, or simply for characterization purposes. 
Unfortunately, the 'top/down' approach is generally limited to the very costly ion-
cyclotron resonance MS/MS. 
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The 'bottom/up' approach is used more extensively in laboratories involved with 
proteomics projects. This approach uses a chemical or enzymatic digestion step prior to 
MS analyses (Jonsson et a/., 2001; van Montfort eta/., 2002). Within the 'bottom/up' 
approach there are basically two strategies to follow. Protein semi purification can be 
done by one or two dimension gel electrophoresis, followed by an in-gel digestion step. 
The digest is analyzed by MALDI-MS to produce a characteristic mass spectrum called 
the peptide mass fingerprint. A list of peaks is obtained from this spectrum to perform a 
database search, from which a list of candidate proteins is retrieved. 
Alternatively, the digestion can be done directly on the protein mixture. Each of 
the resulting peptides is selected for CID-MS/MS. A product ion spectrum is acquired for 
each precursor peptide and analyzed. Product ion spectra of peptides show characteristic 
peaks corresponding to peptide ions which are cleaved at the amide bond during CID, 
which are named b and y ions. 
The analysis of these ions permits the total or partial amino acid sequence to be 
deduced and this information is then used for protein identification via database searches. 
A schematic diagram of this process is shown in Figure 2.4. It is also possible to correlate 
the uninterpreted tandem mass spectra of peptides produced under low energy collision 
conditions with amino acid sequences in the protein databases (Eng et a/., 1994). A 
summary of the most common methods employed in the 'bottom-up' approach for protein 
identification in proteomics is depicted in Figure 2.5. 
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Figure 2.4 Collision induced dissociation of a peptide ion precursor 
The top scheme (A) shows the chemical fragmentation route of a peptide ion precursor 
leading to the formation of the correspoding BandY ions. The center scheme (B) shows 
all the possible B and Y ions generated from a generic peptide chain. The bottom scheme 
(C) shows a schematic representation of a product ion spectrum obtained from the 
peptide described above. 
55 
Protein mixture 
! 
1 D/2D Gel electrophoresis 
l 
in-gel 
Enzymatic/chemical digestions 
1 
Enzymatic/chemical digestions 
l 
1 D/2D Chromatography 
MALDIIMS ·~--'-----+IJo ESI-MS/MS J 
l l 
Peptide mass fingerprint Product ion spectra 
-:;;;;;;;;;;;:- Data 
analysis 
/, ~ 
~ 
Database search 
Protein identification 
Figure 2.5 Classical 'bottom-up' proteomic approach for identification of proteins 
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Chapter 3: Characterization ofvitellogenin by mass spectrometry 
The starting point of this work was based on the structural analyses of Vtg by 
various mass spectrometric techniques. To provide enough starting material, Vtg 
synthesis was induced 'in vivo ' to obtain high plasma concentrations of this protein. 
Details ofthis procedure can be read in Section 3.1.1. Purification ofRT Vtg was carried 
out by a series of filtration steps, size exclusion and ion exchange chromatography. 
Atlantic salmon Vtg was purified by size exclusion chromatography. These methods are 
described in detail in Section 3.1.2. Determination of intact protein molecular masses was 
performed by MALDI-ToF-MS. The partial amino acid sequence ofVtg was obtained by 
MS/MS analysis of the digested protein. The purified Vtg was subjected to solution 
digestions, while in-gel digestions were performed on the plasma samples. The results of 
these experiments are given in the following sections. 
3.1 Materials and methods 
3.1.1 Vitellogenin induction protocol 
Thirteen juvenile RT (purchased from Rainbow Springs Hatchery, Thamesford, 
On, Canada), ten adult AS and twelve adult AC were kept in separate 60 gallon tanks. 
The RT were maintained with running fresh dechlorinated city water, while the AS and 
AC were kept with running sea water. All fish were fed 'ad libitum' with commercial 
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pellets (Vigor Trout/Char Grower 4 Corey Aquaculture fish feed, Corey Feed Mills Ltd., 
Fredericton, NB, Canada). 
A twelve hour light-darkness cycle was programmed for each of the fish tanks. All 
fish were identified by intra-muscular injection of a radio tag under the dorsal fin. After 
one month of acclimatization, experimental fish were injected intraperitoneally four 
times, at one week intervals, with a dose of 1 Omg of 17~-estradiol (Sigma, Prod. No. 
E8875. Sigma, St. Louis, MO, USA) per kilogram of fish body weight using a 10 mg/ml 
solution in oil/acetone (9: 1, v/v). Control fish were injected only with the oil/acetone 
solution. 
One week after the last 17~-estradiol injection, fish were anesthetized usmg 
tricaine methanesulfonate (TMS) and bled from the caudal vein using heparinized 
syringes. Blood samples from each fish were divided in two 1 mL aliquots. Twenty 
microliters of a 4 TIU/mL aprotinin (Sigma, Prod. No. A1153) solution were added to 
one of the aliquots. All samples were collected in lmL plastic tubes on ice and 
centrifuged at 800 g (3000rpm on a Beckman GS-15R Centrifuge. Rotor F2404 Head. 
Beckman-Coulter, Fullerton, CA, USA) for 5 minutes at 0°C. Plasma was separated and 
kept frozen at -80°C until further analysis. All live fish experimentation was approved by 
the Animal Care Committee of the Northwest Atlantic Fisheries Center and the 
procedures were conducted according to its guidelines. 
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3.1.2 Atlantic salmon and rainbow trout vitllogenin purification protocol 
Extraction and purification of RT Vtg was done in Dr. Heeley's laboratory at the 
Department of Biochemistry, Memorial University of Newfoundland. One milliliter of 
plasma was added to an equal volume of a 50 mM TRIS, 0.5 M NaCl, 10 mM EDT A, 100 
TIU/L aprotinin, pH 8.0 at room temperature, then mixed and centrifuged at 16,000g 
(14,000rpm on an Eppendorf5415D Microcentrifuge. Hamburg, Germany) for 3 minutes. 
The supernatant was loaded onto a Sephacryl S300 column (120 em x 1.5 em) at 4°C and 
2.5 mL fractions were collected at a flow rate of 30mL/hr, using the same buffer as 
described above. The protein content of each fraction was assayed by sodium dodecyl 
sulphate polyacrylamide gel electrophoresis (SDS-PAGE) (Laemmli, 1970). 
Electrophoresis was conducted using 8% (rnlv) polyacrylamide of at a constant voltage of 
80V for the first 10 minutes, and 180V for the following 50 minutes. The fractions 74 to 
132 contained a band compatible with that of Vtg and were pooled together. This band 
corresponded to the over-expressed band in 17~-estradiol treated fish. 
Clean-up of the pooled fractions was done by ultrafiltration using an Ami con Y1 00 
membrane to remove proteins of less than 1 00 kDa. The sample was then equilibrated 
against 50 mM TRIS, 6 M Urea, 1 mM EDTA, 0.5 mM dithiothreitol (DTT), pH 8,0 at 
room temperature, and subjected to Ion Exchange Chromatography using an 80mL bed 
volume Fast Q Sepharose column. Fast-flow proteins were collected using a salt gradient 
of 0.0 to 0.4 M NaCl at a flow rate of 40mL/hr in 3 ml fractions. The collected fractions 
were analyzed by SDS-PAGE in the conditions described above (Laemmli, 1970). 
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Fractions 88 to 120, which contained the purified Vtg, were pooled and dialyzed 
extensively against distilled water and finally freeze-dried. 
Atlantic salmon Vtg had been originally purified by Dr. Idlert from Memorial 
University of Newfoundland for the the NAFC, according to So et a/., 1985. Briefly, 5 
mL of plasma was thawed and diluted with an equal volume of 50 mM TRIS, 0.5 M 
NaCl, 10 mM EDTA, 3% aprotinin, pH 8.0 at room temperature and centrifuged at 0°C. 
The supernatant was then chromatographed at 4°C on a 2.6 x 86 em column of Sephacryl 
S-300 which had been previously equilibrated with the same buffer used to dilute the 
plasma. Fractions were collected at 1.5 mL per tube at a flow rate of 15 mL/h. Tubes with 
absorbance at 280 nm were assayed by SDS-PAGE and Coomassie blue staining to locate 
Vtg elution. Those containing Vtg, eluting between fractions 140 and 160 were pooled 
and dialyzed extensively against distilled water and finally freeze-dried and stored at the 
NAFC for further analyses. 
3.1.3 Solution digestion procedures 
The trypsin solution digestion of Vtg was carried out in the laboratory of Dr. 
Pierre Thibault, University of Montreal, QC, Canada. Five hundred Jlg of purified protein 
was reduced and alkylated. The samples were previously denatured in 500 J.!L of 6.0 M 
guanidine/HCl, 0.1 M Tris-HCl, 1 mM ethylenediaminetetraacetic acid (EDTA), pH 8.5 
at room temperature. Argon gas was gently blown over the solution surface for 1 0 min. 
Reduction was carried out by the addition of 50 J.!L of 4 mM DL-DTT and incubation for 
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2 hours at 37°C. Alkylation was performed by adding dropwise 40 11L of 50 mM 
iodoacetamide to the mixture, followed by incubation in darkness for 1 hour at 37°C. The 
excess iodoacetamide was quenched by adding 1 IJ.L of beta-mercaptoethanol and 
subsequently dialyzed against 500 mL of 50 mM ammonium bicarbonate for a minimum 
of24 hours with periodic change of dialysis buffer. The solution was then lyophilized and 
redissolved in 0.5 mL of a 0.1 M ammonium bicarbonate and 0.1 mM calcium chloride 
(at pH 8.0) solution. The tryptic digestion was carried out at 37°C for 12 hours using a 
substrate-to-enzyme ratio of 25:1 (w/w). When not analyzed immediately, samples were 
stored at -20°C for subsequent analysis. 
The cyanogen bromide degradation of purified rainbow trout vitellogenin was 
performed accoring to the following procedure: 1 0 mg of purified protein were dissolved 
in 1 mL of 70% (v/v) formic acid. 1 crystal (aproximately 5 mg) of CNBr was added, 
swirled until dissolution and left 12 hours in the dark under a fume hood. 15 mL of 
deionized water were added. The solution was frozen in liquid nitrogen and finally 
lyophilized until further analysis. 
3.1.4 In-gel digestion procedures 
Separation of Vtg by SDS-PAGE (Laemmli, 1970) and subsequent in-gel 
digestion was performed following the procedure described in detail by Kinter et a!. with 
minor modifications (Kinter and Sherman, 2000). Five microliters of thawed plasma from 
both experimental and control fish were mixed and loaded onto a 6% (w/v) 
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polyacrylamide SDS-PAGE and analyzed in the same conditions as those described in 
Section 3.1.2. The gel was stained using the colloidal Coomassie blue protocol. The band 
corresponding to the induced Vtg was easily recognized by comparison of the protein 
banding from both control and experimental fish. This band was cut into 1mm3 pieces 
using surgical blades and placed into 2 mL plastic vials for enzymatic digestion. An 
unstained piece of gel from one comer of the gel slab was simultaneously processed for 
use as a blank. Samples were destained with serial washes of 50% (v/v) methanol and 5% 
(v/v) acetic acid over a period of 24 hours. These steps are critical for removing the 
excess of SDS and salts in the gel pieces which interfere in most MALDI and ESI 
analysis. Subsequently, the gel pieces were reduced with 30J..tL of a 10 mM solution of 
dithiothreitol (DTT) (Sigma, Prod. No. D9163) and alkylated with 30J..tL of a 100mM 
iodoacetamide (Sigma, Prod. No. I1149) solution. Finally, the gel pieces were dehydrated 
by the addition of 200J..tL of acetonitrile. The gel pieces were further dried in a vacuum 
centrifuge at room temperature. 
Enzymatic digestion was performed by adding 30J..tL of a 20ng/mL solution of 
trypsin (Sigma, Prod. No. T6567) to the dried gel pieces and letting the tubes stand in a 
water bath at 37°C for 24 hours. The tryptic peptides were extracted three times using 30 
uL of a 50% v/v solution of acetonitrile containing 5% v/v formic acid. The final volume 
was reduced to <20 JlL by evaporation in a vacuum centrifuge at ambient temperature. 
Sample volume was finally adjusted to ~20 J..tL with 1% acetic acid. When not analyzed 
immediately, samples were stored at -20°C for subsequent analysis. 
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3.1.5 HPLC-ESI-MS and MS/MS acquisition parameters 
Chromatographic separation of tryptic peptides for sequencing analysis was 
achieved using a HPll 00 (Hewlett Packard, Palo Alto, CA) high performance liquid 
chromatograph equipped with a 15 em x 0.32 mm PepMap capillary column (LC 
Packings, San Francisco, CA, USA) using a binary linear gradient elution of 5 to 95 % 
(v/v) acetonitrile in 35 min (Complementary solvent: 0.2% formic acid). A 100:1 flow 
splitter was mounted before the injector such that only a 3-4 j..tL/min flow rate was 
introduced in the capillary column. The sample was manually injected via a Rheodyne 
six-port valve (Rohnert Park, CA, USA) fitted with a 5 j..tL sample loop 
A Micromass ESI-qTOF instrument coupled in-line to the HPLC was used to 
analyze the tryptic digest. The mass spectrometer was operated in electrospray positive 
ion mode with a source temperature of 80°C, a desolvation temperature of 80°C, 
desolvation gas flow rate of 300 L/hr and a potential of 3.5 kV applied to the capillary. 
MS data was acquired and integrated every 2 seconds. Conventional mass spectra were 
obtained by operating the quadrupole in a RadioFrequency (RF)-only mode while a 
pusher electrode was pulsed to transfer all ions to the time-of-flight analyzer. Data was 
acquired and processed by the Mass Lynx Window NT based data system. 
Tandem mass spectrometric experiments were performed with on a Micromass 
ESI-qTOF instrument coupled to the HPLC system described above. The mass 
spectrometer was operated in electrospray positive ion mode with a source temperature of 
80°C, a desolvation temperature of 80°C, desolvation gas flow rate of 300 L/hr and a 
potential of 3.5 kV applied to the capillary. Product ion spectra of mass selected ions 
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were induced by CID using argon as the collision gas with a 25 V offset between the DC 
voltage of the entrance quadrupole and the RF -only hexapole cell. MS spectra were 
obtained over a mass range varying from m/z 500 to 1700. Mass spectral resolution was 
typically 4,000-5,000. For MS/MS experiments, precursor ions were automatically 
selected from the MS survey by running an Information Dependent Acquisition program 
(IDA). Selection of precursor ions was performed by the first quadrupole while a pusher 
electrode was pulsed to transfer fragment ions formed in the RF only hexapole cell to the 
TOF analyzer, which scanned the fragment ions in a range of m/z 50 to 2000. A scan 
duration of one and two seconds was set for conventional and MS/MS mass spectral 
acquisition, respectively. Data was acquired and processed by the Mass Lynx, Windows 
NT based data system. 
3.1.6 MALDI-MS and MS/MS acquisition parameters 
The purified intact rainbow trout and Atlantic salmon vitellogenin protein was 
analyzed by MALDI-MS. Ten milligrams of purified sample of intact protein was 
dissolved in 1mL water, desalted using Millipore VS membrane filters and mixed with 
equal volumes (1:1, v/v) of a 10 mg/mL solution of sinapinic acid matrix . The sample 
was then analyzed by a MALDI-TOF System (PE Voyager Biospectrometry 
Workstation), operating in the linear mode using the Post Acceleration Detector (PAD) 
(also known as Delayed Extraction Technology). External calibration was done using 
BSA (Bovine Serum Albumin). 
64 
The CNBr and tryptic solution digestions of RT and AS Vtg were analyzed by 
MALDI-MS. Mass spectra of digests were acquired on a PerSeptive Biosystems Elite-
STR (Framingham, MA, USA) equipped with delayed extraction technology. One J..lL 
aliquots of both tryptic and CNBr digests were mixed with 2 J..lL of a saturated solution of 
2,5-dihydroxybenzoic acid (2,5-DHB) MALDI matrix, originally prepared as 0.2 M in 
methanol:deionized water (50:50, v/v). 0.5 J..lL aliquots of this final solution were applied 
to the MALDI target and allowed to evaporate at room temperature prior to mass spectral 
analysis. Reflectron mode was utilized to enhance mass resolution. For the analysis of 
large peptide fragments, 1 J..lL of sample was mixed with 10 J..lL of sinapinic acid (SA) 
matrix solution, prepared as 10 mg/mL in a mixture of methanol:acetonitrile:water (1: 1:1 
, v/v/v). An aliquot of 0.5 J..lL was deposited on the MALDI plate. External mass 
calibration was carried out using the singly-protonated ions of insulin and apo-myoglobin 
and the mass spectra were acquired using linear mode. 
The in-gel digestions of RT and AS VTG were analyze by MALDI-MS. Mass 
spectra of digests were acquired on a QSTAR-XL (Applied Biosystems, Framingham, 
MA, USA) quadrupole-time-of-flight (QqToF) hybrid tandem mass spectrometer 
equipped with a UV nitrogen laser MALDI source (oMALDI 1, from Applied 
Biosystems, Framingham, MA, USA). Ten J..lL of the peptide extract belonging to one of 
the experimental fish and 10 J..lL of 2,5-dihydroxybenzoic acid (2,5-DHB) MALDI matrix 
were mixed together, spotted on the MALDI plate in 1 J..lL aliquots and allowed to 
evaporate at room temperature prior to mass spectral analysis. Upon optimization, typical 
acquisition parameters for the full scan positive ion mode were: Laser frequency 25Hz, 
Laser power 30%, declustering potential (DP) -5V, focusing potential 255V and DP2 
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1 OV. Spectra were acquired over a one minute period by manually centering the laser 
beam on the 'sweet spots' of the crystallized samples on the MALDI plate. All data 
acquired was processed on the AnalystQS software. 
The MALDI-MS/MS of the same in-gel digestions were acquired on the same 
system as described above for the MALDI-MS for PMF. The acquisition parameters for 
the full scan positive ion mode were: Laser frequency 25Hz, Laser power 30%, 
declustering potential (DP) -5V, focusing potential 255V and DP2 lOV The product ion 
spectra were obtained by manually 'ramping' the collision energy from 30V to 120V 
during the acquisition until the spectra showed an adequate pattern of complete 
fragmentation, shown by evenly distributed peaks across the complete mlz range being 
analyzed. Each acquisition lasted typically between 3 and 5 minutes. Argon gas an 
arbitrary value of 6 was used for the low energy collision induced dissociation (CID) 
MS/MS experiments. All data acquired was processed using the AnalystQS software. 
3.1. 7 Bioinformatics tools 
3.1.7.1 Molecular weight calculation and isotopic cluster distribution 
The relative molecular mass and the isotopic distribution pattern of Vtg were 
calculated using an online internet calculator application available at the following 
address: http://www.ch.cam.ac.uk/magnus/MolWeight.html. The molecular formula used 
in the calculations was: Csi38HBo4oNzt960236oS69· This formula was deduced from the RT 
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Vtg amino acid sequence found as entry Q92093 in the Swiss-Prot Database (Appendix 
2). 
3.1.7.2 Protein digestion simulation 
A computer based tryptic simulated digestion of rainbow trout and Atlantic 
salmon Vtg was performed with Micromass MassLynx v3.3 Protein Digestion Simulation 
Software. One missed cleavage was allowed and all the Cys residues were replaced by 
carboxiamidomethyl cysteine to take into account the alkylation process with 
iodoacetamide. 
3.1.7.3 Peptide mass fingerprint database search 
Identification of the Vtg and its derived peptides was achieved using MASCOT 
(http://www.matrixscience.com), a free access internet search engine tool. For each 
search, a list of peptides was built from all the monoisotopic peaks which were clearly 
distinguished from the baseline noise (signal to noise > 10) in each of the MALDI-ToF 
PMF spectra. The Swiss-Prot database was chosen for protein identification purposes. All 
search queries were completed considering a ±2.0 m/z of peptide mass tolerance and one 
missed cleavage for the matching parameters. No taxonomic constraints were selected. 
For the CNBr derived PMFs, homoserine lactone was introduced as a fixed modification. 
67 
For the tryptic digest, carboxyamidomethyl cysteine (Cys CAM) was set as the only fixed 
modification. 
3.1.7.4 'De novo' sequencing of tryptic peptides 
Interpretation of the ESI low energy CID-MS/MS obtained from product ion 
spectra of the tryptic peptides was performed using a computer based sequencing 
algorithm, called Lutefisk. In contrast to other software programs, this program can be 
obtained from its author at no cost. The results from this program were comparable to 
those obtained by other software ( eg, Masslynx Protein Analysis Software, Micromass ). 
However, processing time was considerably shorter using Lutefisk. Furthermore, the 
output file created by Lutefisk can be easily merged into CIDentify, a sequence homology 
program, described below. The sequencing parameters on this program were strictly 
optimized for the ESI-QqToF configuration, which was used for the experiments. The 
peptide mass tolerance was set to 0.50, the fragment ion tolerance to 0.25 and the final 
fragment error to 0.05. All cysteine residues were considered as carboxyamidomethyl 
cysteine for sequencing purposes. 
Altemtively, the interpretation of the MS/MS spectra was performed with 
BioAnalyst, the sequencing algorithm provided with the Bioanalyst software 
(AppliedBiosystems, Foster City, CA, USA). The product ion spectra obtained from the 
MALDI-MS/MS of the tryptic in-gel digestions of AS, RT and AC Vtg were analyzed 
using particular program since Lutefisk is specially designed towards the interpretation of 
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ESI-MS/MS data. The precursor ion was automatically selected by the software. The 
peptide and fragment mass tolerance was set to 0.1 Da. All cysteine residues were 
considered as carboxyamidomethyl cysteines. In the candidate sequence list, leucine (L) 
and isoleucine (I) are both labeled with the letter L. 
3.1.7.5 Sequence alignmente of 'de novo' sequenced peptides 
CIDentify, a homology-based search algorithm program, was used to compare the 
sequenced peptides obtained from Lutefisk with the following sequences: the complete 
rainbow trout Vtg sequence on Swiss-Prot (See Appendix 2), together with the variant 
conflicts found in the four references reported for this protein (Le Guellec et al., 1988; 
Mouchel et a!., 1996; Goulas et al., 1996; Ren et al., 1996), the two partial amino acid 
sequences of AS Vtg (See Appendix 2), the sequence of trypsin (Hermodson eta!., 1973) 
(entry P00761 on Swiss-Prot) and the aprotinin sequence (Creighton and Charles, 1987). 
The trypsin sequence was included to account for possible autolysis fragments. Aprotinin 
was used as a constituent of the buffers used in the Vtg purification process. 
Alternatively, the alignment of the sequenced peptides obtained from the MALDI-
MS/MS of the tryptic in-gel digestions of AS, RT and AC was performed using an 
internet application ofFASTA (Compare Two Sequences with FAST A): 
http://fasta.bioch.virginia.edu/fasta www/cgi/search frm2.cgi 
The sequenced peptides obtained from the in-gel digestions of RT and AS Vtg 
were compared to the RT and AS sequences. The peptides obtained from AC Vtg were 
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compared to haddock Vtg A and Vtg B (entries Q98T86 and Q98T87 on the TrEMBL 
database). For scoring purposes, the parameters chosen were Ktup=2, Scoring Matrix: 
Blosum 50, gap:-1 0 and ext: -2. 
3.2 ESI-MS and MALDI-MS of intact rainbow trout and Atlantic salmon 
vitellogenin 
Attempts to measure the molecular mass of RT Vtg by ESI-MS did not show the 
expected molecular fragment around 180-200 kDa. However, a series of multicharged 
ions, [M+5H]5+ at mlz 1303.01, [M+6H]6+ at mlz 1086.22 and [M+7Hf+ at m/z 931.26, 
were observed. The molecular mass of this fragment was transformed and deconvoluted 
into a single mass peak of 6510.8 Da by the Maximum Entropy algorithm available on the 
"Biolynx Program". This peak was compatible with the phosvitin segment of RT Vtg, 
whose sequence is NGTRASSSSS SSSSSSSRSS SSRSRSRKSR SSSSSSSSSS 
RISKRDGPFP YNPNDRKFKKN (Calculated Mr: 6511.76 Da), although its identity 
should be confirmed by MS/MS. 
The results obtained from the MALDI-ToF-MS experiments provide information 
on both the molecular mass and structural characteristics of the intact Vtg. For high 
molecular mass measurements, where the isotopic cluster of the analyzed ions can not be 
resolved by the mass analyzer, the apex of the peak represents the relative molecular 
mass. The broadness of the peaks obtained also has a structural implication. The peak 
width is given by the isotopic contribution of all the atomic constituents of the molecular 
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ions analyzed. When the empirical formula of the analyzed sample is known, the peak 
width can be predicted. MALDI-ToF-MS spectra also show an increase in the peak width 
due to the inherent energetic population spread of the ions produced in the laser plume of 
the ionization source. This spread can be partly corrected by the delayed extraction 
technology offered by some MALDI-ToF-MS, used in the analysis performed in this 
work. 
The theoretical isotopic envelope and the calculated relative molecular mass for 
RT Vtg, are shown in Figure 3.1. These figures were obtained using a free access 
molecular weight calculator (see Section 3.1.7.1) available on the internet. However, this 
value (Mr 181616) does not include any possible mass contribution due to the post 
translational modifications. No molecular mass for AS Vtg could be calculated since only 
partial amino acid sequences are known for this species. 
The spectra obtained for both AS and RT Vtg samples subjected to MALDI-ToF-
MS can be seen in Figure 3 .2. The methodological details and the acquisition parameters 
for the MALDI-ToF-MS of the intact Vtg analyses were described in Section 3.1.6. The 
intact purified RT Vtg showed two peaks around m/z 181938 and 94279 corresponding to 
the single charged [M+Ht and double charged [M+2Hf+ molecular species. Similarly, 
the AS Vtg showed a spectrum containing two peaks identified as the [M+Ht at m/z 
177153.1 and the [M+2H]2+ at m/z 91250.4. The molecular mass values corresponding to 
the singly charged species are similar to those found in the SDS-PAGE experiments in 
this work and by other researchers. 
The MALDI-ToF-MS spectra corresponding to RT and AS intact Vtg showed 
broad peaks for both species. The widths observed exceeded by 2 orders of magnitude the 
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theoretical calculated values observed in Figure 3.1 according to the empirical formula of 
RT Vtg. For both RT and AS Vtg, the [M+Ht ranged from m/z 170 to 210 kDa. This 
suggests the presence of sample microheterogeneity within the purified Vtg samples, 
which can be attributed to the presence of post translational modifications, or protein 
sequence variants, none of which can be resolved in this MS or typical SDS-PAGE 
experiments. This means that the peak observed in the MALDI-MS represents a family of 
Vtg molecular species, each contributing to the overall peak shape. Therefore, in the 
presence of such broad peaks, the apex of the peaks should be considered as an estimate 
of the relative molecular mass of all molecular species present in the samples. 
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Figure 3.1 Relative molecular mass and isotopic distribution predicted for RT Vtg 
The molecular weight of RT Vtg was calculated based on a molecular formula of 
C813sH13o4oN21960 2360S69, obtained from its corresponding sequence (Appendix 2: Entry Q92093). 
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Figure 3.2 MALDI-MS spectra of intact Vtg 
The top and bottom spectra show the peaks obtained for intact RT and AS Vtg, respectively. 
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The MALDI-ToF-MS spectra of AS Vtg showed an additional interesting feature. 
A small peak in the high mass range was observed at m/z 346713 (Figure 3.3). This peak, 
whose mass is nearly double the mass of the singly charged species, was attributed to the 
presence of the [2M+Ht species. This observation further supports the hypothesis that 
Vtg circulates in the bloodstream as a dimer. This fascinating observation is only possible 
due to the extremely soft ionization conditions offered by the MALDI source. Although 
the molecular mass of this dimer is still below that obtained from other studies using size 
exclusion chromatography under-non denaturing conditions, it is much closer to the 393 
kDa obtained by previous workers using SDS-P AGE. Nonetheless, it is not clear if such 
differences in molecular masses can be attributed exclusively to variations in the PTMs or 
the lipid content in this complex biomolecule. 
280000 
[2M+Ht 
mlz 346713 
'>'.'"~-"'-''' --·', 
3800011 .!MnM 
m/z 
Figure 3.3 High mass range MALDI-MS acquisition of intact Vtg 
The peak observed at m/z 346713 suggests the presence of a dimeric form of AS Vtg. 
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3.3 Digestion analyses of purified vitellogenin 
3.3.1 MALDI-MS of the CNBr and trypsin derived peptides of rainbow trout 
vitellogenin 
The purified RT Vtg was subjected to CNBr and trypsin digestions and the 
digested samples were subjected to MALDI-ToF-MS. CNBr cleaves proteins at the C-
terminal side of all methionine residues, affording homoserinelactone as a modified 
amino acid residue. Trypsin cleaves at the C-terminal side of both arginine and lysine 
residues, expect when followed by proline. The methodology used for these reactions was 
described in Section 3.1.3, while instrumental acquisition parameters were described in 
Section 3.1.6. The spectra obtained for the CNBr cleavage (Figure 3.4) and the tryptic 
digestion (Figure 3.5) confirmed the complexity ofthe samples analyzed. In spite ofthis, 
these spectra yielded a suitable set of peaks to perform the peptide mass fingerprint 
database search, as described in Section 3.1.7.3. The MASCOT (Perkins et al., 1999) 
search results of the CNBr cleavage identified this protein as RT Vtg, entry Q92093 on 
the Swiss-Prot Database. Twenty out of the 78 mlz values searched matched the predicted 
digestion, which allowed 36% sequence coverage. A list of these matching peptides and 
the complete set of searched fragments can be seen in Table 3.1. Identical results were 
obtained from the tryptic digest search. In this case 55 out of the 72 m/z values searched 
matched the predicted digestion, which allowed 3 7% sequence coverage. The results for 
this search are shown in Table 3.2. 
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Figure 3.4 MALDI-MS spectra of the CNBr cleavage of purified RT Vtg 
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The top spectrum was acquired using dihydroxybenzoic acid as matrix, scanning from m/z 800 to 
8000. The bottom spectum was acquired using sinapinic acid as matrix, scanning from mlz 3000 
to 20000. 
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Figure 3.5 MALDI-MS spectra of the trypsin digestion of purified RT Vtg 
The abscissa of the spectrum was split into two mlz ranges to facilitate the visualization of 
the peaks. The top and bottom spectra show the mlz ranges from 700 to 1650 and 1600 to 
3500, respectively. The MALDI-MS was operated in reflectron mode using DHB as matrix 
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Special precautions should be exercised when completing the PMF search queries, 
smce unexpected results can be obtained if the search parameters are not correctly 
evaluated. For example, when ±3 peptide mass tolerance and 2 missed cleavages were 
allowed, Q92093 no longer stood at the top score of the probable protein hits. As seen in 
Table 3.3, increasing the number of allowed missed cleavages did not increase 
significantly the number of matching sequences in the both types of digestions. This 
suggests that practically complete cleavage of the protein had taken place. Increased 
peptide mass tolerance resulted in a higher number of matching peptides, although the 
identity of these peptides should be confirmed in the case of increasing differences 
between the theoretical and the observed m/z values. 
A peptide map was built to show the distribution of the matching peptides of both 
digestions with respect to their positions in the intact Vtg sequence (Figure 3.6). The 
tryptic digest showed a more regular distribution of matching peptides along the main 
protein chain. Interestingly, the gaps between the matching peptides, indicated a large 
number of motifs, that were compatible with likely phosphorylation and glycosylation 
sites as predicted by the SCAN PROSITE (Gattiker et al., 2002; Sigrist et al., 2002; Hulo 
et al., 2004) and GlycoMod Tool programs(Cooper et al., 2001). The SCAN PROSITE 
program allows the user to scan a protein sequence for the occurrence of patterns and 
profiles stored in the database. Two possible N-glycosylation sites were identified in 
positions 1089-1092 (NGTR) and 1627-1630 (NRSE). A series of interlaced peaks found 
in the CNBr digestion of RT Vtg were compatible with a candidate peptide (positions 
1573 to 1643 of RT sequence) with different hybrid/complex glycan structures. These 
glycosylated peptides were tentatively assigned in Table 3.4. 
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Table 3.1 Peptide mass fingerprint ofthe CNBr chemical degradation ofRT Vtg 
The observed m/z corresponds to the monoisotopic peak observed in the MALDI-MS spectrum for this 
protein. The position indicates the location of the matching peptide in the amino acid sequence ofRT Vtg, 
entry Q92093 in the Swiss-Prot Database (See Appendix 2). The '*' shows the presence of an internal 
methionine (M) residue, indicating a missed cleavage site. 
Observed Calculated l::..mlz Sequence Position 
mlz m!z 
955.28 955.44 -0.16 GAATYNYLM 216-224 
1122.4 1122.51 -0.11 QVASFTYSHM 582-591 
1161.53 1161.63 -0.1 DKALHPELRM 543-552 
1187.46 1187.63 -0.17 GVNT AFIQAAIM 857-868 
1413.65 1413.77 -0.12 LACIVLFETKPPM 553-565 
1683.94 1683 0.94 GL VITLASILKTEKNM 566-581 
2039.13 2038.1 1.03 VRDTL TTFNNKKYKINM 1394-1410 
2499.19 2499.2 -0.01 KDFGLAYTEKCVECRQRGEALM 194-215 
2839.46 2838.42 1.04 KP ADNGALILEA TVTELHQFTPFNEM 225-250 
3383.62 3383.65 -0.03 KP ADNGALILEA TVTELHQFTPFNEMSGAAQM* 225-256 
3484.89 3483.64 1.25 KDFGLAYTEKCVECRQRGEALMGAATYNYLM* 194-224 
3925.31 3925.25 0.06 VIILFRL VRADHKIEGYQVTA YLNKA TSRLQIIM 1189-1222 
4062.94 4062.04 0.9 VSKYCVEHPNCP AEL VKPIHELA VQA V ANSKFEELSM 443-479 
4101.09 4101.17 -0.08 LTFVEIKKDPIIVPDNNYVHRGSIRYEFATEILQM 262-296 
4412.29 4410.29 2 VLLKKDHASEQNHINVKISDIDVDL YTEDHGVIVKVNEM 1430-1468 
4495.6 4494.56 1.04 IGKHSVLISVKPSASEPAIERLEFEVQVGPKAAEKIIKVITM 1022-1063 
5217.87 5217.97 -0.1 PIQLLKISNARAQA VKILNHL VTYNT APVHEDAPLKFLQFIQL 297-342 LRM 
5546.95 5547.95 -1 QKDKNNEKQIQFTVV ATSERTLDVILKTPKMTL YKLGVNLP 1317-1365 CSLPFESM* 
RRVIKALSDWRSLATSKPLASIYVKFFGQEIAF ANIDKSIIDQA 
10056.36 10055.61 0.75 LQLANSPSAHALGRNALKALLAGATFQYVKPLLAAEVRRIF 708-800 
PTAVGLPM 
AALDENDNWKLCADGVLLSKHKVT AKIA WGAECKDYNTFI 
10510.86 10511.56 -0.7 T AETGL VGPSPA VRLRLSWDKLPKVPKA VWRYVRIVSEFIPG 1223-1316 
YIPYYLADL VPM 
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Table 3.2 Peptide mass fingerprint of the trypsin digestion ofRT Vtg 
Refer to legend in Table 3 .I for details. The '*' sign shows the presence of an internal lysine (K) or 
arginine (R) residue, indicating a missed cleavage site. 
Observed Calculated l:J.mlz Sequence Position 
m/z mlz 
747.31 747.37 -0.06 DKNNEK* 1319-1324 
777.34 777.40 -0.06 VVDWMK 1516-1521 
788.34 788.44 -0.10 THYVIR 164-169 
811.4 811.53 -0.13 ILLPDLK 1082-1088 
934.38 934.45 -O.o? IAWGAECK 1249-1256 
953.33 953.41 -0.08 DASECLMK 1566-1573 
963.5 963.58 -0.08 IQTHPVLR 425-432 
986.46 986.57 -0.11 LSWDKLPK* 1279-1286 
1028.44 1028.50 -0.06 NVEDVPAER 918-926 
1043.43 1043.51 -0.08 DFGLAYTEK 195-203 
1054.35 1053.51 0.84 DTLTTFNNK 1396-1404 
1071.49 1071.55 -0.06 CLPGCLPVR 1601-1609 
1079.47 1079.55 -0.08 LPPAPENADR 694-703 
1095.51 1095.58 -O.o? FEELSMVLK 474-482 
1108.53 1108.61 -0.08 QMLTFVEIK 260-268 
1122.5 1122.56 -0.06 CYSVEPVLR 1592-1600 
1145.54 1145.62 -0.08 LEFEVQVGPK 1043-1052 
1157.55 1157.63 -0.08 LVESLAFNHK 415-424 
1172.65 1172.73 -0.08 LAPMVIILFR 1185-1194 
1177.64 1177.71 -O.o? FLQFIQLLR 333-341 
1188.64 1188.62 O.o2 QVIVDDRESK* 1582-1591 
1216.52 1214.67 1.85 LEKQVIVDDR* 1579-1588 
1235.7 1235.75 -0.05 ITPLIPAQGVAR 927-938 
1378.67 1378.74 -0.07 QIQFTVVATSER 1325-1336 
1387.5 1387.59 -0.09 DGPDQPYNPNDR 1134-1145 
1408.64 1408.71 -0.07 DSQSTSNVISRSK* 1153-1165 
1419.7 1419.69 0.01 DLNNCQQRIMK* 184-194 
1429.67 1429.71 -0.04 ELTMLGYGTMVSK 433-445 
1459.79 1459.85 -0.06 LTSALAAQFSIPIK 95-108 
1509.87 1509.92 -0.05 LLPVFGTAAAALPLR 499-513 
1515.62 1515.68 -0.06 DGPDQPYNPNDRK* 1134-1146 
1537.72 1537.78 -0.06 MVQEVAVQLFMDK 532-544 
1553.68 1551.78 1.90 DPIIVPDNNYVHR 270-282 
1574.79 1574.90 -0.11 ALGNAGHPASIKPITK 483-498 
1635.7 1635.75 -0.05 ACFEFTSESAAFIR 1001-1014 
1638.8 1638.85 -0.05 TYFAGAAADVLEVGVR 668-683 
1665.78 1665.78 0.00 VNEMEISNDNLPYK 1465-1478 
1679.87 1679.89 -0.02 KDPIIVPDNNYVHR * 269-282 
1700.84 1700.92 -0.08 YEALLLGGLPEEGLAR 34-49 
1739.88 1738.80 1.08 VVDWMKGQTCGLCGK* 1516-1530 
1777.85 1777.92 -O.o? L VNPEIFEYSGVWPK 72-86 
1806.93 1806.99 -0.06 HWILDAVPSIGSSV A VR 363-379 
1894.78 1894.90 -0.12 TQNVYELQEAGAQGVCK 147-163 
1921.89 1921.89 0.00 SSVSF AHSWVLPSDSCR 1549-1565 
1969.01 1969.02 -0.01 IGAAASAFYINDAA TLFPR 642-660 
2032.05 2033.01 -0.96 LGVKACFEFTSESAAFIR * 997-1014 
2063.13 2062.10 1.03 SIIDQALQLANSPSAHALGR 746-765 
2109.06 2108.06 1.00 DYNTFIT AETGL VGPSPA VR 1257-1276 
2132.19 2131.22 0.97 ALLAGATFQYVKPLLAAEVR 770-789 
2156.12 2155.09 1.03 TTPITIGFHCLPVDSNLNR 1610-1628 
2230.3 2229.08 1.22 LSCHFSQAIHLDA YSNPLR 623-641 
2246.17 2245.22 0.95 NVEDVP AERITPLIPAQGV AR * 918-938 
2351.09 2350.28 0.81 GSIRYEFA TEILQMPIQLLK* 283-302 
2386.23 2385.18 1.05 RLSCHFSQAIHLDA YSNPLR * 622-641 
2608.69 2607.33 1.36 FEAFPVSPPEHIAAAHIETF A V AR 894-917 
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Table 3.3 Optimization of peptide mass fingerprint matching parameters 
The top and bottom tables correspond to the CNBr and trypsin digestions, respectively. The number of missed 
cleavages and the peptide mass tolerance were the two parameters which were adjusted for the database 
search. The number of matching peptides and the sequence coverage of RT Vtg are indicated by the letters 
'm' and 'sc', respectively. 
CNBr Number of missed cleavages 
0 1 2 
m sc m sc m sc 
0.5 9 11% 10 13% 10 13% 
Peptide mass 1 15 27% 16 27% 16 27% 
tolerance (rnlz) 2 21 33% 25 36% 25 36% 
3 26 38% 31 41% 31 41% 
Trypsin Number of missed cleavages 
0 1 2 
m sc m sc m sc 
0.5 37 25% 41 27% 43 28% 
Peptide mass 1 41 30% 48 32% 51 33% 
tolerance (rnlz) 2 47 36% 56 37% 59 39% 
3 49 38% 59 38% 63 40% 
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Figure 3.6 Peptide map obtained for RT Vtg 
The horizontal central line represents the sequence ofRT Vtg. The numbers indicate the amino acid 
positions along this protein. The horizontal segments represent the peptides found in the peptide 
mass fingerprints ofthe CNBr and trypsin (T) digestions obtained from the MALDI-MS and ESI-
MS experiments. The positions of post-translational modification (PTM) consensus motifs are 
shown with vertical lines. 
Table 3.4 Putative glycan structures found in RT Vtg 
Proposed structures of different glycans compatible with the peaks found in the MALDI-MS of the 
CNBr cleavage of RT Vtg. Hex stands for hexose, HexNAc for N-acetylhexose amine, NeuGc for N-
glycolyl neuraminic acid, Phos for phosphate, Man for mannose and GlcNAc for N-
acetylglucosamine. 
Glycoform Glycan structures Calculated Observed !J..mlz 
mass [M+Ht [M+Ht 
1927.552 (Hex)1 (HexNAc)2 (NeuGc)I 9825.65 9825.33 -0.32 (Phos)2 + (Man)3(GlcNAc)2 
2157.783 (Hex)1 (HexNAc)4 (NeuAc)1 + 10055.88 10056.36 0.48 (Man)3(GlcNAc )2 
2268.673 (Hex)5 (HexNAc)2 (Phos)2 + 10166.77 10167.17 0.40 (Man)3(GlcNAc )2 
2294.771 (HexNAc)s (NeuGc)I (Phos)I 10192.87 10193.23 0.36 
+ (Man)3(GlcNAc )2 
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3.3.2 ESI-MS of the trypsin derived peptides of rainbow trout vitellogenin 
The separation of the RT Vtg tryptic peptides followed by MS analysis using a 
HPLC-ESI-QqToF MS showed a total ion chromatogram (TIC) with numerous 
overlapping peaks. The analytical parameters selected for the HPLC-ESI-QqToF MS 
acquisition were described in Section 3.1.5. A perusal of the different full scan mass 
spectra revealed a total of eighty-one peptides matching the predicted digestion of RT Vtg 
(Refer to Section 3.1.7.2 for details on the Vtg digestion simulation). Matching was done 
by considering both the mass and charge of each of the peaks obtained in the spectra. The 
total number of peptides generated by the simulated digestion of RT Vtg was 377. In this 
digestion simulation, pairs of peptides were noticed, which, in spite of having different 
empirical formulae, had similar molecular masses. For this reason, it was not surprising to 
find a couple of spectra which contained peaks that could be assigned to more than one 
candidate tryptic peptide, as exemplified in Table 3.5. Eight pairs of isobaric peptides that 
matched peaks obtained in the spectra from the TIC chromatograms were found. For 
these particular isobaric peptides, sequence confirmation can only be achieved through 
MS/MS experiments. When comparing the MALDI-MS and ESI-MS results of the tryptic 
digestion, 29 matching peaks were found. For this, the [M+Ht of the ESI-MS peaks were 
calculated for comparison because most of them were found as multiple charged species 
(Table 3.6). 
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Table 3.5 Isobaric peptides found in the tryptic digestion ofRT Vtg 
The following peaks identified by HPLC-ESI-MS matched isobaric tryptic peptides predicted by the 
simulated digestion ofRT Vtg. 
Theoretical Calculated 
[M+Ht [M+Ht 
Sequence Formula mlz mlz !J.m/z 
TLDVILK C37H6sNs011 801.51 -0.15 
AGVKVISK C36H6sN wO 10 801.52 801.36 -0.16 
QVIVDDR C3sH61NJIOI3 844.45 844.29 
-0.16 
DPFVPAAK C4oH61N9011 844.46 -0.17 
DSQSTSNVISRSK CssH97N 19024 1408.70 1408.43 -0.27 
FAAQLDIANGNFK C64H97N17019 1408.72 0.01 
IHYLFSEVNA VK C67HwzN1601s 1419.76 -0.27 1419.49 
DLNNCQQRIMK Cs6H9sNzoOJ9Sz 1419.68 -0.19 
DASECLMKLESVK C62HwsN16023S2 1509.73 -0.12 
LLPVFGTAAAALPLR CnHJzoNJs017 1509.92 1509.61 -0.31 
HSVLISVKPSASEP AIER Cs4H142N24027 1920.06 -0.37 
1919.69 
EPRMVQEVAVQLFMDK Cs4H 13sNzzOzsS2 1919.97 -0.28 
ILNHLVTYNTAPVHEDAPLK CwzH161N2703o 2245.20 -0.43 
2244.77 
NVEDVPAERITPLIPAQGV AR C9sH16sNz9031 2245.23 -0.46 
84 
Table 3.6 MALDI and HPLC-ESI-MS matching tryptic peptides ofRT Vtg 
Refer to legend in Table 3.1 for details. The mlz values for the peaks obtained from the ESI 
experiments correspond to calculated [M+Ht species. 
ESI MALDI llmlz Sequence Position 
m/z mlz 
811.33 811.40 -0.07 ILLPDLK 1082-1088 
986.35 986.46 -0.10 LSWDKLPK 1279-1286 
1043.20 1043.43 -0.23 DFGLAYTEK 195-203 
1071.33 1071.49 -0.16 CLPGCLPVR 1601-1609 
1095.35 1095.51 -0.16 FEELSMVLK 474-482 
1108.43 1108.53 -0.10 QMLTFVEIK 260-268 
1122.35 1122.50 -0.15 CYSVEPVLR 1592-1600 
1145.41 1145.54 -0.13 LEFEVQVGPK 1043-1052 
1172.47 1172.65 -0.18 LAPMVIILFR 1185-1194 
1177.49 1177.64 -0.15 FLQFIQLLR 333-341 
1188.45 1188.64 -0.19 QVIVDDRESK 1582-1591 
1235.51 1235.70 -0.19 ITPLIPAQGVAR 927-938 
1378.73 1378.67 0.06 QIQFTVV ATSER 1325-1336 
1408.43 1408.64 -0.21 DSQSTSNVISRSK 1153-1165 
F AAQLDIANGNFK 881-893 
1419.49 1419.70 -0.21 IHYLFSEVNA VK 1379-1390 
DLNNCQQRIMK 184-194 
1429.47 1429.67 -0.20 ELTMLGYGTMVSK 433-445 
1459.59 1459.79 -0.20 L TSALAAQFSIPIK 95-108 
1509.61 1509.87 -0.26 LLPVFGTAAAALPLR 499-513 DASECLMKLESVK 1566-1578 
1537.45 1537.72 -0.27 MVQEV A VQLFMDK 532-544 
1638.49 1638.80 -0.31 TYFAGAAADVLEVGVR 668-683 
1665.45 1665.78 -0.33 VNEMEISNDNLPYK 1465-1478 
1679.60 1679.87 -0.27 KDPIIVPDNNYVHR 269-282 
1700.57 1700.84 -0.27 YEALLLGGLPEEGLAR 34-49 
1739.54 1739.88 -0.34 VVDWMKGQTJGLJGK 1516-1530 
1777.63 1777.85 -0.22 L VNPEIFEYSGVWPK 72-86 
1806.61 1806.93 -0.32 HWILDA VPSIGSSV A VR 363-379 
1894.61 1894.78 -0.17 TQNVYELQEAGAQGVCK 147-163 
1921.46 1921.89 -0.43 SSVSF AHSWVLPSDSCR 1549-1565 
1968.69 1969.01 -0.32 IGAAASAFYINDAATLFPR 642-660 
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3.3.3 ESI-MS/MS of the trypsin derived peptides of rainbow trout vitellogenin 
The same instrumentation described in the previous section was used to perform 
the MS/MS experiments. The acquisition and instrument parameters were set as described 
in Section 3.1.5. An Information Dependent Acquisition (IDA) was performed to 
automatically select the most abundant peaks found in the full scan MS. These precursors 
were then automatically selected for collision induced dissociation (CID) MS/MS. 
Unfortunately, only ten product ion spectra contained information of diagnostic value. 
Interpretation of these spectra was done by a computer based sequencing algorithm, 
called Lutefisk (Taylor and Johnson, 1997; Taylor and Johnson, 2001 ), described in 
Section 3 .1. 7 .4. Sequence alignment between the 'de novo' sequenced tryptic peptides 
and the published sequence of RT Vtg was performed using Cidentify (Section 3.1.7.5). 
The top scored sequenced peptides and their alignment with RT Vtg are shown in Table 
3.7. The selected precursor peptide ions at mlz 816.69, 819.75, 849.24, 850.79, 912.91 
and 984.85 showed partial sequence homology with RT Vtg, shown in boldface font in 
the last column of Table 3.7. 
Some sequence variants were observed when comparing the sequences obtained 
by Lutefisk to the published RT Vtg sequence. Sometimes, the information provided by 
the product ion spectrum is insufficient to provide complete 'de novo' sequencing and in 
these cases the software showed the masses of these missing gaps in brackets. Other 
explanations of sequence variants can be attributed to isobaric sequences of amino acids, 
which sometimes render very similar mass patterns. An example of both of these 
situations can be observed for the product ion spectrum of the precursor ion at m/z 819.27 
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where the [264.1] gap corresponds to the same mass as the [TY] fragment, which is 
present in the database sequence. In this same sequence, the internal K residue assigned 
by Lutefisk is isobaric with the [GA] dipeptide fragment observed in the database 
sequence while the remainder of the sequence bears perfect homology with RT Vtg. 
Similar analogies can be made for the rest of the precursor ion spectra. 
Table 3.7 'De novo' sequencing and sequence homology ofRT Vtg tryptic peptides 
Mr indicates the relative molecular mass of the precursor ions. The numbers between brackets under the 
Sequence column indicate mass gaps that could not be assigned to any particular amino acid sequence. 
The matching amino acid residues indicating homology to the RT Vtg sequence are shown in bold font. 
Precursor Charge Mr Sequence Sequnce homolgy ion (m/z) (+) 
816.69 2 1631.37 WALMGAATYNYLMK GEALMGAATYNYLMK 
819.72 2 1637.43 [264.1 ]F AKAADVLEVGVR TYFAGAAADVLEVGVR 
828.83 2 1655.65 W[287.1 ]HYFY[216.0]LPK No match 
849.14 2 1696.27 MA[291.0]LLNAL W AEFK MASSETINAIW AEFK 
850.75 2 1699.49 [292.1 ]ALLLGGL[231.0]MY AR YEALLLGGLPEEGLAR 
858.55 3 2572.64 [274.0][244.0]GD[212.1 ]KYNFLA No match VFAYHGNK 
912.91 2 1823.81 [243.1 ]DEPGMCSGAAKMEAK FTPFNEMSGAAQMEAK 
984.77 2 1967.53 [270.1 ]LSAFYLNDAA TLFPR IGAAASAFYINDAA TLFPR 
1044.26 2 2086.51 [232.0]NEL[346.1 ]D[320.0]TLDG No match ANK 
1064.06 2 2126.11 [269.2]S[ 158.0]S[283.2]LN[213.1] No match LSS[l68.l]TAR 
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An interesting case is illustrated by the sequencing of the precursor ion at mlz 
912.91. There was no peptide that matched the mass of this precursor in the digestion 
simulation of RT Vtg, however, a significant sequence homology was found to a portion 
of this protein. This suggests that a sequence variant that produced a different tryptic 
peptide may be present. 
3.3.4 MALDI-MS of the trypsin derived peptides of Atlantic salmon vitellogenin 
The spectrum obtained by MALDI-ToF-MS for the tryptic digestion of the 
purified AS Vtg is shown in Figure 3.7. The major peaks from this spectrum were used 
for protein identification using the PMF search in MASCOT (Section 3.1.7.3), however 
none of the proteins in the database showed a statistically significant hit from this list of 
peaks. This was expected, since the complete sequence of AS has not yet been reported. 
However, RT Vtg (See Appendix 2: entry Q92093 on the Swiss-Prot Database) 
was the protein with the most matching peptides for this peak list. In fact, thirty-one 
searched peaks matched known peptides resulting from the tryptic digestion of the R T 
Vtg and a list of these can be seen in Table 3.8. Note that the last column shown in this 
table corresponds to the position along the RT Vtg sequence. 
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Figure 3.7 MALDI-MS spectra of the tryptic digestion of purified AS Vtg 
The abscissa of the spectrum was split into two mlz ranges to facilitate the visualization of the 
peaks. The top and bottom spectra show the mlz ranges from 550 to 1750 and 1550 to 3050, 
respectively. 
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Table 3.8 Peptide mass fingerprint of the trypsin digestion of AS Vtg 
Refer to legend in Table 3.2 for details. 
Observed m/z Calculated m/z tJ.mlz Sequence Position 
685.34 683.42 1.92 HKVTAK* 1243-1248 
747.43 747.38 0.05 ALSDWR 713-718 
777.41 777.40 0.01 VVDWMK 1516-1521 
1043.56 1043.51 0.05 DFGLAYTEK 195-203 
1054.61 1055.62 -1.01 VQADAVLALR 514-523 
1071.64 1071.55 0.09 CLPGCLPVR 1601-1609 
1095.62 1095.58 0.04 FEELSMVLK 474-482 
1108.68 1108.61 0.07 QMLTFVEIK 260-268 
1122.63 1122.56 0.07 CYSVEPVLR 1592-1600 
1145.69 1145.62 0.07 LEFEVQVGPK 1043-1052 
1195.79 1197.59 -1.80 SSASSFHAIYK 1166-1176 
1378.84 1378.74 0.10 QIQFTVV ATSER 1325-1336 
1389.89 1389.61 0.28 KSESSSSSSSSSSR* 1116-1129 
1418.80 1419.69 -0.89 DLNNCQQRIMK* 184-194 
1459.94 1459.85 0.09 L TSALAAQFSIPIK 95-108 
1476.89 1477.87 -0.98 SLATSKPLASIYVK 719-732 
1510.10 1509.92 0.18 LLPVFGT AAAALPLR 499-513 
1531.94 1533.89 -1.95 VLISA V AENTYLLK 58-71 
1575.80 1575.72 0.08 VITMNEEEEAPEGK 1060-1073 
1588.96 1589.73 -0.77 SESSSSSSSSSSRISK* 1117-1132 
1639.06 1638.85 0.21 TYFAGAAADVLEVGVR 668-683 
1687.20 1686.80 0.40 CSMVRDTLTTFNNK* 1391-1404 
1740.15 1738.81 1.34 VVDWMKGQTCGLCGK* 1516-1530 
1778.12 1777.92 0.20 L VNPEIFEYSGVWPK 72-86 
1895.09 1894.90 0.19 TQNVYELQEAGAQGVCK 147-163 
1922.19 1922.08 0.11 ATLTPALPETFHAAQLLK 818-835 
1968.36 1969.02 -0.66 IGAAASAFYINDAATLFPR 642-660 
2032.45 2033.02 -0.57 LGVKACFEFTSESAAFIR * 997-1014 
2128.44 2130.10 -1.66 VITMNEEEEAPEGKTVLLK* 1060-1078 
2163.95 2162.15 1.80 TEGIQEALLKLPPAPENADR * 684-703 
2945.53 2944.57 0.96 IFPTAVGLPMELSYYTAAVAKAYVNVR * 791-817 
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No match was found for the tryptic peptide ions at m/z 569.09, 615.08, 643.05, 
676.39, 868.53, 927.50, 960.63, 990.64, 1253.77, 1342.84, 1450.92, 1615.83, 1652.00, 
1726.99, 1872.26, 2094.40, 2183.15, 2192.64, 2318.37, 2369.56, 2453.16, 2562.85 and 
2618.36. These remaining non-identified peaks may tentatively be assigned to either 
exclusive AS Vtg tryptic peptides or post-translational modified peptides, which are not 
taken into account for the peptide mass fingerprint. 
3.3.5 ESI-MS of the trypsin derived peptides of Atlantic salmon vitellogenin 
The analysis of the tryptic digestion of AS Vtg by HPLC-ESI-QqToF MS (Section 
3.1.5) showed numerous full scan spectra containing peaks which matched the masses of 
those predicted by the tryptic simulation (see Section 3.1.7.2) of both the RT and AS Vtg. 
Matching was done by comparing the monoisotopic mlz values seen in the spectra with 
the predicted multiply charged peptide ions considering a mlz peak tolerance of ±0.5. The 
charge of the peptide ions was confirmed by resolving the peak isotopic cluster. These 
matching peptides are presented in Table 3.9. 
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Table 3.9 Separation of AS Vtg tryptic peptides by HPLC-ESI-MS 
The retention time (Rt) of the peptides is given minutes (min). The observed (Obs) and calculated (Cal) 
m/z values are shown for each particular charged molecular species. 
Rt [M+Hr [M+2Hf+ [M+3H]3+ 
Peptide Species min Obs Cal Obs Cal Obs Cal 
mlz mlz mlz mlz mlz mlz 
TLDVILK RT 801.5 401.3 
18.8 801.4 401.2 
AGVKVISK RT 801.5 401.3 
DTLTTFNNK RT 22.5 1054.3 1053.5 527.6 527.3 
VQADAVLALR RT 19.2 1055.4 1055.6 528.2 528.3 
FEELSMVLK RT 21.0 1095.3 1095.6 548.2 548.3 
TEGJQEALLK RT 18.9 1101.4 1101.6 551.2 551.3 
QMLTFVEIK RT 2I.I 1108.4 1108.6 554.7 554.8 
LEFEVQVGPK RT 19.6 1145.4 1145.6 573.2 573.3 
SEGLSSFYEK AS 18.7 1146.3 1146.5 573.6 573.8 
GJLNILQLNIK RT 23.9 1238.5 1238.8 619.8 619.9 
QIQFTVV ATSER RT 21.9 1378.4 1378.7 689.7 689.9 
L TSALAAQFSIPIK RT 21.8 1459.5 1459.9 730.3 730.4 487.2 487.3 
DASECLMKLESVK RT 1509.7 755.4 503.9 
23.5 1509.6 755.3 503.9 
LLPVFGTAAAALPLR RT 1509.9 755.5 504.0 
DGPDQPYNPNDRK RT 1515.7 758.4 505.9 
21.0 1516.4 758.7 506.1 
DASECLMTFESVK AS 1516.7 758.8 506.2 
VLISAV AENTYLLK RT 21.7 1533.5 1533.9 767.3 767.5 511.9 512.0 
VITMNEEEEAPEGK RT 16.6 788.2 788.4 
SESSSSSSSSSSRISK RT 20.3 794.8 795.4 530.2 530.6 
TYFAGAAADVLEVGVR RT 22.2 1638.5 1638.9 819.8 819.9 546.8 547.0 
ADGEVRQEYSTPSGR AS 23.2 1651.5 1651.8 826.3 826.4 551.2 551.3 
AIVVHLEETICVER RT 22.6 834.3 833.4 556.5 555.9 
CSMVRDTL TTFNNK RT 22.0 1686.4 1686.8 843.8 843.9 562.9 562.9 
VVD~KGQTCGLCGK RT+AS 19.9 870.3 869.9 580.5 580.3 
L VNPEIFEYSGVWPK RT 889.5 593.3 
23.1 889.3 593.2 
STAPDFASVAAACNVAVK RT 889.9 593.6 
HSVLISVKPSASEP AIER RT 960.5 640.7 
26.5 959.8 640.2 
EPRMVQEVAVQLFMDK RT 960.5 640.7 
SSVSFAHSVVVLPSDSCR RT+AS 961.5 641.3 
19.8 961.2 641.2 
ATLTPALPETFHAAQLLK RT 961.5 641.4 
IGAAASAFYINDAA TLFPR RT 22.7 984.3 985.0 656.5 657.0 
ISDIDVDL YTEDHGVIVK RT 22.1 I 016.3 1016.0 677.9 677.7 
TTPITIGFHCLPVDSNLSR AS 20.6 1064.3 1064.6 709.9 710.0 
MASSETINAIW AEFKAKPA Y R RT 1192.6 795.4 
INMPLSCYQVLAQDCTTELK RT 22.4 1193.4 1192.6 795.9 795.4 
RLSCHFSQAIHLDA YSNPLR RT 1193.1 795.7 
QKGEGVSL Y APSHGLQEVYF DK AS 19.2 1226.3 1226.6 817.9 818.1 
AQA VKILNHL VTYNT APVHE DAPLK RT 25.2 1370.8 1371.8 914.2 914.8 
IFPTAVGLPMELSYYT AA VA KA YVNVR RT 24.9 1471.9 1472.8 981.6 982.2 
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In this digestion simulation, pairs of peptides were noticed which, in spite of 
having different amino acid composition, had similar molecular masses. For this reason, 
six doubly charged peptide ions observed at mlz 401.16, 755.28, 758.67, 889.25, 959.79 
and 961.24 were assigned to two candidate isobaric tryptic peptides predicted by the 
digestion of AS and RT Vtg, as shown in Table 3.9. In fact, one ion at mlz 1193.35 could 
be assigned three isobaric tryptic peptides. It should also be noted that two [M+2Hf+ 
peaks at mlz 870.29 and 961.24 were assigned to peptides that were present in both AS 
and RTVtg. 
3.3.6 ESI-MS/MS of the trypsin derived peptides of Atlantic salmon vitellogenin 
The instrumental parameters selected for this particular analysis were identical to 
those used for the ESI-MS/MS experiments performed on RT Vtg, described in section 
3.3 .3. The results from these experiments revealed and confirmed the identity of some of 
the tryptic peptides found in the previous section. Unfortunately, a chromatographic 
tailing effect was observed for some peaks. This caused some precursor peptide ions to be 
repeatedly selected throughout the chromatogram during the IDA experiments which led 
to a reduced list of precursors selected for CID-MS/MS. 
Furthermore, because of the strict parameters chosen for Lutefisk analyses (See 
Section 3.1.7.4 for the details on 'de novo' sequencing ofpeptides obtained from MS/MS 
spectra) many of the product ion spectra had to be discarded for sequencing purposes. 
The results ofthe interpretation of all the MS/MS spectra are shown in Table 3.10. 
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Table 3.10 'De novo' candidate sequences ofthe AS Vtg tryptic digestion 
The following candidate sequences were obtained from the Lute fisk analyses of the product ion spectra 
generated by the HPLC-ESI-MS/MS experiments on the AS Vtg tryptic digestion. The letters between 
brackets correspond to pairs of amino acids that match a mass gap, but whose order could not be 
assigned. The numbers between brackets under the Candidate sequences column indicate mass gaps that 
could not be assigned to any particular amino acid sequence. 
precursor ion Charge Calculated Candidate sequences (m/z) (+) Mr 
788.28 2 1574.47 [212.15]TMNEEEEAPEGK 
[212.15]TMNEEEEAPWK 
[212.15]TMNEEEAEPEGK 
573.66 2 1145.31 [216.08]GLSSFYEK 
700.2 2 1398.39 [242.10]AMLGYG[PV][l94.08]R 
[242 .1 O]AMLGYGTL[204.09]K 
794.75 2 1587.55 [l84.08]A VQLEDTLCAER 
[ 184.12]A VKLEDTLCAER 
[l84.12]A VGALEDTLCAER 
834.31 2 1666.61 [276.14][242.14]VLEAL YWKK 
[276.14]ALYLAELV[244.12]QK 
[276.14][242.12]VLEALYWQK 
889.28 2 1776.55 [212.15]NEPLFEYSRWPK 
[212.15]NEPLFEYS[GV]WPK 
[212.15]NEPLFEYSR[l86.07]PK 
[212.15]N[202.1 O]HFEYSRWPK 
[212.15]NEPLFEYS[GV)[l86.10]PK 
819.79 2 1637.57 [TY]F AGAAADVLEVGVR 
[TY]F AGAAADVLEVRR 
[TY]FAGAAADVLEV[l84.12]K 
561.68 2 1121.35 CYSV[DH]WR 
865.27 2 1728.53 [241.14]NLLAALDESDNWK 
[241.14)NLLAALDESDN[l86.07)K 
843.81 2 1685.61 [EY]AL VLG[DH]LL[RC)K 
[EY)A VLLG[DH]VLLA[274.07) 
572.2 2 1142.39 LPTVTE[243 .08)LK 
795.18 1 794.17 M[244.12]QWS 
893.28 2 1784.55 [212.15]TNDDH[204.09]EDW[LP]K 
791.05 4 3160.19 [MT][225.15]LMEFE[WW] [212.15]AA VHFNLEPCANK 
[MT]NELLEFET[RD)[212.15]AA VHFNLEPCANK 
[199.14]EELMEFE[WW][212.15]AAVHDMAGTLNENK 
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Less stringent sequencing parameters would have yielded a higher number of 
matching peaks, however, this would have compromised the sequencing quality, 
increasing the number of candidate peptides for each product ion spectrum. Thus, only 
fourteen product ion spectra were completely sequenced by Lutefisk. An example of two 
product ion scans obtained from doubly charged precursors at mlz 819.79 and m/z 788.24 
are shown in Figure 3.8. B-andY- type fragment ions are indicated above the peaks with 
heir corresponding single letter amino acid code sequence. 
As with other sequencing programs, Lutefisk generates a list of sequence 
candidates. For that reason, some spectra were assigned more than one sequence, as seen 
in Table 3.10. However, it should be noted that many of them are usually simply 
inversion of dipeptides or isobaric amino acid replacements. In addition, incomplete 
sequence data provided the location and mass of a dipeptide, but not the exact sequence. 
In these cases, the sequencing program showed the nominal mass of the corresponding 
dipeptide between brackets, in the position along the sequence. When the mass of the 
dipeptide is accurate enough, its composition is shown between brackets, although the 
order is unknown. The isomeric pair, leucine and isoleucine are not distinguishable under 
the experimental conditions selected for this experiment. For this reason they are both 
designated with the letter L by the sequencing algorithm. 
The results of the alignment of the sequenced peptides obtained by tandem mass 
spectrometry, with the six proteins chosen for comparison using CIDentify (Taylor and 
Johnson, 2001) (Section 3.1.7.5), are shown in Table 3.11. 
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Figure 3.8 Graphical interpretation ofCID-MS/MS spectra 
The left and right figures correspond to the product ion spectra obtained from the precursor 
ions at mlz 788. 24 and 819.79, respectively. The amino acid sequence of the peptides is 
given in the single letter code above the corresponding Y and B product ions. 
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Eleven of them showed at least some degree of homology with the published R T 
Vtg sequence. Two of the sequenced peptides obtained from the precursor ions at m/z 
573.66 and m/z 561.68 also showed homology with the published AS sequence. In fact, 
the sequence from the precursor ion at m/z 573.66 proved to be a better match with the 
AS Vtg than the RT Vtg. Three sequences from the precursor peptide ions at mlz 795.18, 
893.28 and m/z 791.05 did not show any homology with the selected proteins. Finally, 
none of the sequences generated corresponded to trypsin autolysis peptides or aprotinin 
tryptic peptides. 
Table 3.11 'De novo' sequencing and sequence homology of AS Vtg tryptic peptides 
Mr indicates the relative molecular mass of the precursor (Prec) ions. The numbers between brackets under the 
Lutefisk output column indicate mass gaps that could not be assigned to any particular amino acid sequence. The 
matching amino acid residues indicating homology to the RT Vtg sequence are shown underlined. In bold font 
appear the conserved substitutions found in the analyzed peptides. RT 1,2,3 and 4 correspond the four variant 
sequences ofRT Vtg found in the Swiss-Prot database. 
Prec. Calc. Lutefisk output Match Database sequence Mr (rnlz) Mr 
788.3 1574.5 [212.15]TMNEEEEAPEGK RT EKIIK VITMNEEEEAPEGK TVLLK 1574.7 
AS SNLSR EGLSSFYEK SVDLR 1145.5 
573.7 1145.3 [216.08]GLSSFYEK 
RT SNLNR SEGLSSIYEK SVDLM 1111.5 
700.2 1398.4 [242.1 O]AMLGYGTL[204.09]K RT HPVLR ELTMLGYGTMVSK YCVEH 1428.7 
794.8 1587.6 [184.12]AVELEDTLCAER RT KPIIK AlyYHLEETICVER LGVKA 1666.9 
RTI,3,4 EFIPGYIPYYLADL VPMQK DKNNE 2555.3 
834.3 1666.6 [276.14]AL YLAELV[244.12]QK 
RT2 EFIPGHIPYYLADL VPMQK DKNSE 2529.3 
889.3 1776.6 [212.15]NEPLFEYS[GV]WPK RT TYLLK L \'NPEIFEYSGVWPK DPFVP 1776.9 
819.8 1637.6 [TY]F AGAAADVLEVGVR RT VAKAR TYFAGAAADVLEVGVR TEGIQ 1637.8 
561.7 1121.4 CYSV[DH]WR RTand DRESK CYSVEPVLR CLPGC 1121.6 AS 
RTI,3,4 KATSR LQIIMAALDENDNWK LCADG 1772.9 
865.3 1728.5 [241.14]NLLAALDESDNWK 
RT2 TTSDEPQIIT AALDENDNWK LCADG 2260.1 
843.8 1685.6 [EY]A VLLG[DH]VLLA[274.07] RT TYVYK YEALLLGGLPEEGLAR AGVK 1699.9 
572.2 1142.4 LPTVTE[243.08]LK RT GALILEATVTELHQFTPFN 3630.7 
795.2 794.2 M[244.12]QWS none 
893.3 1784.6 [212.15]TNDDH[204.09]EDW[LP]K none 
791.1 3160.2 [MT]NELLEFET[RD][212.15]AA VHFNLEPCANK none 
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A thorough inspection of the alignments (Table 3.11) permitted the elucidation of 
some of the differences found between the sequenced peptide ions and the database 
sequences. The CID-MS/MS of the selected precursor peptide ion at mlz 788.28 showed a 
gap at the beginning of the sequence of 212.15. This mass is compatible with the 
dipeptide VI, which agrees with the sequence found for the RT Vtg. A similar situation 
has been observed in the CID-MS/MS of selected precursor peptide ions at m/z 573.66, 
700.20, 794.75, 834.31, 889.28 and mlz 865.27, in which the 216.08, 242.10, 184.08, 
276.14, 212.15 and 241.14 gaps could be replaced by the dipeptides SE, EL, AI, YI, LV 
and LQ, respectively, confirming protein homology. Although not completely sequenced, 
dipeptides [GV], [TY] and [EY] were correctly assigned in the precursor peptide ions at 
m/z 889.28, 819.79 and mlz 843.81. Additionally, the precursor peptide ion at 834.31 
possessed a gap of244.12 near the carboxyl terminal which, interestingly, agrees with the 
PM dipeptide, in which the methionine has been oxidized. 
It is noteworthy that some non-matching amino acids found between the 
sequenced precursor peptide ions and the database sequences are replacements with 
others of similar physicochemical properties. Some of these sequence variants are 
supported by the difference between the calculated Mr of the precursor peptide ions and 
the theoretical Mr of the tryptic peptides found in the database, as seen in Table 3.11. 
These conservative substitutions can be seen in the precursor peptide ions at m/z 834.31, 
where an aspartic acid (D) residue has been found in place of a glutamic acid (E). 
Another D-E replacement and an alanine (A) in place of a valine (V) in two other sites 
can be seen in the peptide ion at m/z 794.75 (see bold font on sequences in Table 3.11). A 
peak found in the MALDI-ToF-MS at mlz 1588.96 supports this last hypothetical 
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sequence. Surprisingly, this same peak was assigned to another sequence by the peptide 
mass fmgerprint as seen in Table 3.8. This example raises the issue of peptide 
identification when performing peptide mass fingerprinting, especially in the case of very 
large proteins, where the large amount of peaks obtained in a spectrum increases the 
probability of erroneous peptide assignments. 
The MS/MS of the precursor peptide ion at mlz 700.20 is an interesting case 
where the non-matching sequence output L[204.09] has a mass difference of only 0.03 
with respect to the sequence MVS found in the database. This is an example where this 
sequencing algorithm may encounter problems in the interpretation of the spectra. 
Nevertheless, the alanine found in the third position of this fragment differed from the 
threonine found in the database, suggesting the possibility of a sequence variant found in 
the AS Vtg. Note that the expected Mr of this RT Vtg tryptic peptide, differs from the one 
calculated from its precursor peptide ion. A similar case has been observed for the 
MS/MS of the precursor peptide ion at mlz 561.68. In this case, the sequenced [DH]W tag 
found near the carboxyl terminal of the peptide, has a mass of 438.16, while the EPVL 
sequence found in the database has a mass of 438.25. Again, this CID-MS/MS has an 
ambiguous interpretation, as seen in Figure 3.9. B- and Y- type fragment ions are 
indicated above the peaks with their corresponding single letter amino acid code 
sequence. Spectral peaks are compatible with both the sequences of EPVLR (top 
spectrum in Figure 3.9) and DHWR (bottom spectrum in Figure 3.9) obtained from the 
database and peptide sequencing, respectively. 
Coincidentally, the sequenced fragment and the peptide sequence found in the 
database have a Mr difference of only 0.08. Furthermore, the peaks observed in this CID-
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MS/MS can be tentatively assigned to both sequences. In this last case, there is not 
enough evidence to support one structure over the other. 
An interesting observation for the CID-MS/MS of the selected precursor peptide 
ion at m/z 834.31 is that although a match can be observed with the RT Vtg, the database 
sequence does not contain either a residue of lysine (K) or arginine (R) preceding the 
residues matching the beginning of the sequenced peptide. This may indicate that a new 
cleavage site has been introduced next to the N terminal of this peptide on the AS 
sequence, although a non-specific cleavage during sample preparation can not be ruled 
out. 
The selected precursor peptide ions at mlz 788.28, 889.28, 819.70 and 561.68 used 
in the ESI-MS/MS analyses were also found in MALDI-ToF-MS analyses as [M+Ht 
species. These CID-MS/MS sequenced peptides had a perfect match with the RT Vtg 
sequence, with the exception of the precursor peptide ion at m/z 561.68, as described 
above, and a dipeptide inversion in positions 3 and 4 of the sequenced precursor peptide 
ion at mlz 889.28. The CID-MS/MS of the selected precursor peptide ions at mlz 843.81 
and mlz 572.20 showed only to share a small tag with respect to the database search. 
Finally, a remark should be made about the sequenced peptides obtained from the 
CID-MS/MS of the selected precursor peptide ions at mlz 795.18, 893.28 and mlz 791.05. 
These are apparently exclusive of the AS Vtg, possibly indicating regions of sequence 
variability. Further characterization of these and other non-identified fragments should 
allow post translational modifications and genetic variants to be confirmed. 
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Figure 3.9 Ambiguous graphical interpretation ofCID-MS/MS spectra 
Graphical interpretation of the CID-MS/MS spectra obtained from the precursor ion at m/z 
561.68. The amino acid sequence of the peptides is given in the single letter code above the 
corresponding Y and B product ions. As shown in this example, the same peaks can be 
tentatively assigned to different amino acid sequences. 
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3.4 In-gel digestion analyses of vitellogenin 
3.4.1 MALDI-MS of the trypsin derived peptides of rainbow trout vitellogenin 
In-gel trypsin digestions of Vtg were assayed directly from plasma as an 
alternative to digestions of the purified Vtg in solution. The procedure for in-gel 
digestions was described in Section 3.1.4. The rationale behind doing this type of 
digestion was that it avoided the time consuming process of protein purification, thus 
reducing the possibilities of protein degradation or modification. Control and 17~­
estradiol induced plasma samples were analyzed in parallel by SDS-PAGE. After staining 
with Coomassie Blue, the Vtg band was easily distinguished by comparing the intensity 
of the bands between both samples. This is a routine analytical technique which permits 
the perusal of qualitative and semi-quantitative results obtained in protein biochemistry 
experiments. In a classical biochemistry approach to protein characterization and 
identification, these bands could be further blotted onto membranes for amino acid 
sequencing by the Edman degradation reaction. Alternatively, thanks to the sensitivity 
offered by mass spectrometry, they can be enzymatically or chemically digested for 
additional identification and characterization experiments. 
The bands corresponding to Vtg were excised and subjected to in-gel digestion 
with trypsin and the resulting peptides were analyzed by MALDI-MS (see Sectopm 
3.1.6). The MALDI-MS spectrum obtained for RT Vtg is shown in Figure 3.10. The 
details of the PMF are shown in Table 3.12. 
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Figure 3.10 MALDI-MS spectra of the in-gel tryptic digestion ofRT Vtg 
The abscissa of the spectrum was split into four m/z ranges to facilitate the visualization of 
the peaks. 
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Table 3.12 Peptide mass fingerprint ofthe in-gel digestion ofRT Vtg 
The Start and End column indicate the position along the RT Vtg sequence (See Appendix 2). The 
experimental (expt) and calculated (calc) relative molecular masses (Mr) are shown. Miss indicates the 
presence of missed cleavages. The '.' in the Sequence column indicate the cleavage sites. 
Start End Observed Mr (ex£t) Mr (calc) !1 Mass Miss Seguence 
380 384 665.05 664.04 663.40 0.65 I R.FIKEK.F 
713 718 747.40 746.39 746.37 0.02 0 K.ALSDWR.S 
164 169 788.46 787.45 787.43 0.02 0 K.THYVIR.E 
1639 1645 820.45 819.44 820.40 -0.96 0 K.SVDLMEK.A 
1510 1515 825.03 824.02 823.46 0.56 I K.YSWKIK.V 
545 551 835.49 834.48 834.47 0.01 0 K.ALHPELR.M 
1646 1653 913.44 912.43 912.42 0.01 0 K.AEAHV ACR.C 
1522 1530 922.96 92I.95 922.40 -0.45 0 K.GQTCGLCGK.A 
I249 I256 934.45 933.44 933.44 0.00 0 K.IA WGAECK.D 
425 432 963.57 962.56 962.57 0.00 0 K.IQTHPVLR.E 
I279 I286 986.55 985.54 985.56 -0.02 I R.LSWDKLPK.V 
9I8 926 I028.56 I027.55 I027.49 0.06 0 R.NVEDVP AER.I 
I95 203 I043.5I I042.50 I042.50 O.oJ 0 K.DFGLA YTEK.C 
I60I I609 I071.56 I070.55 I070.54 0.02 0 R.CLPGCLPVR.T 
694 703 I079.56 I078.55 I078.54 O.OI 0 K.LPP APENADR.I 
I629 I638 III1.6I III0.60 11Il.54 -0.94 0 R.SEGLSSIYEK.S 
I043 I052 II45.67 II44.66 II44.6I 0.05 0 R.LEFEVQVGPK.A 
4I5 424 II57.67 II56.66 II56.62 0.04 0 K.L VESLAFNHK.I 
333 34I II77.77 II76.76 II76.70 0.06 0 K.FLQFIQLLR.M 
I582 I 59 I II88.78 II87.77 II87.6I O.I6 I K.QVIVDDRESK.C 
927 938 I235.80 I234.79 I234.74 0.05 0 R.ITPLIPAQGVAR.S 
182 I9I I262.65 1261.64 1261.58 0.06 I K.SKDLNNCQQR.I 
I84 I94 I361.73 1360.72 1361.65 -0.93 I K.DLNNCQQRIMK.D 
I134 II45 1387.78 1386.77 1386.58 O.I9 0 R.DGPDQPYNPNDR.K 
I435 I446 1391.72 1390.7I 1390.66 0.05 0 K.DHASEQNHINVK.I 
1379 1390 I4I9.79 I4I8.78 I4I8.76 0.03 0 K.IHYLFSEVNA VK.C 
733 745 I499.79 I498.78 I498.75 0.04 0 K.FFGQEIAF ANIDK.S 
499 513 I509.96 I508.95 I508.9I 0.04 0 K.LLPVFGT AAAALPLR.V 
270 282 I551.84 I550.83 I550.78 0.05 0 K.DPIIVPDNNYVHR.G 
483 498 I574.92 I573.9I 1573.89 0.02 0 K.ALGNAGHPASIKPITK.L 
IOOI IOI4 I635.79 I634.78 I634.74 0.04 0 K.ACFEFTSESAAFIR.N 
668 683 I638.87 I637.86 I637.84 0.02 0 R.TYFAGAAADVLEVGVR.T 
983 996 I667.90 I666.89 I666.87 0.02 0 K.AIVVHLEETICVER.L 
269 282 I679.93 I678.92 I678.88 0.04 I K.KDPIIVPDNNYVHR.G 
34 49 I700.95 1699.94 I699.9I 0.03 0 K. YEALLLGGLPEEGLAR.A 
II9 134 I706.00 I704.99 I704.95 0.04 0 K.VLAPTAVSETVLNVHR.G 
72 86 I777.94 I776.93 I776.9I 0.02 0 K.L VNPEIFEYSGVWPK.D 
363 379 I807.0I 1806.00 I805.98 0.02 0 R.HWILDA VPSIGSSV A VR.F 
1198 I213 I849.99 1848.98 I848.94 0.05 I R.ADHKIEGYQVT A YLNK.A 
I47 I63 I894.92 I893.9I I893.89 0.02 0 K.TQNVYELQEAGAQGVCK.T 
I549 I565 I921.97 I920.96 I920.88 0.08 0 K.SSVSFAHSWVLPSDSCR.D 
287 302 I937.94 I936.93 I936.04 0.89 0 R. YEFATEILQMPIQLLK.I 
642 660 I969.04 I968.03 I968.0I 0.02 0 R.IGAAASAFYINDAA TLFPR. T 
965 982 205I.92 2050.9I 2050.10 0.8I 0 R.SSEIL YSDLPSNFKPIIK.A 
746 765 2062.10 2061.09 2061.10 0.00 0 K.SIIDQALQLANSPSAHALGR.N 
95 113 2098.13 2097.I2 2097.15 -0.03 I K.LTSALAAQFSIPIKFEY AK.G 
I257 I276 2108.06 2I07.05 2I07.06 -O.OI 0 K.DYNTFIT AETGL VGPSPA VR.L 
770 789 2131.22 2130.2I 2130.22 -O.OI 0 K.ALLAGATFQYVKPLLAAEVR.R 
I6IO I628 2I55.10 2I54.09 2I54.09 0.00 0 R.TTPITIGFHCLPVDSNLNR.S 
623 64I 2229.10 2228.09 2228.08 O.OI 0 R.LSCHFSQAIHLDA YSNPLR.I 
9I8 938 2245.48 2244.47 2244.22 0.25 I R.NVEDVPAERITPLIPAQGV AR.S 
29 49 2355.28 2354.27 2354.25 0.02 I K. TYVYKYEALLLGGLPEEGLAR.A 
622 64I 2385.I4 2384.13 2384.18 -0.05 I R.RLSCHFSQAIHLDA YSNPLR.I 
I47 I69 2607.30 2606.29 2606.29 0.00 I K.TQNVYELQEAGAQGVCKTHYVIR.E 
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The increased background and low signal-to-noise observed in this spectrum is 
probably due to the low concentration of peptides extracted from the in-gel digestion step. 
The peaks obtained from this spectrum were selected to perform a PMF search using 
MASCOT (Section 3.1.7.3). RT Vtg was the only significant hit reported in the results of 
this search. No matches were found for the other peaks observed in figure 3.1 0. 
3.4.2 MALDI-MS/MS of the trypsin derived peptides of rainbow trout vitellogenin 
The product ion spectra of the peptides extracted from the in-gel digestions were 
acquired in low energy CID-MS/MS mode with the same instrumentation as described for 
the previous experiments. The parameters chosen for these studies are described in 
Section 3.1.6. The product ion spectra were analyzed using the 'de novo' sequencing 
algorithm provided by the Bioanalyst software (see Section 3.1.7.4). Additionally, the 
spectra were visually inspected to assess the suitability of the sequences suggested by the 
sequencing algorithm. Table 3.13 shows the sequences obtained from the analyses of 
these spectra, together with the matching sequences to RT Vtg (Appendix 2). The 
matching sequences to RT Vtg are shown underlined next to the candidate sequences, 
while discrepancies in amino acid sequences are emphasized in boldface font. For these 
particular peptides, sequence alignment was carried out using the F ASTA alignment 
program available on the internet (see Section 3.1.7.5). The inspection of Table 3.13 
shows some interesting features. The peptide ions at mlz 963.57, 1043.51, 1079.56 and 
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1177.77 were unequivocally sequenced and had perfect alignment with the published RT 
Vtg sequence. 
Some of the candidate sequences had slight differences with the sequence of RT 
Vtg, exemplified by the peptide ions at mlz 1028.56, 1419.79 and 1509.96. However, in 
all these examples, the sequenced peptides had the same molecular mass as those 
predicted from the RT Vtg sequence. This suggests that ambiguous interpretation of the 
product ion spectra by the sequencing software occurred (shown in boldface font on 
Table 3.13). 
Table 3.13 'De novo' sequencing and sequence homology ofRT Vtg tryptic peptides 
obtained by in-gel digestion 
Homology between the Candidate sequence and the Matching sequence is underlined. The non-
mathcing sequences are showed in bold font. The Position column indicates the location of the 
matching peptide in the amino acid sequence of RT Vtg, entry Q92093 in the Swiss-Prot Database 
(See Appendix 2). 
[M+Ht Candidate sequence Matching sequence Position 
m/z 
963.57 LQTHPVLR KIOTHPVLRE 425-432 
1028.56 NVEDVEPAR R NVEDVPAER I 918-926 
1043.51 DFGLAYTEK K DFGLA YTEK C 195-203 
1054.53 HGGGCAGSGPVR No match 
1079.56 LPPAPENADR K LPPAPENADR I 694-703 
1105.56 QQHVEPVLR K CYSVEPVLR C 1595-1600 
1177.77 FLQFLQLLR K FLOFIQLLR M 333-341 
1235.8 QAPGALCGLLHR No match 
1361.73 DSTV£TMAGAAANR T RSTA.r.DFASVAAACNV A VK M 597-607 
1365.57 HGGSYGAFGGVAASK No match 
1419.79 HLYLFSEVNAAR K IHYLFSEVNAVK C 1381-1390 
1509.96 LLASLAIEAAALPLR K LLPVFGIAAAALPLR V 499-513 
2607.3 ( 1891.99)APSLNSK No match 
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For example, for the peptide ion at 1028.56, the sequence EPA is a result of the 
amino acid inversion PAE found in the RT Vtg sequence. This type of amino acid 
inversion is not uncommon when performing 'de novo' sequencing from product ion 
spectra. For the ions at m/z 1419.79 and 1509.96, small tags of isobaric amino acid 
sequences are replaced: AR for VK and ASLA-E for PVFG-A, respectively. This is also a 
common occurrence when the information provided by the product ion spectrum is 
insufficient to provide a detailed fragmentation pattern for the B and Y ions present in 
that particular region of the peptide. The peptide ions at mlz 1105.56 and 1361.73 had 
only partial sequence homology with the RT Vtg sequence. Furthermore, these peptides 
do not agree with the theoretical molecular mass of the corresponding tryptic peptide, 
suggesting these might possibly be sequence variants found for Vtg in this sequence. 
Similarly, no matching sequences were found for the peptide ions at m!z 1054.53, 
1235.80, 1365.57 and 2607.30. 
3.4.3 MALDI-MS of the trypsin derived peptides of Atlantic salmon vitellogenin 
The AS Vtg was analyzed in the same way as described for RT Vtg in section 
3.4.1. The MALDI-ToF-MS spectrum obtained for AS Vtg is shown in Figure 3.11. The 
top, center and bottom spectra show the mass scale from m/z 800-1500, 1500-2000 and 
2000 to 3000, respectively. The peaks obtained from this spectrum were selected to 
perform a PMF search using MASCOT (Section 3.1.7.3). 
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Figure 3.11 MALDI-MS ofthe in-gel tryptic digestion of AS Vtg 
The abscissa of the spectrum was split into four m/z ranges to facilitate the 
visualization of the peaks. 
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As with the solution digestion of AS Vtg, none of the proteins in the database 
showed a significant hit from this list ofMALDI-MS peaks. This was expected, since the 
complete sequence of AS has not yet been reported. However, RT Vtg (Appendix 2: entry 
Q92093 on the Swiss-Prot Database) was the protein with most matching peptides for this 
peak list. The details of the PMF are shown in Table 3 .14. It should be noted that in this 
case the matching peptides and their relative position correspond to those found in RT 
Vtg. 
These results agam show evidence of the striking similarity for this protein 
between these two species. No match was found for the peaks at mlz 868.56, 911.24, 
927.44, 1105.52, 1129.58, 1143.58, 1195.65, 1211.65, 1253.67, 1285.63, 1342.71, 
1450.75, 1461.73, 1588.78, 1598.63, 1726.79, 1739.91, 1872.01, 1884.88, 2094.01' 
2128.05, 2169.00, 2192.11, 2208.11, 2300.09, 2318.12, 2368.11, 2435.17, 2634.21, 
2636.20 and 2943.44. The peaks at mlz 963.55, 1043.49, 1071.53, 1145.60, 1361.68, 
1509.88, 1638.81, 1777.88, 1894.89 and 1921.89, which were assigned to tryptic peptides 
in the RT sequence, were also found in the in-gel digestion ofRT Vtg. 
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Table 3.14 Peptide mass fingerprint ofthe in-gel digestion of AS Vtg 
Refer to legend in Table 3.12 for details. 
Start End Observed Mr (expt)Mr (calc)8 Mass Miss Sequence 
545 551 835.46 834.45 834.47 -0.02 0 K.ALHPELR.M 
425 432 963.55 962.54 962.57 -0.02 0 K.IQTHPVLR.E 
184 191 990.54 989.53 989.43 0.10 0 K.DLNNCQQR.I 
195 203 1043.49 1042.48 1042.50 -0.01 0 K.DFGLA YTEK.C 
1396 1404 1054.49 1053.48 1052.51 0.97 0 R.DTLTTFNNK.K 
1601 1609 1071.53 1070.52 1070.54 -0.01 0 R.CLPGCLPVR.T 
1592 1600 1122.55 1121.54 1121.55 -0.01 0 K.CYSVEPVLR.C 
1043 1052 1145.60 1144.59 1144.61 -0.02 0 R.LEFEVQVGPK.A 
184 194 1361.68 1360.67 1361.65 -0.98 K.DLNNCQQRIMK.D 
1325 1336 1378.68 1377.67 1377.73 -0.05 0 K.QIQFTVVATSER.T 
1116 1129 1389.73 1388.72 1388.60 0.12 R.KSESSSSSSSSSSR. T 
184 194 1418.71 1417.70 1418.68 -0.97 K.DLNNCQQRIMK.D 
95 108 1459.88 1458.87 1458.84 0.03 0 K.L TSALAAQFSIPIK.F 
499 513 1509.88 1508.87 1508.91 -0.04 0 K.LLPVFGT AAAALPLR. V 
58 71 1533.86 1532.85 1532.88 -0.03 0 K. VLISA V AENTYLLK.L 
668 683 1638.81 1637.80 1637.84 -0.04 0 R.TYF AGAAADVLEVGVR.T 
1646 1659 1651.83 1650.82 1650.64 0.19 K.AEAHVACRCSEQCM.-
1391 1404 1686.87 1685.86 1685.79 0.08 K.CSMVRDTLTTFNNK.K 
72 86 1777.88 1776.87 1776.91 -0.04 0 K.L VNPEIFEYSGVWPK.D 
947 964 1785.87 1784.86 1783.88 0.99 0 K.L TSMIADSAASF AGSLSR.S 
147 163 1894.89 1893.88 1893.89 -0.01 0 K.TQNVYELQEAGAQGVCK. T 
1549 1565 1921.89 1920.88 1920.88 0.00 0 K.SSVSF AHSWVLPSDSCR.D 
642 660 1968.02 1967.01 1968.01 -1.00 0 R.IGAAASAFYINDAA TLFPR.T 
1447 1464 2032.01 2031.00 2030.02 0.98 0 K.ISDIDVDL YTEDHGVIVK. V 
1406 1427 2561.35 2560.34 2560.24 0.11 K.YKINMPLSCYQVLAQDCTTELK.F 
1406 1427 2618.20 2617.19 2617.26 -0.07 K. YKINMPLSCYQVLAQDCTTELK.F 
1549 1573 2742.21 2741.20 2741.22 -0.02 K.SSVSF AHSWVLPSDSCRDASECLMK.L 
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3.4.4 MALDI-MS/MS of the trypsin derived peptides of Atlantic salmon vitellogenin 
The peptides obtained from the in-gel trypsin digestion of AS Vtg were also 
subjected to MALDI-MS/MS, as described for the RT Vtg peptides in section 3.4.2. The 
'de novo' sequencing and the alignment results are portrayed in Table 3.15. The matching 
sequences toRT or AS Vtg are shown underlined next to each candidate sequence. AS1 
and AS2 stand for Vtg entries Q800N6 and Q8UWG2, respectively (See Appendix 2). 
Discrepancies in amino acid sequences are emphasized in boldface font. 
As expected, the alignment studies shows fewer candidate sequences because of 
the sequence variants found in AS Vtg with respect to RT Vtg and because only two 
partial sequences of AS Vtg are known at the present time. Therefore, most non-matching 
sequenced peptides are believed to be sequence variants found in the non-sequenced 
regions of AS Vtg. However, as shown in this table, some peptides exhibited a marked 
homology with the RT Vtg sequence. 
Some interesting cases found in this table are worth mentioning for discussion. 
The ions at mlz 927.44 and 1739.91 were found to partially align with sequences of both 
RT and AS Vtg. Interestingly the sequence homology with RT was better than with AS, 
for both cases. Furthermore, the molecular mass of the peptides did not agree with that 
predicted from the sequence ofRT or AS Vtg. 
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Table 3.15 'De novo' sequencing and sequence homology of AS Vtg tryptic peptides 
obtained by in-gel digestion 
Homology between the Candidate sequence and the Matching sequence is underlined. The non-mathcing 
sequences are showed in bold font. The Species column indicates whether the matching sequence 
corresponds to rainbow trout (RT, entry Q92093) or one of the two published sequences of Atlantic 
salmon Vtg (AS1, entry Q800N9 and AS2, entry Q8UWG2 in the Swiss-Prot Database). The position 
indicates the location of the matching peptide in the amino acid sequence of the corresponding proteins. 
[M+Ht Candidate Sequence Matching sequence Species Position 
m/z 
RT 1592-1597 
911.24 hHNVEPGR K hYSVEPVLR C 
AS2 108-113 
K YEALLLGGLPEEGLARAGVK V RT 45-52 
927.44 EGVAHCGVR 
K YEALLLGGLPEEGLSRAQIK V AS1 45-52 
990.53 GGLGGAGHLPR K ALGNAGHPASIK P RT 484-489 
K DFGLA YTEK C RT 195-203 
1043.48 DFGLAYTEK 
K EFGLA YTENCVECQQK G AS1 195-202 
AS2 121-125 
1054.50 AAGGNPCLPVR R CLPGCLPVR T 
RT 1605-1609 
RT 1595-1600 
1105.52 QQHVEPVLR K CYSVEPVLR C 
AS2 111-116 
1195.65 EQMFLQLLR K ELQFIOLLR M RT 333-341 
1342.71 FAANPLPANQGSR No match 
1361.68 FGADT A VDGHSER No match 
1378.68 QSVPF ASCNAAQR R AVVLALTLALVASQSYNFAPDFAASK T RT 16-28 
1418.71 CALPSGAAQADLFR No match 
1450.75 HLTSYLADLFDR No match 
1509.88 LLASLLTI'GAALPLR K LLPVFGT AAAALPLR V RT 499-513 
1638.81 FYTAGAAWVLEVGVR R T.YFAGAAADVLEVGVR T RT 669-683 
1686.86 YEAL VVQMNLQSHR No match 
K VLAPT A VSETVLN-VHR G RT 125-134 
I 739.91 AMDA VVVSETVLGGVHR 
K VFAPTGVSETVLN-IHR G AS1 125-134 
K LVNPEIFEYSGVWPK D RT 83-86 
1777.89 WGWVGSLVGGLHVWPK 
K LVDPEIFEYSGVWPK D ASl 83-86 
1872.00 RrYE.DVKPQVSHMMR K YCVEHPNQAJ;;L VKPIHELAVQAV ANSK F RT 454-460 
1921.88 (951.3158)WSHVVGMR No match 
1968.00 NAGPGV AHMFDPAATLFPR) R IGAAASAFYINDAATLFPR T RT 648-660 
2094.01 (1227.4888)LVGPSPAAR K DYNTFITAETGLVGPSPAVR L RT 1268-1276 
2128.05 (1437.6974)DSNPCR RLSCHFSQ~AYSNPLRI RT 637-641 
2368.11 (1376.5099)LVQPLHER KYCVEHPNCPAELVKPIHELAVQAVANSKF RT 457-463 
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Similar examples where the molecular mass of the sequenced peptides did not 
agree with the molecular masses of the predicted RT and AS Vtg tryptic peptides were 
found for the peptide ions at m/z 911.24, 990.53, 1054.50, 1105.52, 1195.65, 1378.68, 
1739.91, 1872.00, 2094.01, 2128.05 and 2368.11. These discrepancies are likely to occur 
due to sequence variants within the analyzed peptide and/or to the introduction of new 
enzymatic cleavage sites which produces peptides which differ in length, but conserve 
sequence homology. 
The peptide ion at m/z 1043.48 matched the sequence of RT Vtg perfectly. 
However, the published sequence of AS Vtg contains a similar sequence, but lacks the 
terminal lysine residue found in the analyzed peptide. The presence of this peptide 
suggests a sequence variant to the entry Q800N6 found in the protein database. The 
peptide ions at mlz 1509.88, 1638.81 and 1968.00 also matched the molecular mass ofthe 
tryptic peptides predicted from this digestion, however, only partial amino acid sequences 
were found to match the sequenced peptides. 
Another interesting example is that ofthe peptide ion at m/z 1777.89. The four C-
terminal amino acids found in this peptide matched sequences found for RT and AS Vtg. 
However, the database sequence for this tryptic peptide in both species differs by one 
amino acid in position 3, where Asn is found in RT, while Asp in found in AS. In this 
case, the molecular mass of the analyzed peptide coincides with the RT Vtg tryptic 
peptide. This finding suggests that this particular site might be susceptible to sequence 
variants or postranslational amidation of the Asp residue. Also, inconsistencies in the 
protein databases are likely to exist due to errors in cloning and sequencing experiments. 
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3.4.5 MALDI-MS of the trypsin derived peptides of Atlantic cod vitellogenin 
The efficiency ofVtg induction with 17P-estradiol was assessed by SDS-PAGE as 
seen in Figure 3.12. The strong induced band which appeared in the experimental fish 
was excised and subjected to in-gel trypsin digestion as described in Section 3.1.4. 
The peptides extracted from the digestion were subjected to MALDI-ToF-MS 
(Figure 3.13) as described in Section 3.1.6. Both spectra correspond to the same 
acquisition and the axes have been cut to improve peak visualization. The top and bottom 
spectra correspond to a mlz range of 800-1800 and 1700-3000, respectively. 
Although no sequence for Atlantic cod Vtg is currently available, the peptide ions 
obtained in the enzymatic digestion were compared with those generated 'in-silico' in the 
protein databases, since Vtg sequences from other species have already been reported. 
The [M+Ht ions present in the spectra were used for protein identification using the 
Mascot Peptide Mass Fingerprint database search engine (Section 3.1.7.3). 
Interestingly, the two known different forms of haddock Vtg (VtgA and Vtg B, 
entries Q98T86 and Q98T87 on the TrEMBL database, respectively) gave statistically 
significant hits with the search query. Atlantic cod and haddock are two ground fish 
species which are evolutionary related to one another. Both species belong to the family 
Gadidae, subfamily Gadinae (Nelson, 1984). As described in literature, haddock, in 
common with other species, co-expresses more than one form ofVtg (Reith et al., 2001) 
which have been shown to have different biological roles after being incorporated into the 
oocyte. 
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c E 
Vtg Band 
Figure 3.12 Induction ofVtg synthesis in AC fish 
Plasma from control (C) and experimental (E) fish was subjected to SDS-PAGE. Five )lL 
of plasma were loaded into each lane and electrophorosed in the conditions described in 
Section 3 .1.2. The banding profile indicates the increased synthesis of Vtg in the fish 
treated with ~-estradiol. 
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The abscissa of the spectrum was split into two m/z ranges to facilitate the visualization of the peaks. 
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A careful analysis of the MALDI-ToF-MS matching peptides between both 
species showed that some of the Atlantic cod Vtg peptides matched those of Vtg A, and 
others ofVtg B, while some were common to both Vtg A and B, as shown in Table 3.16. 
The sequences that correspond to haddock Vtg A and Bare marked in superscript 1 and 2 
respectively. 
A close look at Table 3.16 shows some interesting information. The peptide ions 
at mlz 1009.53 and 11 01.63 corresponded to pairs of peptides which were not identical, 
but contained leucine-isoleucine substitutions. The ion at m/z 1130.72 matched a pair of 
peptides in which two amino acids have switched positions. Alternatively, the ions at mlz 
1089.56 and 1743.13 were assigned to pairs of isobaric peptides with absolutely no 
sequence homology between them. 
3.4.6 MALDI-MS/MS of the trypsin derived peptides of Atlantic cod vitellogenin 
Product ion spectra were acquired by MALDI-QqToF MS/MS, as described in 
Section 3.1.6, to confirm the identity of both matching and non-matching peptide ions. 
The results ofthese analyses are shown in Table 3.17. As mentioned earlier, 'de novo' 
sequencing of peptides from product ion spectra is an intensive, time-consuming 
procedure. Computer software has made this task faster, yet not necessarily more 
accurate. When such programs are used, a list of candidate peptides is shown in score 
order. Such a score depends, among other parameters, on the number of matching 
fragment ions and their respective mass error. 
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Table 3.16 Peptide mass fingerprint of the in-gel digestion of AC Vtg 
The headings Vtg A and Vtg B correspond to the entries Q98T86 and Q98T87ofhaddock Vtg found in 
the Swiss-Prot database. In the Sequence column, superscript I and 2 refer to the Q98T86 and Q98T87 
entries, when a match was found for both sequences. 
[M+Ht Vtg Vtg Vtg Sequence 
mlz A B A+B 
813.50 X IKHFIR 
942.47 X YESFAVAR 
948.46 X VAWGIDCK 
963.46 X DLNNCQEK 
1009.53 X X X DLGLA YTEK 1 and DIGLA YTEK 2 
1081.57 X LPQAPVDADR 
1089.56 X X X LCADGILLSK 1 and INLNAAF AKK 2 
1101.63 X X X TEGLQEALLK I and TEGIQEALLK 2 
1106.59 X CFSVEPVLR 
1124.62 X VHVDAILAMR 
1130.72 X X X FLELIQVLR I and FVELIQLLR 2 
1166.61 X LESEDASFIR 
1221.71 X MAAAL VLFETR 
1293.73 X FTWDKLPTSAK 
1349.79 X IVKDLGLA YTEK 
1363.81 X IT AATVETF AlAR 
1372.70 X DNIEQNWINVK 
1458.78 X FFGQEIGF ASIDK 
1465.82 X FLGQEIAF ANLDK 
1479.84 X TPIAPVNAQYLHR 
1743.13 X X X IVPIIPAEILEPLIGR I and LTLALTSDKTLNIVLK 2 
1796.01 X VYSPEGISTTVLNIFR 
1834.05 X VQLILANL VEENHWR 
2008.11 X ASATPALPQNFL WTHLLK 
2020.06 X VHEDAPLKFVELIQLLR 
2073.16 X AIIDQLIQVATGPSVATYGR 
2225.11 X LASNSVSY AQSWVIP AESCR 
2294.29 X LESEDASFIRNTPL YQLIGK 
2320.29 X GSLQYEF ATELLQTPIQLLR 
2665.17 X DA VSY AHSWVIPAENCQDASECR 
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Nevertheless, each candidate sequence was manually checked since it is very 
common to find errors in peak assignment, especially with regard to the correct 
identification of the monoisotopic peak. Therefore, the candidate sequences shown in 
Table 3.17, correspond to those which best matched the MS/MS spectra, but did not 
necessarily match with the highest score. 
Unfortunately, not all the ions found in the peptide mass fingerprint were suitable 
for MS/MS analysis since some spectra did not yield sufficient diagnostic peaks to permit 
full sequencing of the peptides. Nevertheless, some partial sequences could be obtained. 
In these cases a mass value between brackets is shown to account for the amino acid 
sequence gaps. 
Examination of Table 3.17 reveals some very interesting information. The product 
ion spectrum ofthe precursor ion at m/z 1089.54 (see Figure 3.14) was shown to have a 
sequence similar to that found in Vtg B of haddock, yet the peptide mass fingerprint had 
erroneously assigned this ion to other haddock peptides. The expected fragmentation 
pattern is shown in the figure inset while the observed diagnostic B and Y peptide product 
ions are outlined in boxes. There is evidence to support this new sequence 
(FDDVEPVLR), since the mass of this peptide differs from the theoretical mass of the 
corresponding haddock peptide (CFSVEPVLR, Mr 1105.56). Interestingly, the product 
ion spectrum ofthe ion at m/z 1106.58 (see Figure 3.15) showed no apparent similarity to 
the peptide assigned to it on the peptide mass fingerprint. These two proposed peptides 
should be considered tentative, since not all the expected B and Y ions were found. 
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Table 3.17 'De novo' sequencing and sequence homology of AC Vtg tryptic peptides 
obtained by in-gel digestion 
The number between bracket under the Proposed sequence column corresponds to mass gaps that could not 
be assigned to any particular amino acid sequence. Comments A and B mean a perfect match was found with 
respect to haddock Vtg sequence A and B, respectively (See legend in Table 3.16 for details). Comments C 
and D mean that partial sequence homology was found with respect to haddock Vtg sequence A and B, 
respectively. Comment E was used when no homology was found to haddock Vtg. 
Precursor 
Proposed sequence 
mlz 
942.49 YESFAVAR 
1009.53 DLGLAYTEK 
1081.56 QPLMNDAHR 
1089.54 FDDVEPVLR 
1106.58 HLGLTTPPDR 
1124.62 VHVDALLAMR 
1130.71 FLEVLQLLR 
1166.60 LESEPLLPLR 
1221.67 ACV AL VLFETR 
1237.70 RPGVVWDPVGR 
1293.64 WDTFQMQLPK 
1363.75 SSPPGMETF ALAR 
1381.81 VPLPQFLPLAMR 
1433.75 ALAAGVDLTEGNFR 
1458.74 FFGA WVAFAEADK 
1465.82 FLGGPCLAF ANLDK 
1479.81 EPQAAPVNTFLHR 
1519.76 (805 .41 )EWSHR 
1540.90 GV AAGFLPLAASLTPR 
1588.90 (789.3369)VLELGLR 
1602.90 TTLGSFNVDALLPVR 
1704.95 HSAATVLESWTFTVR 
1743.13 (833.51)LLEPLLGR 
1796.01 (1133.59)LNLFR 
1834.97 HPHQRPLDLENHWR 
2073.99 (975.5507)NPYQVAGGHR 
2131.02 NAVGSGYNHTFEHATVATVR 
2226.00 (1410.56)LP ASSGGAR 
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Figure 3.14 Product ion spectrum ofthe [M+Ht ion at mlz 1089.54 
The inset shows the fragmentation pattern indicating the formation of the expected B and Y 
ions. The product ions which were found are labeled on the peaks and with boxes in the inset. 
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Figure 3.15 Product ion spectrum of the [M+Ht ion at mlz 1106.58 
See legend in Figure 3.14 for details. 
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The product ions spectra of ions at mlz 942.49, 1009.53 and 1124.62, shown in 
Figures 3.16A, Band C were correctly assigned by the Bioanalyst sequencing algorithm 
to the theoretical amino acid sequence corresponding to the haddock tryptic peptides. 
This is shown by the matching B and Y ions found in the spectra. Note that leucine and 
isoleucine cannot be distinguished from each other for sequencing purposes and are 
marked with the letter L by the sequencing software to indicate both amino acids. 
The product ion spectrum ofthe selected precursor ion at m/z 1743.13, which had 
been assigned to two different peptides in Table 3.16, was partially sequenced to match 
the Vtg A of haddock Vtg. The remaining ions showed either partial or no sequence 
homology with the haddock Vtg. 
It is important to mention that there was a senes of ions obtained in the 
conventional MALDI-ToF-MS at mlz 826.47, 884.98, 920.43, 1123.61, 1952.94,2142.12, 
2391.19, 2408.18, 2440.36, 2460.33, 2585.56, 2637.35, 2729.49, 3387.66, 3435.72 and 
3450.78, which did not match any of the predicted haddock Vtg tryptic peptides with the 
chosen database search parameters. These ions were tentatively designated as diagnostic 
for AC Vtg. 
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Figure 3.16 Product ion spectra of [M+Ht precursor ions 
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Figures 3.16 A, Band C correspond to the product ion spectra obtained from precursors at mlz 
942.49, 1009.53 and 1124.13, respectively. See legend in Figure 3.14 for remaining details. 
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Chapter 4: Development of a quantitative assay for vitellogenin using tandem mass 
spectrometry 
The previous chapters have laid the basis for the final objective of this work, that 
1s, developing a simple mass spectrometric quantitative technique for measuring the 
plasma levels of AS and RT Vtg. The technique chosen to accomplish this task is known 
as the 'signature peptide' approach. The following sections describe all the steps that 
were necessary for the selection of the 'signature peptide'. Also, a detailed account of the 
tuning and optimization of the analytical methods involving the HPLC-ESI-QqToF-
MS/MS is described. 
4.1 Quantitative methods in proteomics 
Recent advances in mass spectrometry have provided researchers with powerful 
quantitative techniques in the area of proteomics (Zhang et al., 2004b ). Quantification of 
proteins can be achieved by using either a relative or an absolute technique. Relative 
quantification is usually sufficient in those studies which focus on differential protein 
expression between control and experimental groups. The objective of this kind of studies 
is to determine whether protein expression in an experimental group varies with respect to 
a control group, under the effect of an external stimulus, which can be either physical ( eg. 
temperature change) or chemical ( eg. administration of a therapeutical drug). The final 
result is either increased, decreased or no change in protein expression. Although 
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semiquantitative results may be obtained, usually, no units are expressed in these type of 
studies. Different strategies have been adopted for this type of quantification. For 
example, some authores have used of isotopically labeled functional groups in proteolytic 
peptides by means of derivatization agents (Ji eta!., 2000; Geng eta!., 2000; Riggs eta!., 
2001). Similar techniques use more sophisticated isotope-coded affinity tags (Gygi eta!., 
1999; Gygi eta!., 2002; Ong et a!., 2002; Yu et a!., 2004; DeSouza et a!., 2005), many of 
which are commercially available. Relative quantification can be done by 180 labeling of 
enzymatically digested proteins with H2180 (Yao eta!., 2001; Yao eta!., 2003) All these 
techniques rely on selectively tagging the analyzed protein in the experimental group with 
a specific mass label which can be selected and monitored in a mass spectrometer, and 
compared relatively to the non-labeled protein expressed in the control group. 
Alternatively, relative quantification can be done by measuring accurate mass and time 
tags (Masselon eta!., 2000; Conrads eta!., 2000; Smith eta!., 2002; Wang eta!., 2003; 
Strittmatter et a!., 2003; Pasa-Tolic eta!., 2004; Elias et a!., 2005; Norbeck et a!., 2005; 
Qian et a!., 2005; Silva et a!., 2005). In this approach, the proteins expressed in the 
control and experimental groups are proteolitically cleaved and analyzed by HPLC 
coupled to mass spectrometry. Each biomarker peptide is assigned a characteristic mass 
and time pair, which serves as a coordinate for the study of the complete proteome of a 
specific organism. This technique does not require tagging of the studied proteins and can 
be scalable to less sophisticated MS-only spectrometers. However, reproducible 
chromatographic conditions are critical, and a high resolution mass spectrometer is 
required for the asignment of the accurate mass values. 
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Absolute protein quantification requires a different approach. In these types of 
studies, the absolute concentration of proteins in a specific sample ( eg. blood plasma) is 
expressed in some kind of units (eg. mg/mL, mM, etc). Usually, these studies are done to 
compare the protein expression with a reference value. Biomarkers are frequently assayed 
by this approach to determine if their concentrations are above or below a threshold 
value, usually indicating the limits of an altered or pathological condition. 
In this study, an absolute quantification method was selected for Vtg using the 
signature peptide approach. The rationale for this approach is that peptides generated by 
the digestion of complex mixtures may be used as analytical surrogates for the protein 
from which they are derived. This approach is based on the fact that single peptides are in 
many cases easier to separate and identify than the intact proteins. Furthermore, the 
synthesis of custom made peptide standards and internal standards is occasionally easier 
than the isolation and purification of the intact proteins for calibration purposes. The 
internal standards usually consist of homologues of the analyzed peptides in which one or 
more atoms have been replaced by stable isotopes (e.g. 13C, 15N, 2H etc). Variations of 
this approach have been applied to different proteins: fathead minnow (Pimephales 
promelas) Vtg, rhodopsin, apolipoprotein A-1 and a hemoglobin f3-chain derived glycated 
hexapeptide have been quantified using triple quadrupole mass spectrometers (Barret al., 
1996; Jeppsson et al., 2002; Barnidge et al., 2003; Zhang et al., 2004a). This strategy for 
quantification has also been described by other authors, and is known as the AQUA 
(Absolute QUAantification) strategy (Gygi and Aebersold, 1999; Gerber et al., 2003; 
Kirkpatrick et al., 2005). A variation of this method, the SISCAP A (Stable Isotope 
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Standards and Capture by Anti-Peptide Antibodies) approach, uses an additional step, 
where the peptide of interest is isolated by antibody-affinity chromatography prior to the 
HPLC separation, confering additional sensitivity to the technique by enriching the 
concentration of the peptide and reducing the background noise level (Anderson et al., 
2004). 
A different approach for absolute quantification of fathead minnow Vtg using 
HPLC-MALDI-MS has recently been published (Wunschel et al., 2005). However, in this 
technique, the intact protein was analyzed and quantified by HPLC using a UV detector, 
and MALDI-MS was used to confirm the identity of the eluting proteins by peptide mass 
fingerprinting. In this study, the minimun detectable level ofVtg injected that produced a 
visible peak was lf.lg and the sam pes analyzed were all in the order of mg/mL. 
4.2 The 'signature peptide' approach 
Fried tongues of cod fish are a culinary delicacy in St. John's, Newfoundland. 
According to historians, many decades or even centuries ago, fishermen used to cut the 
tongues of the cod as soon as the nets were brought on deck. In doing so, the catch could 
be easily estimated for commercial purposes by counting the 'small' tongues collected 
instead of having to deal with the huge amount of fish stored in the ship's hold 
(Chrestien, 2005). Quantification of proteins by the 'signature peptide' approach is 
essentially the same, instead of 'counting' big protein molecules in a complex protein 
mixture, the focus is placed on one of their small pieces. 
127 
As described in previous chapters, a wide spectrum of analytical methods has 
been developed for quantification of Vtg levels. Indirect measurement of Vtg has been 
achieved by colorimetrically determining the alkaline-labile phosphorous content of fish 
plasma (Wallace R.A. and Jared D.W., 1968). More recently, a number ofimmunoassays, 
such as the competitive enzyme-linked immunosorbent assays (ELISA) (Palmer et al., 
1998; Denslow et al., 1999; Tyler et al., 2002) and radioimmunoassays (RIA) (Campbell 
and Idler, 1980; So et al., 1985; Norberg and Haux, 1988) have been developed. 
Similarly, Vtg mRNA levels have been assayed (Bowman and Denslow, 1999; Garcia-
Reyero et al., 2004) although the use of liver homogenate samples in this technique is 
prohibitive for large scale animal monitoring. 
In this study a mass spectrometric technique is presented, by which both plasma 
Vtg levels of RT and AS can simultaneously be quantified using an adaptation of the 
'signature peptide' approach. The simplicity of this approach relies on a single step 'one 
pot' trypsin digestion of the serum, without the need for protein isolation and purification. 
A characteristic 'signature' proteolytic peptide, common to both RT and AS Vtg was 
monitored by high performance liquid chromatography (HPLC) coupled to an 
electrospray ionization quadrupole-time-of-flight (ESI-QqToF-MS/MS) tandem mass 
spectrometer. The concentration of peptide present in the digestion will be proportional to 
the concentration of Vtg in plasma. Absolute concentration values obtained from the 
'signature peptide' approach were calculated considering a 1:1 mole ratio of the 
'signature peptide' to the Vtg molecule, their individual molecular masses and the 
dilution factors involved in sample processing. 
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The rationale behind choosing a common peptide for both RT and AS Vtg as 
standard was to use the same standard calibration curve to analyze samples of both 
species in one batch. This feature resembles the 'cross reactivity' of immunological 
assays which allows homologous proteins sharing common epitopes to be detected using 
the same polyclonal and/or monoclonal antibodies. A diagram of the work scheme is 
summarized in Figure 4.1. 
Plasma 
•-t------2mL 
plastic tube 
Trypsin 
Digestion 
Protein 
digest 
+ Deuterated 
Internal Standard 
Signature 
peptide 
HPLC-ESI-QToF 
MS/MS operated in 
'pseudo' SRM mode 
Figure 4.1 Work scheme for the 'signature peptide' approach. 
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4.3 Materials and methods 
4.3.1 Pre-analytical sample preparation 
Blood was extracted from fish and centrifuged to obtain the plasma. Five 
microliters of plasma were mixed with 100 ~L of 8M urea, 4mM dithiothreitol denaturing 
solution and heated at 65°C. Then, 300 ~L of a 50mM solution ofNH4HC03 were added, 
followed by 95 ~L of a 20~g/mL trypsin (Sigma, Prod. No. T6567) solution which was 
freshly prepared for each batch analysis. The unused trypsin solution was separated in 
aliquots and frozen at -20°C for upto one month for subsequent digestions. The amount of 
enzyme was calculated based on the recommendation of the trypsin supplier which 
recommends a 1: 100 w/w ratio of enzyme to total protein content. Considering that the 
average total protein concentration in RT plasma is approximately 43 g/L (Rehulka eta/., 
2005), 5 ~L of plasma would contain approximately 215 ~g of total protein. Thus, 95 ~L 
of a 20~g/mL trypsin solution would contain 1.9 ~g of trypsin. Calibration curves were 
constructed by preparing and injecting 0.05, 0.1 0, 0.25 and 0.50 ~g/mL solutions of 
signature peptide (Genemed Synthesis Inc, San Fransico, CA, USA) m 
H20:acetonitrile:acetic acid, 70:30:0.1 (v/v/v) into the HPLC-MS/MS. All standards were 
spiked with internal deuterated signature peptide standard (Genemed Synthesis Inc, San 
Fransico, CA, USA) to produce a final concentration of 0.10~g/mL of the deuterated 
signature peptide. 
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Digestion was carried out at 3 soc for 24 hours. Aliquots of 1 00 ~L of the digested 
samples were mixed with 380 ~L of H20:acetonitrile:acetic acid, 70:30:0.1 (v/v/v) and 
spiked with 20 ~L of 5 ~g/mL deuterium-labeled standard solution. Finally, samples were 
passed through 0.45 ~m filters (Millipore, Cat. No.SJHV004NS. Millipore, Billerica MA, 
USA,) prior to injection into the HPLC. After the labeled peptide was added to the trypsin 
digestion, the samples were analyzed using an HPLC coupled to a QqToF-MS/MS. 
Samples and standards were analyzed with a HPLC system (HP 1050, Hewlett-Packard, 
Palo Alto, CA, USA) coupled in-line to a QqToF (QStar XL, Applied Biosystems, Foster 
City, CA, USA) tandem mass spectrometer equipped with an ESI ion source 
(TurbolonSpray). Reverse phase chromatographic separation was achieved on a 30mm 
length, 2mm internal diameter, Gemini 5~ C18 llOA column (Phenomenex, Torrance 
CA, USA). All samples and standards were loaded into a 10 ~L loop connected to a 10 
port Valco (Houston, TX,USA) switching valve. The mobile phases labeled A, B and C 
contained distilled water, acetonitrile and acetic acid in 95:5:0.1, 70:30:0.1 and 5:95:0.1 
(v/v/v) proportions, respectively. Table 4.1 gives the step-wise solvent elution profile 
used for all chromatographic separations. The parameters shown in this table were chosen 
to optimize the signals which were monitored during the MS/MS acquisition. Note that 
the flow rate was reduced from the 4th minute to the lOth minute, at which time the 
'signature peptide' eluted from the chromatography column. 
The product ion spectra used in quantification were acquired in a 'pseudo' SRM 
mode. The word 'pseudo' is used in terms of comparing this mode of analysis to that 
performed traditionally in triple quadrupole mass spectrometers. The mass spectrometer 
was programmed to alternatively monitor the selected product ions from the precursor 
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ions at m/z 819.9 and 824.4, corresponding to the doubly charged species [M+2H]2+ of 
the 'signature peptide' and its deuterated isotopic homologue, respectively. This cycle 
was automatically repeated 750 times throughout the 25 minute chromatographic run. 
Table 4.1 Solvent elution profile and flow rates for 
the chromatographic separation. 
Time Flow rate Mobile phase (%) 
(min) (mL/min) A B c 
0.0-0.5 0.2 100 0 0 
0.5-4.0 0.2 0 100 0 
4.0-10.0 0.05 0 100 0 
10.0-15.0 0.4 0 0 100 
15.0-25.0 0.2 100 0 0 
The ToF analyzer was set to scan the product ions produced from mlz 800 to 1300. 
The tuning parameters of the mass spectrometer were optimized in terms of maximizing 
the signals produced by the mlz 819.9--~{957.5 - 1028.57 - 1156.6) and the mlz 
824.4~(960.5 - 1034.61 - 1165.7) transitions. The diagnostic product ions monitored 
correspond to the Y9, Y10 and Y12 fragments ofboth the 'signature peptide' and its labeled 
homologue (Biemann, 1990) and were selected as product ions for quantification, as 
explained in the following sections. These ions were additionally enhanced by setting the 
ion release delay (IRD) and the ion release width (IRW) parameters to 102.0 and 44.2 ms, 
respectively, to increase the duty cycle of the ToF detector for these particular ions. The 
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remammg tuning parameters used were: 4700 V for ionization energy, 50 psi for 
nebulizer gas, 80 psi for auxiliary gas, 300°C for probe temperature, 40 V for declustering 
potential (DP), 190 V for focusing potential, 15 V for DP2 and 36 V for the collision 
energy. The collision gas used was nitrogen at an arbitrary value of 5 set on the 
AnalystQS software. The first selecting quadrupole was operated at low resolution to 
further increase the product ion signal. 
For quantification purposes, the extracted ion chromatograms of the diagnostic 
product ions listed above were generated using a 2 Da mass range window around the 
selected product ions and manually integrated. The ratio between these two peak areas 
was taken as the dependant variable for the calibration curve and the same ratio was used 
for the digested plasma samples. The values of signature peptide in plasma were 
interpolated from the calibration curve, corrected using the corresponding dilution factors 
and finally converted to mg/mL ofVtg assuming a 1:1 mole ratio of'signature peptide' to 
Vtg molecule. The relative molecular masses considered for Vtg were 181938 and 
177153 Da for rainbow trout and Atlantic salmon, respectively. These values were 
obtained from MALDI-MS experiments on the native intact Vtg proteins, reported in 
Section 3.2 (Figure 3.2) and recently published (Banoub et a/., 2003; Banoub et a/., 
2004). Results were also expressed in J.tM units, considering a relative molecular mass for 
the 'signature peptide' of 1638.819 Da. 
Quantification by mass spectrometry has commonly been performed on triple 
quadrupole (QqQ) tandem mass spectrometers. These instruments have shown 
exceptional results when operated in Selected Reaction Monitoring (SRM) mode. 
Alternatively, in this work, the use of the hybrid QqToF-MS/MS instrument has been 
133 
explored for quantification purposes (Chemushevich, 2000; Chemushevich et al., 2001). 
Although the QqToF-MS/MS configuration has already been used for quantitative 
analysis of a variety of compounds ranging from cocaine, tyrosine to goserelin, an 
analogue of luteinizing hormone-releasing hormone (Jeanville et al., 2000; Marvin et al., 
2003; Michalet et al., 2003; Luo et al., 2004), no research has yet been published using 
this system for the quantification of such a complex protein. 
This method, developed by adjusting and optimizing the tuning parameters of the 
QqToF analyzer was termed as 'pseudo' SRM. This CID-MS/MS method was 
programmed to operate in a mode that monitors three diagnostic product ions of both the 
'signature peptide' and its deuterated isotopic homologue, used as an internal standard. 
The ratio of each of the diagnostic product ions to its isotopic homologue was used as the 
analytical quantitative response signal for identification purposes. 
Figure 4.2 shows a schemtic diagram of the MS/MS operating in the 'pseudo' 
SRM mode. Tryptic peptides separated by the HPLC system are analyzed 'in line' by 
MS/MS. The first mass analyzer alternatively selects the 'signature peptide' and its 
isotopic homologue while the product ions of these precursors are monitored by the 
second stage mass analyzer. The ratio of the signals produced by these two product ions is 
considered as the analytical response signal for calibration and quantification purposes. A 
signal is obtained for each pair of diagnostic product ions (product ions at mlz 957.5 -
1028.57 - 1156.6) and their corresponding isotopic homologue (960.5 - 1034.61 -
1165.7). These three pairs are individually monitored and used to obtain three separate 
calibrations curves obtained from the standards, from which the unknown samples are 
interpolated. Finally, the three concentrations are averaged to obtain the final result. 
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Figure 4.2 HPLC-MS/MS operated in the 'pseudo' SRM mode. 
EIC stands for Extracted Ion Chromatogram. During analysis, individual pairs of EICs are 
obatined for each one of the three diagnostic product ions monitored. 
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4.3.2 Selection of the 'signature peptide' 
The sequence of the selected 'signature peptide' was the following: 
Thr-Tyr-Phe-Ala-Gly-Ala-Ala-Ala-Asp-Val-Leu-Glu-Val-Gly-Val-Arg. 
The selection of this 'signature peptide' was based on previOus 'de novo' 
sequencing studies performed on Vtg tryptic peptides described in Chapter 3 and recently 
published (Banoub et al., 2003; Banoub et al., 2004). Basically, a long list of candidate 
peptides from both species was elaborated. Many of the peptides belonging to RT were 
corroborated from the sequences found in the protein databases (See Appendix 2, entry 
Q92093), since Vtg from this species had been completely sequenced. On the other hand, 
only a few peptides of the AS Vtg matched the database search since only the 284 N 
terminal (Appendix 2: entry Q800N6) and the 175 C terminal (Appendix 2: entry 
Q8UWG2) amino acids of this species have been sequenced. Nevertheless, only a few 
peptides were found common to both species, reducing significantly the list of candidate 
peptides. 
A critical question to answer when selecting this 'signature peptide' was whether 
an identical peptide sequence could be found in nature in any protein other than Vtg. 
Although the genome of both species has not yet been totally elucidated, the Basic Local 
Alignment Search Tool (BLAST) (Altschul et al., 1990; McGinnis and Madden, 2004) 
was used against all known protein and DNA databases with no taxonomic restriction and 
provided no significant matches. 
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The ammo acid composition of the candidate sequences was also considered 
influential in the final selection. Peptides containing methionine and cysteine were 
discarded because of their propensity to form oxidized residues under different 
experimental conditions. Therefore, the presence of less-reactive residues such as Ala and 
Gly was preferred. Furthermore, tryptic peptide sequences starting with or having proline 
following the terminal lysine or arginine, i.e. X-X-Arg/Lys-Pro-X, X being any other 
amino acid, were ignored because, when found at these positions, these amino acids are 
known to block the proteolytic action of trypsin. 
The presence of post translational modification in the 'signature peptide' location 
of the protein would also weaken the technique in two ways: it would increase the 
probability of peptide heterogeneity and increase enzymatic blockage during sample 
digestion. The selected 'signature peptide' lacked both glycosylation and phosphorylation 
consensus motifs, reducing the chances of these post translational modifications to occur. 
A prerequisite for the synthesis of the peptide standard was the incorporation of 
stable isotopes for the internal standard. Ideally, this internal standard should have a 
molecular mass high enough to distinguish itself clearly from the isotopic cluster 
corresponding to the non-labeled standard. This was achieved by incorporating three 
consecutive L-alanine-3,3,3-d3 into the 'signature peptide' sequence. The fact that the 
same deuterated amino acid was used and that they were situated in adjacent positions 
significantly reduced its synthesis cost. 
Finally, the selection of the 'signature peptide' was based on empirical 
circumstances. There are many experimental parameters which can affect the final results 
of this method. Slight modifications in the sampling, digestion or MS conditions can 
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result in changes that can affect the outcome of the experiments. Sometimes, these 
changes are known or can be predicted and in these cases, the results can be accordingly 
corrected to reflect the changes in the final results. However, very often, the experimental 
variations in these conditions are unseen or even unknown. The fact that the selected 
'signature peptide' consistently appeared in all our previous characterization experiments 
proves it to be very robust under a variety of experimental conditions. This peptide 
appeared in the PMF of both solution and in-gel digestions of RT (Tables 3.2, 3.6 and 
3.12) and AS (Tables 3.8, 3.9 and 3.14) Vtg. It was also successfully sequenced in the 
MS/MS experiments from both species using MALDI and ESI as ionization sources 
(Tables 3.7, 3.10, 3.11 and 3.15). Thus, if this peptide had 'survived' such variety of 
experimental conditions, it was clearly the winner of the 'signature peptide' contest. It 
was of course present in the RT Vtg sequence found in the Swiss-Prot Database (See 
position 668 in entry Q92093 of Appendix 2). However, while this peptide is not found in 
any of the published sequences of AS Vtg (Appendix 2: entries Q800N9 and Q8UWG2), 
strong evidence from all the previous experiments was sufficient to claim its presence. 
4.3.3 Tuning and optimization of the HPLC-MS/MS acquisition parameters 
Initially, the dilemma of which precursor ion, [M+Ht or [M+2H]2+, was going to 
be selected for the CID-MS/MS experiments had to be resolved. A standard solution of 5 
j.!g/mL of the 'signature peptide' dissolved in H20:acetonitrile:acetic acid, 70:30:0.1 
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(v:v:v) was directly infused in the MS and analyzed in full scan mode, and this is shown 
in the top spectrum ofFigure 4.3. 
The bottom left and right spectra show the enlarged peaks corresponding to the 
[M+2Hf+ and [M+Ht, respectively. The doubly charged species [M+2Hf+ was found at 
mlz 819.94. This monoisotopic peak was only 0.01 Da apart from the predicted m/z at 
819.93, corresponding to a mass accuracy of only 15ppm. This peak exhibited a much 
stronger ion count than that of the singly charged species [M+Ht at mlz 1638.9. From 
this observation, the [M+2H]2+ ion was selected as the precursor for the CID-MS/MS 
experiments. The distribution of peptide ions observed in this spectrum was expected, 
since this peptide contains two functional groups likely to be protonated; one at the amino 
group at theN-terminal of the signature peptide and the other at the guanidinium group of 
the C- terminal arginine residue. The intensity of each precursor is proportional to the 
abundance of each protonated species in the nozzle tip of the ESI cappilary. 
Figure 4.4 shows the CID-MS/MS spectra obtained from the [M+2H]2+ species of 
the 'signature peptide' standard (top spectrum) and its deuterated homologue (bottom 
spectrum) when infused directly into the mass spectrometer. The insets indicate the b-and 
y-type product ions expected from the classical peptide fragmentation routes (Biemann, 
1990). Also, highlighted are the diagnostic Y9, Y10 and Y12 product ions at mlz 957.5, 
1028.57, 1156.6 and at mlz 960.5, 1034.61, 1165.7 which were monitored during the 
'pseudo' SRM-MS/MS experiments. Also, all the product ions selected contained the 
deuterated moieties. 
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Figure 4.3 Full scan spectrum of the 'signature peptide' standard 
The top spectrum shows the [M+Ht and the [M+2Hf+ at mlz 1638.9 and 819.9, 
respectively. The bottom left and right spectra show the same peaks in an enlarged scale. 
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Figure 4.4 Product ion spectra of the 'signature peptide' 
The top (A) spectrum corresponds to the signature peptide and the bottom (B) to its 
deuterated isotopic homologue. The amino acid A* stands for the deuterated amino acid L-
Alanine-3,3,3-d3. See legend in Figure 3.14 for remaining details. 
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The decision to monitor these particular ions was based on a trade-off between 
sensitivity and specificity. The fact that the product ions monitored had higher m/z values 
than those of the selected doubly charged precursor ions allowed for an increase in the 
specificity of the method. Under this criterion, any singly charged ion precursors with the 
same mlz as the 'signature peptide's were neglected. However, this decision compromised 
the sensitivity of the method, given that some less specific product ions below mlz 400 
would have rendered a much higher intensity signal as shown in Figure 4.4. 
Once the monitored product ions were selected, the acquisition parameters of the 
tandem mass spectrometer had to be tuned and optimized. By default, these instrumental 
parameters are typically set to encompass a wide range of biomolecules with different 
physicochemical properties over a wide mlz range. However, to obtain optimum results, 
each one of these parameters had to be adjusted for every particular compound, in this 
case, a tryptic peptide. 
Although there are at least twenty parameters that can be modified in the mass 
spectrometer, only seven of them were shown to significantly affect the signal produced 
by the product ions. A diagram of the general components of the ESI-QqToF-MS/MS is 
shown in Figure 4.5. The parameters optimized and their location is also illustrated in this 
figure. The open brackets indicate the positions where the electric fields are applied. The 
ionization energy (IE), the nebulization gas (GAS 1) and the auxiliary gas (GAS 2) are 
critical parameters associated with the ESI ionization source and optimization of these 
translated into high ionization efficiency of the precursor ions and proper focusing into 
the mass spectrometer. 
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Figure 4.5 Schematic diagram of an ESI-QqToF tandem mass spectrometer 
The diagram includes the instrumental parameters which were tuned for the 'pseudo' SRM-
MS/MS acquisitions: Gas I, Gas 2, the ionization energy (IE), the declustering potential I and 2 
(DPI and DP2), the focusing potential (FP) and the collision energy (CE). The horizontal brackets 
indicate the location where the electric potentials are applied. 
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The declustering potentials one and two (DP1 and DP2, also known as the Cone 
Voltage) and the focusing potential (FP) play a critical role in the steering of the ions 
within the mass spectrometer and should be carefully tuned to avoid 'in-source' 
fragmentation of the precursor ions. All these parameters were optimized and adjusted by 
direct infusion of a 5 J.lg/mL solution of the standard 'signature peptide' while monitoring 
the mlz 1156 signal corresponding to the Y 12 product ion. The results of this tuning 
procedure are graphically illustrated in Figures 4.6 and 4.7. Each parameter was manually 
ramped, while the remaining parameters were fixed at the following values: Gas 1: 40, 
Gas 2: 50, IE: 4700V, DP1: 40V, DP2: 10V, FP: 200V and CE: 34V. The Gas values are 
given in arbitrary units displayed in the AnalystQS software program. 
The collision energy imparts the energy to the precursor ion for CID. In the case 
of quadrupole mass analyzers, this process is called 'low-energy' CID because of the 
relatively small amount of energy which the precursor ions possess before collision with 
the inert collision gas. Modification of the CE produces distinctive mass spectral profiles. 
With low CE, the precursor ion can survive the CID and appear in the product ion 
spectrum. Also, the low CE spectra have a predominance of larger fragments. As the CE 
is increased, the intensity of the precursor ion in the product ion spectrum starts to 
decrease with a concomitant increase in the amount of smaller product ions (Data not 
shown). 
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Figure 4.7 Optimization of the declustering potential (1 and 2) and 
the focusing potential. 
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The spectra acquired at different collision energies are shown in Figures 4.8 and 
4.9. For particular experimental purposes in this work, a compromise was selected where 
the CE was increased to maximize the intensity of the signal at rn/z 1156 and reduce the 
signal of the doubly charged precursor ion [M+2H]2+ at rnlz 819.9. This situation is 
portrayed graphically in Figure 4.1 0. The graph shows a steady decline in the intensity of 
the precursor ion with increasing CE. At a CE of 36 V, a maximum of product ion is 
produced while the signal produced by the precursor ion is close to baseline noise. 
Once the parameters for the MS/MS acquisitions were optimized, a calibration 
curve was prepared and a digested plasma sample was analyzed by direct injection into 
the mass spectrometer to test if it could be used for quantification purposes, without the 
use of the HPLC. The rationale behind this idea lies in the fact that during MS/MS 
acquisition, the first mass resolving analyzer (a quadrupole mass analyzer in the 
instrument used) is fixed at a specified mass window. This could have been sufficient to 
isolate the 'signature peptide'. 
Ten microliters each of standards and plasma samples were loaded into the 
injection loop and sequentially injected. The product ions were also monitored in 
'pseudo' SRM mode. Certainly, this approach worked adequately for the calibration 
standards and it even made sample analysis much faster, reducing the acquisition times 
from 25 to 3 minutes (See Figure 4.11). The top figure shows the TIC 'chromatogram' 
obtained from a 0.25 ug/mL standard. The two center figures show the product ion 
spectra obtained for the 'signature peptide' (center top) and the internal standard (center 
bottom). The calibration curve is shown in the bottom ofFigure 4.11. 
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Figure 4.8 Product ion spectra of the 'signature peptide' at varying collision energies 
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The different figures correspond to collision energies (CE) from 30 to 40 V, as indicated in each 
spectrum. 
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Figure 4.9 Product ion spectra of the 'signature peptide' at varying collision energies 
The different figures correspond to collision energies (CE) from 42 to 48 V, as indicated in each spectrum. 
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Figure 4.10 Optimization ofthe collision energy for 'pseudo' SRM-MS/MS experiments 
However, when the digested plasma sample was analyzed, no signal was produced 
when monitoring the diagnostic product ions. In fact, when the same sample was 
analyzed in full scan MS mode, the peaks corresponding to the 'signature peptide' and the 
internal standard were hardly distinguishable from the baseline noise in the spectrum, as 
shown in Figure 4.12. 
The top portion in Figure 4.12 shows the full scan spectrum of digested RT 
plasma with internal standard, from mlz 400 to 850. The center spectrum shows an 
expanded scale of the same specturm from at mlz 815 to 835. The complex mixture 
present in the plasma digest probably explains this observation, since the ionization 
competition among the tryptic peptides and other interfering species at the ESI source 
results in the suppression and/or masking of the 'signature peptide' and internal standard 
signals. 
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Figure 4.11 Calibration ofthe 'signature peptide' by direct 'loop' infusion 
The top figure (A) shows the total ion count 'chromatogram' after an injection of lOJ.lL of a 0.25J.lg/mL 
'signature peptide' standard. Figures Band C show the product ion spectra obtained for the standard and 
its labeled isotopic homologue, respectively. The bottom graph (D) shows the callibration curve 
obtained by direct loop injection, when monitoring the Y9, Y10 and Y12 diagnostic product ions. 
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Figure 4.12 Full scan spectra of samples obtained by direct 'loop' infusion 
The top (A) and middle (B) figure show the full scan spectrum of digested plasma directly 
infused into the mass spectrometer. The high abundance of background peaks does not permit the 
visualization of the 'signature peptide' or its isotipic homologue at mlz 819.9 and 824.9, 
respectively. The bottom figure (C) shows, for comparison, an acquisition of a 0.25f.lg/mL 
standard spiked with the internal standard under the same conditions. 
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This spectrum contrasts with that of the standards alone, also acquired in regular 
MS mode as observed in the bottom spectrum of Figure 4.12. In the latter spectrum, the 
[M+2H]2+ species at mlz 819.9 and 824.4, corresponding to the 'signature peptide' and 
the deuterated internal standard, are clearly visible (Note that the calibration of the ToF 
analyzer is slightly off in these spectra). Furthermore, all the species having the same m/z 
would be 'collectively' selected by the first mass resolving analyzer, resulting in 
fragmentation competition during the CID. This would further affect the appearance of 
the product ion spectrum. The presence of isobaric species was confirmed, as described 
later, when the peptides were separated in-line by HPLC prior to MS/MS analyses. 
The use of this HPLC-MS/MS hyphenated technique permits the tryptic peptides 
to be gradually introduced into the mass spectrometer for analysis. Valley-to-valley peak 
separations of individual peptides typically expected for HPLC are not required when 
using MS/MS as a detector. In fact, it would be unreasonable, nearly impossible, to 
expect the many thousands of peptides produced during a complete enzymatic digestion 
of plasma to be individually separated in a 25 minute separation occurring within a 3 em 
chromatographic column. Nevertheless, the chromatographic conditions optimized for 
this method allowed for the production of strong signals from the product ions derived 
from the 'signature peptide' and the co-eluting deuterated internal standard. 
During the chromatographic separation of a complex plasma tryptic digest, the 
chances of encountering a peptide with a similar m/z value to that of the 'signature 
peptide', with overlapping retention times, can not be ruled out. This situation is 
illustrated in Figure 4.13. The chromatogram of a plasma tryptic digest was acquired in 
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both MS and MS/MS modes and the corresponding extracted chromatograms for the 
precursor and product ions are shown. Figure 4.13A shows the complexity of the protein 
digest illustrated by the conglomeration of peaks present in the total ion count (TIC) 
chromatogram acquired in full scan mode. This chromatogram was simplified when the 
[M+2H]2+ 'signature peptide' at mlz 819.9 was extracted, as seen in the extracted ion 
chromatogram (EIC) shown in Figure 4.13B. However, as expected for such a complex 
peptide mixture, other peaks at different elution times were also observed for that 
particular mass. 
The same sample was acquired in the 'pseudo' SRM scanning mode (see Figure 
4.13C). As expected, this TIC chromatogram is very similar to that found in Figure 
4.13B, since both signals are generated or reconstructed from the same selected masses. 
Figure 4.13D shows the added specificity afforded by tandem mass spectrometry. This 
figure shows the overlaid EICs corresponding to the Y9, Y10 and Y12 diagnostic product 
ions at mlz 957.5, 1028.57 and 1156.6 obtained from Figure 4.13C. 
The traces of these three chromatograms appear as superimposed (an expanded 
scale view is shown in the inset of Figure 4.13D). None of these diagnostic product ions 
were observed at other retention times, proving the enhanced specificity of this technique. 
Furthermore, the EIC (Figure 4.13D) chromatograms show reduced baseline signal and 
increased signal to noise ratio compared to the TIC chromatograms obtained from the 
precursor ions (Figure 4.13C). 
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Figure 4.13 Analysis of a digested RT plasma by HPLC-MS and MS/MS 
The top figure (A) shows the total ion count (TIC) chromatogram of a digested RT plasma 
analyzed by full scan MS. Its extracted ion chromatogram (EIC) for m/z 819.9 is shown in figure 
B. The same sample was acquired in the 'pseudo' SRM-MS/MS mode. The TIC chromatogram is 
shown in figure C. Finally the three diagnostic product ions, Y 9, Y 10 and Y 12, were extracted from 
the spectrum shown in C. The traces of the three overlaid EICs for these ions are shown in figure 
D. The inset in this last figure shows an expanded scale for the peak eluting at 6.5 minutes. 
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It should be noted that during the chromatographic separation, the solvent flow 
rate was decreased to 0.05 mL/min during chromatographic elution of the signature 
peptide (see Table 4.1) in order for enough ion counts to be accumulated for the product 
ion spectra. This procedure increased the analytical sensitivity when compared to higher 
flow rate acquisitions. Also, after the elution of the signature peptide, the flow rate was 
increased to 0.40 mL/min (see Table 4.1), reducing the chromatographic separation time 
to 25 minutes, convenient enough to perform reasonable throughput analyses for larger 
scale sampling. 
The extraction of ions from a TIC chromatogram using a TOF detector operated in 
pseudo-SRM mode is a post-acquisition process. To test whether increased resolution of 
the QqTOF offers any advantage over the QqQ, the extracted chromatograms were 
generated using different mass ranges. Figure 4.14A shows the TIC chromatogram of the 
precursor at m/z 819.9 acquired in the 'pseudo' SRM scanning mode from a plasma 
digestion sample. Figures 4.14B and 4.14C show the windows of 0.3 and 2.0 Da used 
around the Y12 product ion at mlz 1156 to obtain the EICs shown in Figures 4.14D and 
4.14E, respectively. The 0.3 Da mass window includes the monoisotopic peak exclusively 
while, the 2.0 Da window is wide enough to include the complete isotopic cluster. 
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"''*' Figure 4.14 Optimization of mass ranges for extracted ion chromatograms 
Figure A shows the TIC chromatogram of a digested plasma acquired in the 'pseudo' SRM-
MS/MS mode. Figures B and C show the product ion spectra obtained during the elution of the 
signature peptide. The peak shown in both spectra corresponds to the Y 12 product ion at m/z 
1156. Figures D and E correspond to the EICs taking into account a mass range of 0.3 and 2.0 
Da, respectively. These mass ranges are portrayed as the shaded areas in spectra Band C. 
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The analysis of Figure 4.14 clearly shows there was no clear increase in 
specificity by using the higher resolution offered by the QqTOF. None of the extracted 
chromatograms (Figures. 4.14D and 4.14E) showed a difference in their profile, i.e. no 
interfering peaks were observed in either chromatogram. However, sensitivity was 
compromised by half with the narrower extraction window (Figure 4.14D), as shown by 
the less intense peak. 
Identical results were obtained from the extracted ion chromatograms of the Y 9 
and Y 10 product ions at m/z 957.5 and 1028.57, respectively. Moreover, the use of a wider 
window would avoid any inconvenience caused by a subtle modification in the ToF 
calibration parameters, where a slight change would be translated into increased peak 
integration errors during automated hatched data acquisition analysis. Therefore, all 
subsequent extracted chromatograms were analyzed using a mass range window of2 Da. 
The internal standard was directly infused into the mass spectrometer and 
analyzed by ToF-MS to confirm that no residual non-deuterated L-alanine had been 
incorporated instead ofL-alanine-3,3,3-dJ during its synthesis (see Figure 4.15). The peak 
at mlz 824.5 corresponds to the [M+2H]2+ species. The absence of peaks at mlz 819.9 
corresponding to [M+2Hf+ of the non-labeled peptide confirmed the purity of the labeled 
standard. This requirement was critical, since all the samples analyzed in this study were 
spiked with the internal standard. 
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Figure 4.15 Full scan spectrum of an infused labeled 'signature peptide' standard 
The absence of a peak at m/z 819.9 confirms the absence of unlabeled residues in the internal 
standard. 
4. 4 Sample analysis 
After adjustment of the experimental parameters, a calibration curve was 
constructed for each of the product ions monitored in the 'pseudo' SRM experiments 
acquired on the HPLC-ESI-Qq-ToF MS/MS. The calibration standards were prepared at a 
concentration of 0.05, 0.1 0, 0.25 and 0.50J.lg/mL of signature peptide. All standards and 
unknown plasma samples were spiked with internal standard to produce a final 
concentration of 0.1 OJ.lg/mL of the deuterated signature peptide. The three calibration 
curves and the regression parameters obtained for the three monitored product ions are 
depicted in Figure 4.16. Note that all monitored product ions gave a similar linear 
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regression equation. The dependent variable was obtained from the area ratios of the Y 9, 
Y 10 and Y 12 monitored product ions to their isotopic homologues. 
The values obtained from the regression analysis again confirm the robustness of 
this method. The limit of quantification (LOQ) for this method was calculated as the 
interpolated concentration produced by a baseline noise peak multiplied by a factor of ten. 
This translated into a value of 0.0008 J..lg/mL of 'signature peptide', equivalent to 0.009 
mg/mL ofVtg. 
The importance of adding the internal standard to correct for instrumental and 
processing variations is demonstrated in Figure 4.17. This figure shows the same 
calibration curves as before, but in these graphs the dependent variable is assigned to the 
absolute areas of the monitored product ions Y 9, Y 10 and Y 12, instead of the area ratios. 
There is an increase in the scattering of the experimental data, statistically indicated by 
the decrease in the value of the R2• 
This increase in reproducibility, however, compromised the sensitivity of the 
method. When single precursor product ion spectra are acquired, the 1st stage mass 
analyzer is fixed on a single mass range value. When operating in SRM mode, the tandem 
mass spectrometer is programmed to monitor both the products of the 'signature peptide' 
and its deuterated homologue. This decreased the overall acquisition time for each 
precursor by a factor of two, since the 1st stage analyzer sequentially selected one of the 
precursors at a time for the product ion spectra to be obtained. However, the increased 
precision was considered more beneficial than the decrease in analytical sensitivity. 
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Figure 4.16 Calibration ofthe 'pseudo' SRM-MS/MS experiments 
The calibration curves for the diagnostic Y 9, Y 10 and Y 12 product ions is shown in figures A, B 
anc C, respectively. In all cases, the area ratios of the product ions to the corresponding isotopic 
homologues were taken as the response signals for the dependent variables. All standards were 
spiked with internal standard to produce a fmal concentration of 0.1 OJ.lg/mL of the deuterated 
signature peptide. 
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Figure 4.17 Calibration of classical MS/MS experiments 
The calibration curves for the diagnostic Y 9, Y 10 and Y 12 product ions is shown in figures A, 
B anc C, respectively. In all cases, the absolute area values of the product ions were taken as 
the response signals for the dependent variables. An increased scattering of data is observed. 
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After injecting the highest concentration standard of 0.50J.!g/mL, a blank sample 
(Solvent B) was injected to check for 'carryover' signal. This procedure was repeated 
after any sample which had a peak corresponding to the 'signature peptide', whose 
intensity was more intense than that of the highest calibration standard. 
The digested plasma samples were run under the same conditions as the standards. 
Figure 4.18 shows a RT sample prior to (Figure 4.18A) and after 17~-estradiol induction 
(Figure 4.18B). These figures show the overlaid extracted ion chromatograms of the Y 9, 
Yw and Y12 product ions of both 'signature peptide' (SP) and labeled internal standard 
(IS) at mlz 957.5, 1028.57 and 1156.6, and m/z 960.5, 1034.61 and 1165.7, respectively. 
The traces obtained from the 'signature peptide' before 17~-estradiol induction were 
nearly indistinguishable from the baseline while the traces corresponding to the internal 
standard formed a clear peak in both samples. The inset shows the expanded scale of 
these traces, confirming the absence ofVtg before treatment (Figure 4.18A). 
The 'signature peptide' and equivalent Vtg plasma concentrations from all the 
samples analyzed are given in Table 4.2. The identities of the samples analyzed were 
confirmed by the presence of all three product-ions (Y9, Y10 and Y12) in the 'pseudo' 
SRM analyses at the corresponding elution time of the 'signature peptide' 
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Figure 4.18 Detection of the 'signature peptide' by HPLC-MS/MS 
The overlaid EICs obtained from the 'pseudo' SRM-MS/MS analysis for the same fish prior to (Figure 
A) and following !3-estradiol injection (Figure B) are shown. The absence of a signal for the signature 
peptide (SP) is observed in the control sample (figure A). The trace of the internal standard (IS) is 
similar in both samples. The inset figures show an expanded scale of the peaks eluting at 6.5 minutes. In 
these insets, the ovelaid signals produced by the Y 9, Y 10 and Y 12 product ions appear as overlapped 
traces .. The concentration ofthe deuterated signature peptide was O.lOJ.lg/mL. 
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Table 4.2 Results obtained for the plasma samples analyzed by the 'signature 
peptide' approach 
The results for both control (C) and experimental (E) rainbow trout (RT) and Atlantic salmon (AS) are 
expressed as 'siganture peptide' (SP) and Vtg concentrations. Only the experimental (E) samples 
showed significant P values in the t-test for paired samples before and after 17~-estradiol induction. 
Sample Type Before ~-estradiol After ~-estradiol t-test 
SP Cone Vtg Cone SP Cone Vtg Cone p 
J..Lg/mL mg/mL J..LM J..Lg/mL mg/mL J..LM 
RT c <LOQ <LOQ <LOQ 0.096 5.329 0.029 0.11 RT c 0.041 2.276 0.013 0.085 4.718 0.026 
RT E <LOQ <LOQ <LOQ 0.576 31.973 0.176 
RT E <LOQ <LOQ <LOQ 0.799 44.352 0.244 
RT E 0.068 3.775 0.021 0.562 31.196 0.171 
RT E <LOQ <LOQ <LOQ 0.456 25.312 0.139 
RT E <LOQ <LOQ <LOQ 0.615 34.138 0.188 
RT E 0.029 1.610 0.009 0.771 42.798 0.235 <<0.001 
RT E <LOQ <LOQ <LOQ 0.197 10.935 0.060 
RT E <LOQ <LOQ <LOQ 0.368 20.428 0.112 
RT E <LOQ <LOQ <LOQ 0.185 10.269 0.056 
RT E <LOQ <LOQ <LOQ 0.564 31.307 0.172 
RT E 0.025 1.388 0.008 0.754 41.854 0.230 
AS c 0.008 0.444 0.002 0.054 2.998 0.016 
AS c 0.290 16.098 0.088 0.209 11.601 0.064 0.23 AS c <LOQ <LOQ <LOQ 0.063 3.497 0.019 
AS c <LOQ <LOQ <LOQ 0.103 5.717 0.031 
AS E <LOQ <LOQ <LOQ 0.628 34.860 0.192 
AS E 0.223 12.379 0.068 0.969 53.789 0.296 
AS E <LOQ <LOQ <LOQ 0.439 24.369 0.134 
<<0.001 
AS E <LOQ <LOQ <LOQ 0.653 36.248 0.199 
AS E 0.008 0.444 0.002 0.540 29.975 0.165 
AS E <LOQ <LOQ <LOQ N/A NIA N/A 
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For quantification purposes, the concentrations obtained from each of the 
diagnostic product ions were averaged. The coefficient of variation was typically below 
1 0% among the three concentrations obtained for each sample. The significance of the 
concentrations should be placed in the order of magnitude. For this reason, none of these 
results were corrected for recovery. Concentration values of zero analytically mean less 
than the LOQ. As expected, most of the juvenile RT had non-detectable plasma levels of 
Vtg before 17~-estradiol induction, except for a couple of larger female trout which were 
probably at stages of early sexual maturation. As for the AS, two samples were confirmed 
as females, after the animals were killed and their ovaries were found to be filled with 
eggs. This would explain the high levels of Vtg found in some of the fish before 17~­
estradiol induction, characteristic of the vitellogenic reproductive phase. 
A t-test for paired samples was applied to each one of the groups (control RT, 
experimental RT, control AS and experimental AS). As expected, a statistically 
significant (P<<0.001) increase in Vtg plasma concentration was established for all 
experimental fish, whereas no significant increase was observed for the control fish. 
4.5 Recovery studies 
Four peptide standard solutions of 0.1 11g/mL were prepared and processed under 
the exact conditions to which the plasma samples were subjected, to test for the recovery 
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of the entire procedure, starting from the denaturing step before the enzymatic digestion 
step (see section 4.3 .1 ) . 
The results from the recovery tests are depicted in Table 4.3. The peptide 
concentration for each recovery sample was calculated as the average concentration 
obtained from each of the Y 9, Y 10 and Y 12 calibration curves. An average of these, the 
standard deviation (SD) and the coefficient of variation (CV) percent were calculated. 
Reproducibility of this methodology was within acceptable limits having a coefficient of 
variation of 3.4%. However, recovery results averaging 67% were not as good as 
expected. Nevertheless, because of the systematic and reproducible loss of peptide under 
the described experimental conditions, these recovery results could be incorporated into a 
correction factor to account for peptide loss during sample handling and experimental 
procedure. 
Table 4.3 Statistical analysis of recovery studies 
Four O.lJlg/mL signature peptide solutions were prepared (R1 toRt). After analysis, the 
average concentration, the standard deviation (SD) and the percent coefficient of 
variation (CV %) were calculated. The recovery% was based on O.lOJlg/mL as 100% 
recovery. 
Peptide Cone. Average Cone. SD 
Sample Jlg/mL Jlg/mL Jlg/mL CV% Recovery % 
RI 0.070 
Rz 0.069 
R3 0.067 
0.067 0.002 3.4 67 
Rt 0.064 
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A possible cause for this low recovery could have been the chemical 
transformation of the peptide. The enzymatic digestion occurs under mild reaction 
conditions (37°C and pH 7.4), however the previous denaturing step takes place at 60°C 
in 8M urea. Carbamylation of terminal NH2 groups in proteins could occur under these 
conditions as described in the literature (Cejka et al., 1968; Makler, 1980; Lippincott and 
Apostol, 1999). 
To check for this and any other possible chemical modifications of the standard 
peptide, an Information Dependant Acquisition (IDA) survey scan was performed on one 
of the recovery sample tubes. The product ion spectra, excluding that corresponding to 
the 'signature peptide', obtained from all the additional minor peaks present in the 
chromatogram were investigated to see whether any of these were derived from the 
'signature peptide'. A careful analysis of all these spectra showed that none of them 
contained the carbamylated sequence tags characteristic ofthe 'signature peptide'. 
One of the major concerns with the proposed technique was the possibility of 
incomplete digestion of the plasma samples. Other authors have also addressed this 
problem in different ways. For example, some researchers have shown the differences in 
SDS-PAGE plasma protein profiles prior to and after the digestion step (Zhang et al., 
2004a). Alternatively, another study assessed the completion of enzymatic digestion by 
monitoring the peptides obtained from surrogate synthetic peptides containing the same 
tryptic cleavage site as the native protein analyzed (Bamidge et al., 2003). 
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In this study, possible incomplete digestion of Vtg was analyzed using a different 
approach. A series of hypothetical candidate sequences corresponding to the product of 
enzymatic missed cleavages of the 'signature peptide' were proposed. These can be 
observed in Table 4.4. Subsequently, digested plasma samples of RT were injected into 
the HPLC-MS/MS and processed in the 'pseudo' SRM mode, except that a different 
precursor ion from Table 4.4 was selected for each run. 
The TIC chromatograms obtained for these precursors at mlz 819.92, 933.49, 
1361.22, 1474.79, 1182.65 and 1891.65, revealed some suspicious peaks, which are 
shown in Figures 4.19 A, B, C, D and E, respectively. However, the product ion spectra 
obtained from them showed no evidence of any of the fragment ions expected from the 
candidate peptides. This suggested that digestion was complete, at least in this region of 
the protein. 
Table 4.4 Candidate peptides for the incomplete digestion ofRT Vtg 
The first peptide in the list (*) corresponds to the 'signature peptide'. The slash (-) in the remaining peptides 
indicates the positions of missed cleavage sites. 
[M+Ht [M+2H] + 
Peptide sequence 
mlz mlz 
TYF AGAAADVLEVGR * 1638.84 819.92 
AR-TYFAGAAADVLEVGR 1865.98 933.49 
TYF AGAAADVLEVGR-TEGIQEALLK 2721.44 1361.22 
AR-TYFAGAAADVLEVGR-TEGIQEALLK 2948.58 1474.79 
TVV AK-AR-TYFAGAAADVLEVGR 2364.30 1182.65 
TYF AGAAADVLEVGR-TEGIQEALLK-PPAPENADR 3781.97 1891.49 
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Figure 4.19 Candidate peaks for incomplete digestion peptides ofVtg 
A 'pseudo' SRM-MS/MS analysis was performed for all the candidate peptides of the incomplete Vtg 
digestion listed in Table 4.4. The spectra A, B, C, D and E correspond to the TIC chromatograms 
obtained for the [M+2Hf+ precursors at m/z 933.49, 1361.22, 1474.79, 1182.65 and 1891.49, 
respectively. 
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To further test the completion of the digestion step, a study was performed to 
follow the production of the 'signature peptide' at timed intervals during enzymatic 
incubation. A RT plasma was subjected to the digestion step explained with varied 
incubation times. The results obtained at 2, 6, 14, 18, 24 and 30 hours after the initiation 
ofthe digestion are illustrated in Figure 4.20. 
0.40 
0.35 
0.30 
lr'l .9 0.25 
"'1i:i ::o::: \0 c:l 0.20 
lr'l ~ 
<t: 0.15 
0.10 
0.05 
0.00 
0 
~ ~ 
~ 
10 20 
L 
/ 
/ 
/ 
/!! 
30 40 Tirre (h) 50 
Figure 4.20 'Signature peptide' release during incubation with trypsin 
The progress of the enzymatic digestion was monitored during a 30 hour period (o) by measuring 
the release ofthe 'signature peptide' analyzed HPLC-MS/MS. After 24 hours, a second aliquot of 
trypsin was added and monitored for an additional 24 hour period (~). 
At 24 hours, there is a clear plateau, indicating that the digestion process has 
stopped. In a parallel experiment, the same sample was subjected to the same enzymatic 
conditions, with the addition of an extra aliquot of enzyme after the initial 24hours 
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(indicated in Figure 4.20 by the 24+24 hour incubation label). The reaction was 
monitored to a total of 30 and 48 hours from the initiation of the digestion. The results are 
also portrayed in Figure 4.20. The increase in the signal of the 'signature peptide' 
indicated that the digestion process did not conclude in the initial 24 hours. Thus, the 
plateau referred earlier is probably due to inactivation or degradation of the enzyme 
present in the digestion. This is very important since, some of the published literature 
usually regard this plateau as the completion of the digestion reaction (Zhang et al., 
2004a). 
4.6 Vitellogenin stability studies 
Finally, the preservation of samples prior to analysis was studied to observe the 
effect of freeze-thaw cycles on the final results. This is a critical issue since blood 
sampling usually occurs during fieldwork, and very rarely under laboratory conditions, 
and there may be a considerable period of time between sampling and laboratory 
processing. This lag time increases the possibility of Vtg loss as this protein is known to 
be highly susceptible to degradation (Silversand et al., 1993). To examine the storage 
stability of Vtg, unstable conditions were simulated by subjecting the same sample to an 
increasing number of freeze-thaw cycles prior to analysis. 
A fresh plasma sample of Atlantic salmon was separated into 4 aliquots. The first 
was frozen and stored at -20°C. The remaining three were subjected to 2, 4 and 6 freeze-
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thaw 24 hour cycles and finally stored at -20°C. The four aliquots were analyzed as 
regular plasma samples. 
The results of this study are given in Table 4.5 and demonstrate that harsh storage 
conditions assayed in this test clearly do not affect the results obtained. In addition, the 
reproducibility of the concentration values is consistent with that obtained from the 
recovery test. 
Table 4.5 Effect of freeze-thaw cycles on final concentrations 
After analysis, the average concentration, the standard deviation (SD) and the percent coefficient of 
variation (CV %) were calculated. The latter was consistent with the values obtained in the Recovery 
studied shown in Table 4.3. 
Freeze-thaw Peptide cone. Average SD 
cone. 
CV% 
cycles (J.tg/mL) (J.tg/mL) (J.tg/mL) 
1 0.431 
3 0.449 0.451 0.019 
5 0.449 
4.17 
7 0.477 
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Chapter 5: Discussion and conclusions 
5.1 Similarities between Atlantic salmon and rainbow trout vitellogenin 
In the past, Vtgs of different species have been sequenced and stored in protein 
databases. A BLAST search was performed using the RT Vtg as the query input. Results 
showed a list of at least fifty vitellogenic related proteins and precursors exhibiting 
homology. When comparing specifically the published sequences of the RT (See 
Appendix 2: Q92093) and AS Vtg (Appendix 2: Q8UWG2 and Q800N9), protein 
homology was evident as seen in the result ofthe FAST A (Pearson, 1990; Pearson, 1991) 
output file (Figure 5.1) using the local alignments (Lalign) program (see Section 3.1.7.5). 
Q92093 exhibited a 91.429% identity in a 175 amino acid overlap with Q8UWG2, and 
81.041% identity in a 269 amino acid overlap with Q800N9. Extracted and purified under 
the same conditions, the molecular mass of AS Vtg seemed to have a Mr only 2.6% 
smaller than that of the RT Vtg, according to the results of the MALDI-ToF-MS 
experiments. 
Conservative substitutions, that is, aminoacids with similar chemical properties 
have been replaced (eg. Leu for Ile, Glu for Asp etc) were found along the sequence of 
both proteins. As observed in Figure 5.1, evidence suggested that further similarities 
between the Vtg of both species would be found in the study. Indeed, the results shown in 
the present study seem to support this. 
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RT Vtg (Q92093) vs AS Vtg (Q800N9) 
10 20 30 40 50 60 70 80 
spiQ92 MRAVVLALTLALVASQSVNFAPDFAASKTYVYKYEALLLGGLPEEGLARAGVKVISKVLISAVAENTYLLKLVNPEIFEY 
:. :::.:::::::::: :::::.: ::::::::::::::::::::::.:::.::::::::::.: . :. ::::.:::::: 
triQ80 MKAVVFALTLALVASQHVNFAPEFEASKTYVYKYEALLLGGLPEEGLSRAGIKVISKVLISAIAPTIYMLKLVDPEIFEY 
10 20 30 40 50 60 70 80 
90 100 110 120 130 140 150 160 
spiQ92 SGVWPKDPFVPAAKLTSALAAQFSIPIKFEYAKGVVGKVLAPTAVSETVLNVHRGILNILQLNIKKTQNVYELQEAGAQG 
::::::::::::.:::::::::. ••••••••••••••••••••••••••••• 0... • 00.0 •• 0 ••••••• 0 ••• 0 •••• 0 •• 0 0 •• 0 •••••••••••••••••••• 0 •••• •••• 0 0 ••• 0 ••• 
triQ80 SGVWPKDPFVPASKLTSALAAQLLTPIKFEYANGVVGKVFAPTGVSETVLNIHRGILNILQLTFKKTQNVYEMQEAGAQG 
90 100 110 120 130 140 150 160 
170 180 190 200 210 220 230 240 
spiQ92 VCKTHYVIREDAKAERIHLTKSKDLNNCQQRIMKDFGLAYTEKCVECRQRGEALMGAATYNYLMKPADNGALILEATVTE 
• 0 0 0 0... • • • • • •••• 0 ••• ••••••••••• 0 • 0 0. 0 • • •• 0 • 0 •• 0 0 0 0 ••••• 0 • 
• • 0 •••• 0 • • • • • • •••• 0. 0 0 0 0 ••••• 0 ••••••••• 0 •••• 0 0 ••• •••••••••• 0 ••••••• 0. 0 0 0 0. 
triQ80 VCKTHYVISEDAKTGYIHLTKTKDLNHCQERIIKEFGLAYTENCVECQQKGKNLRGAAAYNYIMKPTATGAIIMEATVTE 
170 180 190 200 210 220 230 240 
250 260 270 280 290 300 310 320 
spiQ92 LHQFTPFNEMSGAAQMEAKQMLTFVEIKKDPIIVPDNNYVHRGSIRYEFATEILQMPIQLLKISNARAQAVKILNHLVTY 
::::0:::::.::::::::: . 0:::::: 
tr1Q80 LHQFSPFNEMNGAAQMEAKQTFAFVEIKKT 
250 260 270 
RT Vtg (Q92093) vs AS Vtg (Q8UWG2) 
1450 1460 1470 1480 1490 1500 1510 1520 
spiQ92 VKISDIDVDLYTEDHGVIVKVNEMEISNDNLPYKDPSGSIKIDRKGKGVSLYAPSHGLQEVYFDKYSWKIKVVDWMKGQT 
:: . ::.:::::::::::::::::: ::::.::::::::: 
tr1Q8U KIKQKGEGVSLYAPSHGLQEVYFDKNSWKIRVVDWMKGQT 
10 20 30 40 
1530 1540 1550 1560 1570 1580 1590 1600 
spiQ92 CGLCGKADGENRQEYRTPSGRLTKSSVSFAHSWVLPSDSCRDASECLMKLESVKLEKQVIVDDRESKCYSVEPVLRCLPG 
:::::::::: :::: :::::::::::::::::::::::::::::::: . :::::::::::::.:::::::::::::::: 
tr1Q8U CGLCGKADGEVRQEYSTPSGRLTKSSVSFAHSWVLPSDSCRDASECLMTFESVKLEKQVIVDDKESKCYSVEPVLRCLPG 
50 60 70 80 90 100 110 120 
1610 1620 1630 1640 1650 
spiQ92 CLPVRTTPITIGFHCLPVDSNLNRSEGLSSIYEKSVDLMEKAEAHVACRCSEQCM 
::::::::::::::::::::::.:::::::.::::::: ::::::::::::.::. 
triQ8U CLPVRTTPITIGFHCLPVDSNLSRSEGLSSFYEKSVDLREKAEAHVACRCSQQCI 
130 140 150 160 170 
Figure 5.1 Sequence homology between RT and AS Vtg 
Local alignment results of the published sequence of RT Vtg (spJ92)) against the two known 
sequences of AS Vtg (trJQ80) and (trJQ8U). Numbers indicate the residue position along the 
sequence. The':' and'.' symbols denote identities and conservative substitutions, respectively. 
The MALDI-ToF-MS of the tryptic digestion of the AS Vtg showed a large 
number of peptide peaks which matched those of the tryptic RT Vtg peptides, although 
only some of them could be confirmed by the MS/MS sequencing experiments. 
Nevertheless, eleven sequenced fragments showed noticeable similarity with regions of 
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the RT Vtg, two of which had also matched the partial sequence of the published AS Vtg. 
In spite of the similarities, there is some evidence to postulate amino acid variants. 
Finally, a remark should be made about the sequenced peptides obtained from the CID-
MS/MS of the selected precursor peptide ions at m/z 795.18, 893.28 and 791.05. These 
are apparently exclusive to the AS Vtg, possibly indicating regions of sequence 
variability. Further characterization of these and other non-identified fragments will allow 
post translational modifications and genetic variants to be confirmed. 
5.2 The 'signature peptide' approach: The advantages and disadvantages 
A simple and straightforward HPLC-MS/MS technique has been presented and 
published for the quantification of Vtg plasma levels in both RT and AS (Cohen et al., 
2006). The use of a QqToF operated in the 'pseudo' SRM mode allowed us to monitor 
three diagnostic product ions, enhancing specificity without compromising sensitivity. 
The specificity was not increased by reducing the mass window of the extracted ion 
chromatograms from 2 to 0.3 Da. Moreover, sensitivity was reduced by a factor of 
approximately two. 
The use of the common 'signature peptide' for both species is a great advantage in 
regions where both species play an important role in commercial aquaculture ventures. 
Furthermore, it would not be surprising to find in the future other related species that 
share this common tryptic peptide. This will almost certainly be corroborated with 
genomic studies advancing in these other species. Nevertheless, it would be a mistake to 
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choose this and any other candidate 'signature peptide' based only on their presence in 
the sequences of the protein databases. The experiments carried out in this work clearly 
show that not all of the predicted tryptic peptides appear and/or are amenable to MS/MS 
analysis. Different conditions can explain this behavior such as presence of PTM in the 
'signature peptide', regions or sequences not accessible to enzymatic digestion, or 
structures that are resilient to CID fragmentation in tandem mass spectrometry. These 
situations are not always predictable based on the information of the peptide sequence. 
Therefore, the selection of the 'signature peptide' must be supported by prior 
characterization of the protein by similar techniques as those used during the 
quantification method. Evidently, the support of the sequence information given by the 
protein databases facilitates the selection process. 
The 'signature peptide' approach described herein is a rapid and facile technique 
that could be considered an alternative to the existing immunoassays, such as ELISA and 
RIA. Figure 5.2 shows, in summary, the steps required for the development of a classical 
immunoassay versus the development of the 'signature peptide' approach. 
The 'signature peptide' approach circumvents the intensive work required for the 
development and production of specific polyclonal and monoclonal antibodies. Moreover, 
it takes advantage of a laboratory synthesized high quality homogeneous standard 
peptide, and overcomes the difficulty of purifying this complex phosphoglycolipoprotein 
from fish blood. A detailed comparison of samples analyzed by the 'signature peptide' 
approach and a commercial kit available for quantification ofRT Vtg is given in the next 
section. 
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Additionally, there has been a declining trend in the use of RIA due to 
radioactivity hazards, higher regulatory costs and significant disposal problems caused by 
radiochemicals. 
Classical 
Immunoassay 
approach 
I Protein purification I 
Immunization 
step 
Preparation of 
monoclonal or 
polyclonal 
antibodies 
Validation of 
Immunoassay 
Signature 
peptide approach 
I Peptide sequencing J 
Selection and 
synthesis of 
'signature peptide' 
Development of 
HPLC-MS/MS 
method 
Validation of 
HPLC-MS/MS 
technique 
Figure 5.2 Comparison of the 'signature peptide' approach to classical 
immunoassay method development 
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In contrast to antibody affinity in immunoassays, the specificity of this technique 
relies on the distinctiveness of the 'signature peptide' and the power of tandem mass 
spectrometry to detect its diagnostic product ions. This is definitely one of the strong 
points of this procedure since this method will probably be less susceptible to the false 
positive results sometimes encountered in immunological assays. This hypothesis will 
eventually be tested when large-scale analyses of Vtg are performed and compared to 
results from both techniques. 
As described in the discussion here, the trade off in this technique is the 
sensitivity, which is acceptable as long as the analytical LOQ is not significantly 
compromised. The LOQ for the 'signature peptide' method is in the order of ng/mL. 
However, when expressed in protein concentration, there was a loss in sensitivity by an 
approximate factor of 150 due to the molecular mass difference between the 'signature 
peptide' and the native protein. This yields a LOQ (0.009 mg/mL) for Vtg plasma levels 
that is well below those of the physiological levels found in mature female fish, which 
accoring to a study varies between 0.01 to 0.20 mg/mL (Copeland et al., 1986). Thus, for 
this particular study, the LOQ did not require any improvement. However, when used as a 
biomarker for ecotoxicolgical purposes, this limit might not be low enougth as those 
reported by some immunological tests, in the order of ng/mL of Vtg. It is important to 
point out that the method described in this work uses only 5 )lL of plasma for the 
digestion step. Nevertheless, taking into account all the dilution factors, only 20 nL of the 
original plasma are finally injected for HPLC separation. Furthermore, considering the 
nebulization and ionization efficiency of the ESI source, the actual amount of plasma 
entering the mass spectrometer possibly lies in the order of the picoliters. 
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If required, the limit of detection and sensitivity of this method could be improved 
in several ways. However, it should be noted that any change to the analytical method 
would compromise its performance or advantages in some way. These modifications can 
be introduced at the level of sample processing or further on, during instrumental 
analyses. Table 5.1 lists a summary of these modifications, together with a brief 
explanation on the consequences of these changes. The combination of some of these 
changes might result in an increase in sensitivity of several orders of magnitude. All these 
issues were considered when optimizing the technique, although they can obviously be 
changed according to the particular objectives and requirements for different types of 
experiments. When adapting this technique, it is important that the enzymatic digestion 
step should be optimized to yield the highest amount of signature peptide, by both 
adjusting the concentration of enzyme added and the digestion incubation time. 
Another benefit of the described technique is the low volume (5J.tL) of plasma 
required for analysis. Although blood extraction is definitely an invasive but non-
destructive procedure for biomarker analysis (Casin et a/., 2002), the small volume used 
allows the fish to be returned to their habitat with minimal stress impact. 
The technique described uses extreme protein denaturing conditions and thorough 
enzymatic digestion prior to HPLC-QqToF-MS/MS analysis and therefore, partial protein 
hydrolysis is less likely to affect this method. In addition, as described earlier, because 
non-reactive hydrophobic amino acids are predominant, the probability of peptide 
modification within the 'signature peptide' region is minimized. As shown in the stability 
studies discussed earlier in section 4.6, sample handling and storage should become a less 
serious issue when compared to other techniques when this stage is critical. 
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Table 5.1 Modifications that could increase sensitivity and limit of detection of the 
'signature peptide' approach. 
Modification 
Increasing volume of 
plasma 
Reducing dilution factors 
post digestion 
Increasing injection 
volumes into HPLC-MS/MS 
Reducing chromatographic 
flow rate 
Aligning tip ofESI capillary 
to skimmer of MS 
Monitoring a product ion 
with stronger signal at lower 
m/z. 
Level 
Sample 
processmg 
Sample 
processmg 
Intrumental: 
HPLC 
Intrumental: 
HPLC 
Intrumental: 
MS/MS 
Intrumental: 
MS/MS 
Consequences 
Higher quantities of trypsin needed for 
digestion. 
Need for larger HPLC column 
Increased analysis cost 
Dirtier samples injected into HPLC-
MS/MS 
Reduced lifetime of HPLC column 
Higher maintenance of MS interface 
Increased analysis cost 
Need for larger HPLC column 
Increased 'carryover' signal 
More cleaning steps required 
Increased analysis time 
Increased analyses cost 
Increased time of analysis 
Higher maintenance of MS interface 
Increased analysis cost 
Reduced specificity 
Finally, a good point to mention is the issue as to what units should be used for 
quantification of Vtg. Usually all reported work in the literature expresses Vtg plasma 
levels in mass per volume units ( eg mg/mL ). This brings up an inherent problem if the 
concentrations are to be converted to molarity, because the molecular mass of Vtg can 
vary according to the degree of post translational modifications and its lipid content. The 
approach described herein for this particular 'signature peptide' lacks this inconvenience 
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since the molar ratio of this peptide to Vtg is known. For this reason, in future studies 
measuring Vtg with a similar approach, the concentration results expressed as moles (or 
fractions) per volume as presented here ( eg ~M), is recommended. This would 
standardize results and make it extremely convenient for comparing results from different 
species that have Vtg molecules of different molecular masses. 
5.3 ELISA vs. the 'signature peptide' approach: Which is better? 
As described earlier, the 'signature peptide' approach described in this work is an 
alternative to developing immunoassays, such as ELISA. However, several commercial 
kits are already available for measuring Vtg levels for many species. Such is the case for 
RT Vtg. In order to compare the performance of both methods, the same samples 
analyzed by HPLC-MS/MS were also tested by an ELISA developed for RT Vtg (See 
Appendix 3 for procedure details). The results are given and compared in Table 5.2. 
A graphic representation of these results is given in Figure 5.3, in which all the 
results from the 'signature peptide' approach are plotted against the ELISA results. A 
thorough examination of this table and figure reveals some interesting observations. With 
respect toRT Vtg, all values below the LOQ of the 'signature peptide' approach (0.009 
mg/mL) were also below this value for the ELISA. Most of these samples corresponded 
to the fish prior to 17~-estradiol induction. This situation is portrayed in the top graph of 
Figure 5.3 as overlapping experimental at the intersection of both axes. 
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Table 5.2 Comparison ofVtg concentrations obtained from 
ELISA and HPLC-MS/MS using the signature peptide approach 
The results for the 'signature peptide' approach taken from Table 4.2. The results for both control (C) and 
experimental (E) rainbow trout (RT) and Atlantic salmon (AS) are expressed as Vtg concentrations in 
mg/mL units. 
Vtg concentrations (mg/mL) 
Before ~-estradiol After ~-estradiol 
Sample Type HPLC-MS/MS ELISA HPLC-MS/MS ELISA 
RT c <LOQ 0.001 5.329 2.849 
RT c 2.276 2.188 4.718 13.014 
RT E <LOQ 0.000 31.973 17.605 
RT E <LOQ 0.020 44.352 17.760 
RT E 3.775 9.155 31.196 17.643 
RT E <LOQ 0.001 25.312 17.919 
RT E <LOQ 0.002 34.138 18.498 
RT E 1.610 0.602 42.798 17.685 
RT E <LOQ 0.008 10.935 16.914 
RT E <LOQ 0.000 20.428 18.000 
RT E <LOQ 0.000 10.269 12.333 
RT E <LOQ 0.001 31.307 17.248 
RT E 1.388 0.595 41.854 17.949 
AS c 0.444 0.000 2.998 0.000 
AS c 16.098 0.151 11.601 0.000 
AS c <LOQ 0.000 3.497 0.000 
AS c <LOQ 0.000 5.717 0.000 
AS E <LOQ 0.000 34.860 0.425 
AS E 12.379 0.063 53.789 0.717 
AS E <LOQ 0.000 24.369 0.386 
AS E <LOQ 0.000 36.248 0.304 
AS E 0.444 0.000 29.975 0.248 
AS E <LOQ 0.000 N/A NIA 
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Elisa vs 'Signature peptide': Rainbow trout Vtg 
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Figure 5.3 Comparative plots for samples analyzed by the 'signature 
peptide' approach and ELISA 
The top and bottom graph correspond to the rainbow trout and Atlantic salmon samples, respectively. 
In both plots, the results obtained by the 'signature peptide' approach are plotted in the ordinate (SP) 
and the ELISA results in the abscissa. 
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A good correlation was observed for the experimental points below 15mg/mL for 
RT Vtg. Beyond this point, the results from the ELISA kit seem to plateau, unable to 
detect higher concentrations. This situation is due to the high absorbance values obtained 
for these samples by the microplate reader, almost at the limits of that obtained for the 
highest concentration standard. It should be noted that this unusual response in the ELISA 
method could be corrected by preparing additional dilutions of the plasma samples. This 
is a common situation encountered in ELISA where, usually, serial dilutions of the 
sample have to be prepared to insure the samples will fall within the valid response range 
ofthe standard curve. 
Another advantage of the 'signature peptide' approach lies in the fact that serial 
dilutions do not seem to be necessary since the analytical response of the HPLC-MS/MS 
is linear from the LOQ to the high end mg/mL levels. Nevertheless, the comparison of the 
results obtained for the same samples analyzed by both methods shows them to be within 
the order of magnitude. In spite of the differences observed for each individual sample, 
these results obtained are encouraging, considering that, under physiological conditions, 
the concentrations of plasma Vtg can vary by several orders of magnitude, ranging from 
ng/mL to the mg/mL levels (Copeland et al., 1986; Wallaert and Babin, 1994; Bonet al., 
1997). However, large scale field studies should be carried out to validate this technique. 
These would provide sufficient data to perform statistical analyses in order to compare 
the commercial ELISA kits with the technique presented in this thesis. 
Another interesting issue is raised when analyzing the data obtained for the AS 
plasma samples. Although the ELISA kit is intended for use in RT samples, the antibody 
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used for Vtg recognition exhibits some cross reactivity to AS Vtg. This situation is 
evident in the bottom graph of Figure 5.3. However, the concentration values differ by 
one order of magnitude. To correct this difference, this ELISA kit should have been 
calibrated using AS Vtg as a Standard. This would have considerably affected the 
sensitivity of the ELISA kit since, clearly, the affinity of the antibody used is much lower 
for AS Vtg. 
Once more, similar results were obtained from both methods when analyzing most 
of the AS samples prior to, and after 17~-estradiol induction, as shown by the overlapping 
data at the intersection of both axes (Bottom graph of Figure 5.3). However, the ELISA 
method was unable to detect some low Vtg levels found in some of the lowest 
concentrations. Above 1 Omg/mL measured by the signature peptide approach, a 
reasonable linear relationship was found between the methods. 
Is one method better than the other? Unfortunately, the word 'better' is too broad 
to obtain a generalized answer. Both methods have advantages and disadvantages. 
Probably, the specific conditions required for a particular objective will determine 
whether one method should be chosen over the other. 
5.4 Atlantic cod vitellogenin sequence: Similarities to haddock and its 
implications 
As a result of the experiments performed on AC Vtg, the sequences of some 
diagnostic tryptic peptides have been elucidated. The database search has shown that AC 
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Vtg shares a series of common peptides with the two different known Vtg sequences of 
haddock, a closely related species. These findings suggest that Atlantic cod might also co-
express at least two distinct forms of Vtg (Cohen et al., 2005). This is further supported 
by the finding of the tryptic peptide ions at mlz 1458.74 and 1465.82. These two 
overlapping variant peptides belonging to haddock Vtg B (FFGQEIGF ASIDK) and Vtg 
A (FLGQEIAF ANLDK) have been simultaneously extracted from the trypsin digestion 
ofthe Atlantic cod Vtg band in the SDS-PAGE. 
For quantification of AC Vtg, a similar HPLC-MS/MS approach can be adopted 
as described earlier for AS and RT Vtg. Unfortunately, none of the peptides sequenced in 
this work by MS/MS for AS and RT matched those of AC Vtg. Sequence alignment of 
RT and haddock Vtg have shown that a few common tryptic peptides are present in both 
species. However, as described previously, this observation is not sufficient to propose a 
peptide as a candidate 'signature peptide'. Furthermore, its presence in haddock does not 
imply its presence in AC Vtg. 
Nonetheless, the use of a common peptide found in both AC and haddock Vtg 
could be used with the same advantages as described for AS and RT Vtg. The fact that 
these species appear to express two distinct forms of Vtg would further exploit the 
advantages of the 'signature peptide' approach. The selection of a peptide which is 
present in both forms would allow quantification of total Vtg in a single assay. For 
example, the tryptic peptide DLGLA YTEK, sequence by MS/MS in AC Vtg was also 
found in haddock Vtg. Also, since this peptide is present in both forms of haddock Vtg, it 
may be a perfect candidate for total Vtg quantification. Alternatively, tryptic peptides like 
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YESF A V AR or VHVDALLAMR could be used to distinctively quantify one of the Vtg 
forms. 
In this sense, the 'signature peptide' approach would offer a great advantage over 
immunoassays. Because purification and isolation of these two forms of Vtg would be 
extremely difficult, production of antibodies from the immunization protocols would be 
greatly impaired. Moreover, even if these two forms of Vtg were able to be individually 
purified, developing epitope specific antibodies distinct to each would be more than a 
challenge. 
5.5 Application of the 'signature peptide' approach to future studies 
As a result of the work described in this thesis, a new horizon has emerged for 
different research projects in which measurements of Vtg are involved. It is now possible 
to develop in a relatively short period of time, a simple, specific and accurate technique 
for quantification of plasma Vtg. Currently, at the Northwest Atlantic Fisheries Center in 
Newfoundland, Canada, several projects are taking place, in which measurement of Vtg 
plays an important role. 
A research group led by Dr. Atef Mansour is currently studying the causes of 
gastric dilation and air sacculitis in RT. This disease is of great concern in aquaculture, 
since it diminishes the commercial value of the cultured fish. Environmental parameters 
such as temperature and salinity are suspected to be possible causes of this disease. Early 
maturation has also been proposed for affecting the onset of this sickness. Plasma Vtg 
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levels will be used in this work, together with other histological techniques to determine 
the stage of sexual maturation in these fish. If early maturation proves to be a cause of 
this disease, aquaculture might make use of this information to determine the most 
convenient time for animal slaughter in order to optimize the commercial return from the 
caged stocks. 
Another project led by Dr. Mansour is studying the effect of the photoperiod on 
the maturation of Atlantic cod. Once more, aquaculture is particularly interested in this 
issue, since sexual maturation stops the growth of fish muscular tissue. Thus, the 
commercial value of the fish, which is mostly dependant on the size of the fillets, is 
affected. There is evidence suggesting that increasing the hours of light in the light-
darkness cycle would slow down the process of sexual maturation. This is done 
practically by illuminating the fish with an artificial source of light during the night hours. 
Again, in this study, a quantitative method for measuring Atlantic cod Vtg will be 
developed using the same approach as described in this thesis. The sexual maturation of 
the fish under this controlled photoperiod experiment can then be assessed by the Vtg 
levels in plasma. 
Finally, a research proposal supervised by Dr. Joseph Banoub and Dr. Joanne 
Morgan has recently been approved and funded to investigate the causes of the decrease 
of the stocks of Greenland halibut (Reinhardtius hippoglossoides), also known as 
Greenland turbot, a species which has been declared endangered. An alteration in the 
spawning cycle of this species, probably due to an increase in the average temperature of 
waters in this region, is believed to be one of the causes for this situation. Once more, 
plasma Vtg levels will be used to assess the reproductive status of this species. A similar 
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approach as described in this thesis will be taken to develop a quantitative technique for 
Greenland halibut Vtg. This project is even more challenging, since the Vtg sequence for 
this particular species is completely unknown. 
Finally, I am completely aware, that in the not too distant future (and probably 
even sooner than I imagine), even most of the sophisticated and advanced techniques used 
in this work will also be considered a relic. Nevertheless, the ideas expressed in this thesis 
should build a bridge between the traditional techniques employed for protein 
quantification and the virtues offered by the power of chromatography coupled to tandem 
mass spectrometry. 
5.6 Summary and recommendations 
In this thesis, proteolytic peptides of RT, AS and AC Vtg have been characterized 
and sequenced using ESI and MALDI MS and MS/MS. A new method for quantification 
of AS and RT Vtg has been proposed and developed using HPLC coupled to ESI-MS/MS 
availing of a characteristic 'signature peptide' common to both species. This approach 
could be considered as an alternative to developing immunoassays, especially in cases 
when no commercial kits are available for a particular protein. The specificity attained by 
this technique was the most remarkable feature, although the LOD levels, in the order of 
f.!g/mL, were not as low as expected. A critical step for this procedure is the enzymatic 
digestion, and precaution should be taken when adapting this technique to other 
conditions. 
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Appendix 1. Single and three letter codes for the protein amino acids 
Alanine A Ala 
Cysteine c Cys 
Aspartic Acid D Asp 
Glutamic Acid E Glu 
Pheny I alanine F Phe 
Glycine G Gly 
Histidine H His 
Isoleucine I lie 
Lysine K Lys 
Leucine L Leu 
Methionine M Met 
Asparagine N Asn 
Proline p Pro 
Glutamine Q Gln 
Arginine R Arg 
Serine s Ser 
Threonine T Thr 
Valine v Val 
Tryptophan w Trp 
Tyrosine y Tyr 
216 
Appendix 2. Amino acid sequences of rainbow trout and Atlantic salmon 
vitellogenin 
Rainbow trout vitellogenin sequence: ENTRY Q92093 
10 20 30 40 50 60 
MRAVVLALTL ALVASQSVNF APDFAASKTY VYKYEALLLG GLPEEGLARA GVKVISKVLI 
70 80 90 100 110 120 
SAVAENTYLL KLVNPEIFEY SGVWPKDPFV PAAKLTSALA AQFSIPIKFE YAKGVVGKVL 
130 140 150 160 170 180 
APTAVSETVL NVHRGILNIL QLNIKKTQNV YELQEAGAQG VCKTHYVIRE DAKAERIHLT 
190 200 210 220 230 240 
KSKDLNNCQQ RIMKDFGLAY TEKCVECRQR GEALMGAATY NYLMKPADNG ALILEATVTE 
250 260 270 280 290 300 
LHQFTPFNEM SGAAQMEAKQ MLTFVEIKKD PIIVPDNNYV HRGSIRYEFA TEILQMPIQL 
310 320 330 340 350 360 
LKISNARAQA VKILNHLVTY NTAPVHEDAP LKFLQFIQLL RMASSETINA IWAEFKAKPA 
370 380 390 400 410 420 
YRHWILDAVP SIGSSVAVRF IKEKFLAGDI TIFEAAQALV AAVHMVAADL ETVKLVESLA 
430 440 450 460 470 480 
FNHKIQTHPV LRELTMLGYG TMVSKYCVEH PNCPAELVKP IHELAVQAVA NSKFEELSMV 
4 90 500 510 520 530 540 
LKALGNAGHP ASIKPITKLL PVFGTAAAAL PLRVQADAVL ALRNIAKREP RMVQEVAVQL 
550 560 570 580 590 600 
FMDKALHPEL RMLACIVLFE TKPPMGLVIT LASILKTEKN MQVASFTYSH MMSLTRSTAP 
610 620 630 640 650 660 
DFASVAAACN VAVKMLSNKF RRLSCHFSQA IHLDAYSNPL RIGAAASAFY INDAATLFPR 
670 680 690 700 710 720 
TVVAKARTYF AGAAADVLEV GVRTEGIQEA LLKLPPAPEN ADRITKMRRV IKALSDWRSL 
730 740 750 760 770 780 
ATSKPLASIY VKFFGQEIAF ANIDKSIIDQ ALQLANSPSA HALGRNALKA LLAGATFQYV 
790 800 810 820 830 840 
KPLLAAEVRR IFPTAVGLPM ELSYYTAAVA KAYVNVRATL TPALPETFHA AQLLKTNIEL 
850 860 870 880 890 900 
HAEVRPSIVM HTFAVMGVNT AFIQAAIMAR AKVRTIVPAK FAAQLDIANG NFKFEAFPVS 
910 920 930 940 950 960 
PPEHIAAAHI ETFAVARNVE DVPAERITPL IPAQGVARST QQSRDKLTSM IADSAASFAG 
970 980 990 1000 1010 1020 
SLSRSSEILY SDLPSNFKPI IKAIVVHLEE TICVERLGVK ACFEFTSESA AFIRNTLFYN 
1030 1040 1050 1060 1070 1080 
MIGKHSVLIS VKPSASEPAI ERLEFEVQVG PKAAEKIIKV ITMNEEEEAP EGKTVLLKLK 
1090 1100 1110 1120 1130 1140 
KILLPDLKNG TRASSSSSSS SSSSSRSSSS RSRSRKSESS SSSSSSSSRI SKRDGPDQPY 
1150 1160 1170 1180 1190 1200 
NPNDRKFKKN HKDSQSTSNV ISRSKSSASS FHAIYKQDKF LGNKLAPMVI ILFRLVRADH 
1210 1220 1230 1240 1250 1260 
KIEGYQVTAY LNKATSRLQI IMAALDENDN WKLCADGVLL SKHKVTAKIA WGAECKDYNT 
1270 1280 1290 1300 1310 1320 
FITAETGLVG PSPAVRLRLS WDKLPKVPKA VWRYVRIVSE FIPGYIPYYL ADLVPMQKDK 
1330 1340 1350 1360 1370 1380 
NNEKQIQFTV VATSERTLDV ILKTPKMTLY KLGVNLPCSL PFESMTDLSP FDDNIVNKIH 
1390 1400 1410 1420 1430 1440 
YLFSEVNAVK CSMVRDTLTT FNNKKYKINM PLSCYQVLAQ DCTTELKFMV LLKKDHASEQ 
1450 1460 1470 1480 1490 1500 
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NHINVKISDI DVDLYTEDHG VIVKVNEMEI SNDNLPYKDP SGSIKIDRKG KGVSLYAPSH 
1510 1520 1530 1540 1550 1560 
GLQEVYFDKY SWKIKVVDWM KGQTCGLCGK ADGENRQEYR TPSGRLTKSS VSFAHSWVLP 
1570 1580 1590 1600 1610 1620 
SDSCRDASEC LMKLESVKLE KQVIVDDRES KCYSVEPVLR CLPGCLPVRT TPITIGFHCL 
1630 1640 1650 
PVDSNLNRSE GLSSIYEKSV DLMEKAEAHV ACRCSEQCM 
Atlantic salmon vitellogenin sequence: ENTRY Q800N9 
10 20 30 40 50 60 
MKAVVFALTL ALVASQHVNF APEFEASKTY VYKYEALLLG GLPEEGLSRA GIKVISKVLI 
70 80 90 100 110 120 
SAIAPTIYML KLVDPEIFEY SGVWPKDPFV PASKLTSALA AQLLTPIKFE YANGVVGKVF 
130 140 150 160 170 180 
APTGVSETVL NIHRGILNIL QLTFKKTQNV YEMQEAGAQG VCKTHYVISE DAKTGYIHLT 
190 200 210 220 230 240 
KTKDLNHCQE RIIKEFGLAY TENCVECQQK GKNLRGAAAY NYIMKPTATG AIIMEATVTE 
250 260 270 
LHQFSPFNEM NGAAQMEAKQ TFAFVEIKKT 
Atlantic salmon vitellogenin sequence: ENTRY Q8UWG2 
10 20 30 40 50 60 
KIKQKGEGVS LYAPSHGLQE VYFDKNSWKI RVVDWMKGQT CGLCGKADGE VRQEYSTPSG 
70 80 90 100 110 120 
RLTKSSVSFA HSWVLPSDSC RDASECLMTF ESVKLEKQVI VDDKESKCYS VEPVLRCLPG 
130 140 150 160 170 
CLPVRTTPIT IGFHCLPVDS NLSRSEGLSS FYEKSVDLRE KAEAHVACRC SQQCI 
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Appendix 3: ELISA test for rainbow trout and Atlantic salmon vitellogenin 
Rainbow trout and Atlantic salmon plasma samples were analyzed by an ELISA 
kit for RT Vtg (Biosense Laboratories, Bergen, Norway), according to its instruction 
manual. Although this kit is specific for RT Vtg, the suppliers of this kit claim it can be 
used for AS Vtg, using a correction factor of 20. Briefly, all plasma samples were diluted 
1:100, 1:3000 and 1 :90000 according to their concentration estimated in the HPLC-
QqTof-MS/MS experiments. Simultaneously, a calibration curve was prepared by 
dilution of the RT Vtg stock solution to produce concentrations ranging from 200 to 
0.39ng/mL. All dilutions were kept on ice until use. 
One hundred J..LL of standards and diluted samples were loaded in duplicate to the 
ELISA plate and incubated at 4°C overnight. Subsequently, the ELISA plate was washed 
three times with 300J..LL of the provided washing buffer per well. Next, all wells were 
incubated at room temperature with the detecting antibody for 1 hour on an orbital shaker. 
After 5 washing steps with 300J..LL of washing buffer per well, 100J..LL of the Ellman's 
reagent substrate solution were added to each well. The plate was placed on the orbital 
shaker in the dark for one hour. Finally, the plate was placed in a microplate reader 
(Synergy HT, Bio-tek Instruments. Winooski VT, USA), and the absorbance of each well 
was read at 405 nm. A 4-parameter transformation of the data was used for regression 
analysis of the standard curve, and for extrapolating the concentration of the unknown 
samples. The latter were then corrected by the corresponding dilution factors. 
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